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Résumé 
La voie de signalisation Notch joue un rôle central dans la régulation de processus 
fondamentaux tels que la maintenance des cellules souches, la prolifération ou encore la 
différentiation. Récemment, nous avons enquêté sur les gènes potentiellement régulés par 
Notch1 durant la différentiation de l’épiderme. Pour cela, nous avons fait une analyse de puce 
à ADN de 14'000 gènes de la souris lors de gain et de perte de fonction de Notch1 dans des 
keratinocytes primaires murins. Treize gènes furent ensuite choisis selon leurs niveaux 
d’expression et l’importance de leur voie de signalisation pour une validation par PCR en 
temps réel. Parmi ceux-ci, nous nous sommes concentrés sur une Rho GTPase nommée RhoV 
qui démontrait une différence de régulation consistante dans les deux conditions. Nous avons 
donc généré des souris transgéniques exprimant une forme dominante active ou négative de 
RhoV spécifiquement dans la peau. 
Les analyses morphologiques et histologiques n’ont pas révélé de phénotype apparent 
chez les souris transgéniques. De plus, des expériences sur la cicatrisation démontrèrent une 
guérison des plaies normale chez les souris transgéniques et aucun dysfonctionnement de la 
migration et/ou de la différentiation des keratinocytes. Ainsi nos résultats suggèrent que ni le 
gain ni la perte de RhoV ne perturbe le développement et l’homéostasie de la peau, et 
n’affecte pas non plus le processus de cicatrisation. 
En outre, nous avons généré un modèle de souris à invalidation conditionnelle du gène 
Jagged2 ainsi qu’une souris transgénique reporter spécifique pour Notch2. La souris 
« floxée » Jagged2 permettrait la délétion du ligand pour étudier son rôle dans un contexte de 
perte de fonction.  
La souris reporter Notch2-spécifique est un outil permettant l’analyse in vivo de cellules 
ayant reçu un signal par activation du récepteur Notch2. La stratégie utilise des éléments du 
système Tet-Off et permet l’identification de cellules recevant un signal spécifiquement par 
Notch2 dans un tissu choisi et à n’importe quel moment. 
Mots-clés Voie de signalisation Notch, peau, Rho GTPase, souris transgéniques, 
système Tet-Off  
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 Abstract 
The evolutionarily conserved Notch signaling cascade plays a pivotal role in the 
regulation of many fundamental processes such as stem cell maintenance, proliferation, and 
differentiation. Recently, we aimed to identify downstream target genes regulated by Notch1 
during epidermal differentiation. For this purpose an Affymetrix mouse gene chip array of 
14.000 genes was performed in both Notch1 gain and loss of function experiments using 
murine primary keratinocytes. Thirteen genes positively or negatively regulated, based on 
expression levels and relevance of the involved signaling pathways, were further validated by 
real-time PCR. Among these, we decided to focus on the Rho GTPase RhoV because it 
showed robust up- and down-regulation under both gain- and loss-of-function conditions. 
Therefore, we generated different transgenic mice expressing either a dominant active or a 
dominant negative form of RhoV specifically in the skin.  
Morphological and histological analyses did not reveal any overt skin phenotype in 
transgenic mice. In addition, challenging the system by performing wound healing assays 
demonstrated that the healing process in transgenic mice occurred normally and that the 
migration and/or differentiation of keratinocytes was unimpaired. Taken together, our data 
suggest that gain or loss of RhoV function does not perturb skin development and 
homeostasis, and does not affect the wound healing process. 
In addition to the investigation of the potential Notch target gene RhoV, we sought to 
generate both a floxed Jag2 gene targeted mouse line and a Notch2-specifc reporter mouse. 
The former was intended to enable conditional deletion of the Notch ligand Jagged2 and 
therefore allow its role to be studied in a loss-of-function context. 
The Notch2 reporter mouse is a tool enabling the in vivo study of cells that receive a 
Notch2-mediated signal. The strategy employs elements of a Tet-Off system and allows cells 
receiving a Notch2 specific signal to be identified in any tissue at any given time point. 
Keywords Notch signaling, skin, Rho GTPase, transgenic mice, Tet-Off system 
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Introduction 
 
1. The Notch signaling pathway 
Thomas Hunt Morgan (1866-1945), an American geneticist and embryologist, was 
awarded the Nobel Prize in Physiology or Medicine in 1933 for his work on genetics using 
Drosophila melanogaster as a model system. In 1917 he described a strain of fruit flies with 
notches at the margin of their wing blades (Morgan, 1917). The gene causing this haplo-
insufficiency phenotype - that was named Notch - was cloned in the mid-1980s and found to 
be a single-pass transmembrane receptor consisting of a ligand-binding extracellular domain 
and a signal transduction cytoplasmic domain (Kidd et al., 1986; Wharton et al., 1985). The 
family of Notch receptors is evolutionarily conserved through worms to humans (Greenwald, 
1998).  
1.1 Structure of Notch receptors and ligands 
In mammals there are four Notch receptors (Notch1-4) (del Amo et al., 1993; Lardelli et 
al., 1994; Uyttendaele et al., 1996; Weinmaster et al., 1992) and five ligands (Jagged1-2 and 
Delta-like1, 3 and 4) (Bettenhausen et al., 1995; Dunwoodie et al., 1997; Lindsell et al., 1995; 
Nye and Kopan, 1995; Shawber et al., 1996; Shutter et al., 2000). The Notch receptors are 
expressed as heterodimers at the cell surface and initiate signaling by interaction with their 
DSL (Delta/Serrate/LAG2) ligands expressed by neighboring cells. The Notch receptors and 
their ligands contain several protein domains important for interaction and modulation of the 
signaling which are depicted in Fig.1. 
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 Heterodimeric Notch receptors are first synthesized as single precursor proteins and 
then cleaved in the Golgi by a Furin-like convertase during their transport to the cell surface 
(Blaumueller et al., 1997; Logeat et al., 1998). During cell-cell contact, the Notch pathway 
activation involves direct binding of the N-terminal ligand domain of one of the membrane-
anchored ligands to the epidermal growth factor (EGF)-like repeat region of the Notch 
receptor. Modulation of the responsiveness of the receptor to different DSL ligands is possible 
by N- and O-linked glycosylation, e.g. by Fringe glycosyltransferases (Moloney et al., 2000). 
Notch receptors modified by Fringe glycosyltransferases cannot mediate signaling via the 
Jagged ligands, whereas their affinity for Delta is increased (Bruckner et al., 2000; Hicks et 
al., 2000; Moloney et al., 2000).  
Figure 1. Structure of Notch receptors and their ligands. Drosophila flies contain one Notch receptor 
(dNotch) that is bound by two transmembrane DSL-ligands (Delta and Serrate). Mammalians possess four 
Notch receptors (Notch1–4) and five ligands (Jagged1 and 2, which are homologous to Serrate, and Delta-
like (Dll) 1, 3 and 4, which are homologous to Delta). Notch receptors are expressed on the cell surface as 
heterodimeric proteins. Their extracellular portion contains 29–36 epidermal growth factor (EGF)-like 
repeats that are associated with ligand binding, followed by three cysteine-rich LIN repeats that prevent 
ligand-independent signalling, and a heterodimerization domain. The intracellular portion of the receptor 
harbours two protein interaction domains, the RAM domain (R) and six ankyrin repeats (ANK), two nuclear 
localizations signals (NLS) and a transactivation domain (TAD, which has not yet been defined for Notch3 
and 4), and a PEST (P) sequence. Notch ligands are also expressed as membrane-bound proteins. They all 
contain an amino-terminal DSL domain (Delta, Serrate and Lag2) followed by EGF-like repeats. Ligands of 
the Serrate family also harbour a cysteine-rich (CR) domain downstream of the EGF-like repeats. PM, 
plasma membrane. (Radtke et al., 2005) 
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1.2 Canonical Notch signaling 
Upon Notch-ligand interaction, a proteolytic cleavage site in the extracellular portion of 
the Notch C-terminal is exposed. The subsequent cleavage by the metalloprotease 
ADAM10/TACE (tumor necrosis factor -converting enzyme) releases the extracellular 
Notch subunit which is endocytosed by the ligand-expressing cell (Mumm et al., 2000). The 
next proteolytic cleavage in the transmembrane domain is mediated by the multisubunit intra-
membrane aspartyl protease -secretase complex and releases the Notch intracellular domain 
(NIC or NICD). This proteolytic complex includes presenilin and nicastrin proteins, which are 
also involved in the cleavage of amyloid precursor proteins (dysfunctional in Alzheimer's 
disease) (Li et al., 2003; Wong et al., 1997). 
In the absence of NIC, Notch target genes are maintained in an actively repressed state 
through transcriptional complexes involving the transcription factor CSL 
(CBF1/Su(H)/LAG1, also known as RBP-J in mice) and several co-repressors such as 
histone deacetylase (Oswald et al., 2005). Once NIC translocates to the nucleus it binds to 
CSL via its RAM (regulation of amino-acid metabolism) domain and ankyrin repeats. 
Subsequent displacement of the co-repressors allows formation of a ternary transcriptionally 
active complex of NIC, CSL and Mastermind-like (MAML), which in turn recruits other co-
activators (Wu et al., 2000). Expression of Notch target genes occurs through transactivation 
once the transcription complex is bound to CSL-binding sites found within the promoter of 
genes, such as the Hairy/Enhancer of Split (Hes) transcriptional repressors (Jarriault et al., 
1998). Figure 2 summarizes the various steps involved in Notch signaling. 
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Finally, the proteolysis generating NIC is irreversible, and hence the turnover of the 
signaling molecule must be tightly controlled by ubiquitination and proteosomal degradation. 
One protein involved in controlling the amount of NIC in the cell is the E3 ubiquitin ligase 
Fbw7/Sel-10. Fbw7 acts by targeting NIC for degradation after phosphorylation on its C-
terminal PEST domain by cyclin-dependent kinase 8 (Gupta-Rossi et al., 2001; Oberg et al., 
2001; Wu et al., 2001). 
1.3 Non-canonical Notch signaling 
Another E3 ubiquitin ligase identified as Deltex in Drosophila suggests an alternative 
Notch signaling route found to be independent of CSL (or RBP-J)-transcription complex 
Figure 2. Notch signaling pathway. Fringe glycosyltransferases modify EGF-like repeats by adding N-
acetylglucosamine within the Golgi. Notch signaling is initiated after ligand-receptor interaction, which 
induces two sequential proteolytic cleavages. The first cleavage within the extracellular domain is mediated 
by the metalloprotease TACE. The cleaved extracellular subunit of the receptor is 'trans-endocytosed' by the 
neighboring ligand-expressing cell. This process seems to be controlled by Neuralized and/or Mindbomb E3 
ubiquitin ligases. The second cleavage occurs within the transmembrane domain and is mediated by the -
secretase activity of the multi-protein complex of presenilins (PS), which includes Nicastrin, APH-1 and 
PEN-2. The liberated intracellular domain of Notch (NICD) translocates into the nucleus and binds to the 
transcription factor CSL (CBF1 in humans, Suppressor of Hairless in Drosophila and LAG in C. elegans). 
This interaction leads to transcriptional activation by displacement of co-repressors (CoR) and simultaneous 
recruitment of co-activators (CoA), including mastermind-like proteins (MAML1). (Radtke et al., 2005) 
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formation (Hori et al., 2005). Deltex-mediated positive regulation of Notch signaling does not 
require ligand interaction.  Hence, this mechanism reflects a cell-intrinsic signal that evidently 
is not initiated by neighboring cell contact. This pathway might be utilized by some cells to 
maintain a basal level of Notch activation that dampens signaling noise or potentiates 
signaling induced by a ligand. However, gene targeting of two mammalian homologues 
Deltex-1 and -2 in murine T cell progenitors did not impair thymocyte development, even 
though Notch signaling was more potent in the double-deficient cells (Lehar and Bevan, 
2006). 
In vitro experiments conducted in cell lines identified another non-canonical signaling 
through cytosolic NIC. Notch inhibited neglect apoptosis, i.e. due to withdrawal of nutritional 
cues, by activation of the kinase Akt through mammalian target of rapamycin complex 2 
(mTORC2) (Perumalsamy et al., 2009). Thus, this study revealed the integration of non-
canonical Notch signaling with a new pathway, which ultimately promotes cell survival. 
1.4 Functions of Notch signaling 
Notch signaling plays many important roles during embryonic and post-natal 
development, such as in proliferation, cell-fate decisions and apoptosis (Fig.3) (reviewed in 
Artavanis-Tsakonas et al., 1999). 
 
 
Figure 3. Multiple functions of Notch signaling. Depending on the cell context, Notch maintains stem 
and/or transit-amplifying (TA) cells in an undifferentiated state (e.g. intestine), specifies one cell lineage at 
the expense of another (e.g. T vs. B cell lineage) and promotes terminal differentiation of TA cells (e.g. 
skin). Notch also induces proliferation (e.g. skin) while playing an anti-apoptotic role (e.g. double-negative 
T cells). 
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The influence of Notch signaling on the proliferation of cells was shown in Drosophila 
by expression of NIC in precursor cells of the imaginal disc. Activated Notch induced mitotic 
activity, synergistically with the wing patterning genes Vestigial and Wingless (Go et al., 
1998). In mammalian epithelial cells, activated Notch1 infected into primary murine 
keratinocytes in vitro induced an increase in the cyclin-dependant kinase inhibitor protein 
p21WAF1/Cip1 and subsequent withdrawal from the cell cycle. In this context Notch1 was also 
shown to promote early differentiation markers of the epidermis, such as keratin1 and 
involucrin (Rangarajan et al., 2001). 
Binary cell fate choices occur regularly during development and in self-renewing 
tissues. As a pathway activated by cell-cell contacts, Notch signaling plays an important role 
during these lineage decisions. During the developing eye of the Drosophila, for example, 
establishment of planar polarity of photoreceptors R3 and R4 is mediated by Notch and Delta 
signaling. Briefly, upon Wingless signaling by Frizzled and Disheveled, precursor cells of R3 
cell fate up-regulate Delta expression on their surface, thereby inducing Notch signaling in the 
neighboring R4 precursors (Fanto and Mlodzik, 1999). In the mammalian hematopoietic 
system, Notch specifies T cell lineage at an early stage as induced Notch1-deficient mice 
illustrated a block in T cell development and an accumulation of de novo ectopic B cells in 
the thymus (Radtke et al., 1999; Wilson et al., 2001). Conversely, mice reconstituted with 
bone marrow transduced with an NIC-expressing retrovirus developed extra-thymic T cells 
and a B cell differentiation blockade (Pui et al., 1999). 
In addition to proliferation, differentiation and cell fate decisions, Notch signaling was 
also shown to be involved in cell death. One example is the protective effect of Notch1 in T 
cell lines from T cell receptor (TCR)-dependant apoptosis. The orphan nuclear hormone 
receptor Nur77 is required for apoptosis of maturing thymocytes and was shown to physically 
interact with Notch1 in T hybridoma cells in vitro. This interaction inhibits Nur77-dependant 
cell death, and consequently, Notch1 was suggested to be an anti-apoptotic factor involved in 
double-negative thymocytes (Jehn et al., 1999). 
1.5 Context-dependency of Notch signaling 
Another feature adding to the complexity of Notch signaling is the context-dependent 
differences in its function. As previously mentioned, Notch promotes differentiation of 
epidermal keratinocytes by inducing cell cycle arrest of the transient-amplifying cells and 
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expression of early differentiation markers (Rangarajan et al., 2001). However, the Notch 
pathway can also inhibit differentiation and maintain stem and/or progenitor cells in the 
mammalian gastrointestinal tract. A genetic study over-expressing NIC in the intestinal 
epithelium resulted in an expansion of proliferating progenitors and greatly impaired cell 
differentiation (Fre et al., 2005). Reciprocally, gut-inducible inactivation of RBP-J in mice 
resulted in complete loss of the progenitor compartment and conversion of transit-amplifying 
cells into mucus secreting goblet cells. Outcome of a pharmacological treatment of wild-type 
mice with a -secretase inhibitor, which blocked Notch signaling in the intestine, was 
indistinguishable from the consequences of genetic inactivation (van Es et al., 2005).  
1.6 Notch: oncogene vs. tumor-suppressor 
Since Notch signaling interplays in many organs with many essential pathways, it is not 
surprising that Notch deregulation is involved in several diseases as well as in a number of 
cancers. Notch was first linked to a human cancer known as T cell acute lymphoblastic 
leukemia (T-ALL) by investigating a chromosomal translocation breakpoint, t(7;9), found in 
less than 1% of patients. The sequence revealed a juxtaposition of the C-terminal region of 
EGF-like repeat 34 of human Notch1 (TAN1 for translocation-associated Notch homologue1) 
to the TCR -enhancer. This translocation lead to the expression of a constitutive Notch1 
receptor causing aberrant Notch signaling and, consequently, T cell leukemia (Ellisen et al., 
1991). Constitutive Notch signaling was further associated with T-ALL tumors as activating 
mutations within Notch1 were found in a majority of Notch-dependent T-ALL cell lines. The 
mutations were localized within the heterodimerization and/or PEST domains rendering the 
Notch1 receptor unusually stable (Weng et al., 2004). 
The oncogenic role of Notch was also described in other systems, such as the murine 
intestinal epithelium. Notch signaling blockade, by pharmacological treatment of a mouse 
model for intestinal tumorigenesis, resulted in a 50% reduction in the number of adenomas in 
the small intestine. The mechanism by which this reduction occurred was through the 
derepression of Krüppel-like factor 4 (Klf4), a zinc finger transcription factor which inhibits 
cell proliferation (Ghaleb et al., 2008). 
The oncogenic ability of the Notch pathway, previously shown in the hematopoietic 
system and in the gastro-intestinal tract, is also context dependent. Evidence of the tumor-
suppressive role of Notch signaling was revealed by studies in the skin (Nicolas et al., 2003). 
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After induced Notch1-deletion in the epidermis, mice spontaneously developed basal cell 
carcinoma-like tumors within 9 months after inactivation. Furthermore, tumorigenicity was 
facilitated after chemical-induced carcinogenesis treatment of the Notch1-deleted mice 
(Nicolas, 2003; Nicolas et al., 2003). Thus, Notch signaling was suggested to have a different 
function in the skin. 
2. The skin and its appendages 
The skin is the body’s largest organ, typically 1.5 to 2m2 of surface area for an adult 
human being, and serves as an outer covering protection against physical, biological (e.g. 
infectious agents) and environmental assaults. It is a waterproof barrier formed by a stratified 
epithelium, hair follicles, sweat and sebaceous glands. The skin also functions as a 
temperature regulator, conveys sensation, and allows synthesis of vitamin D. The skin is 
composed of three main parts: the outermost epidermis (from the Greek “epi” meaning 
“upon”), the dermis, where the appendages are found, and the deepest region called the 
hypodermis or subcutaneous adipose layer. (Fig.4) 
 
 
2.1 The epidermis 
The epidermis is itself stratified in several distinct cell layers of squamous epithelium 
comprising mainly of keratinocytes. Other cell types that can be found are macrophages 
(Langerhans cells), Merkel cells associated with the sensory neurons, and the pigment-bearing 
melanocytes. The first layer above the basal lamina is called the basal layer from which cells 
migrate upwards and differentiate to form the spinous and granular layers. These cells finally 
Figure 4. Structure of the skin. The 
epidermis, dermis, and hypodermis (or 
subcutaneous fat) are the three layers that 
form the skin. Three appendages can also 
be observed: the sweat and sebaceous 
glands, and the hair follicle. (Image from 
MayoClinic.com) 
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lose their nuclei and become keratinized forming the outermost cornified layer. Thus, the 
terminally differentiated stratum corneum has a limited lifespan and continually sheds, a 
process called desquamation. During embryogenesis in mice the stratification is completed by 
embryonic day 17.5 (E17.5). In adult mice, the homeostatic differentiation process takes 
approximately 14 days, whereas in humans it takes 1 month. Constant shedding of the dead 
cells requires a renewal of the epidermis by stem cells during homeostasis of the skin as well 
as in response to wounding. 
Epidermal stem cells of the interfollicular epidermis (IFE) are located in the basal layer. 
These stem cells give rise to transit-amplifying (TA) cells which continuously execute their 
terminal differentiation program by moving outwards in a columnar fashion. These cells 
which possess proliferative potential switch off the expression of keratins 5 and 14 and 
concomitantly start expressing keratins 1 and 10. The latter markers of the spinous layer form 
a robust intermediate filament network which reinforces cell-cell junctions, thereby providing 
resistance to external mechanical stresses (Fuchs and Green, 1980). Cells continue to 
differentiate by expressing structural proteins that are deposited beneath the plasma 
membrane and form indestructible sacs, which gave rise to the name of the granular layer. 
The proteinaceous sac serves as a scaffold for lipid bilayers which confer the waterproofing of 
the skin surface. Several proteins are used as markers of late differentiation, such as 
involucrin (Rice and Green, 1979), loricrin (Mehrel et al., 1990) and filaggrin (Scott and 
Harding, 1986). When the cells die and form the stratum corneum, involucrin and loricrin are 
cross-linked by a calcium-dependent enzyme called transglutaminase for the assembly of the 
cornified envelope (Ishida-Yamamoto et al., 1999; Simon and Green, 1988). The stratified 
structures of the skin and the epidermis are summarized in Fig.5. 
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2.2 The hair follicle 
In addition to its protective function, the skin also encompasses several appendages 
essential for survival: sweat and sebaceous glands, and hair follicles. Sweat glands secrete and 
excrete water and minerals which regulate the body temperature. In some mammals, such as 
mouse, rat and cat, these glands are restricted to the underside of the paws. The sebaceous 
glands, formed by sebocytes, are associated with hairs and secrete oils which protect and 
lubricate the hair channel as well as the skin surface. The insulation of the skin is augmented 
by hair follicles, or feathers and scales in vertebrates other than mammals, which can also 
serve as camouflage or sexual characteristics. All skin appendages arise from reciprocal 
interactions between the developing epidermis and the underlying mesenchyme, the dermis 
(Hardy, 1992). 
Figure 5. The skin and the structure of the epidermis. The skin is devised into three main layers: the 
hypoderm, the dermis and the epidermis. Three appendages are found within the dermis: the hair follicle, the 
sweat and the sebaceous glands. The dermis and the epidermis are separated by the basement membrane or 
basal lamina. (Modified from Fuchs and Raghavan, 2002) The epidermis is also stratified in several layers 
which consist of keratinocytes at different differentiation stages. The epidermal stem cells as well as the 
transit-amplifying cells are localized in the basal layer and express keratins 5 and 14. The suprabasal layers 
are formed by the spinous and granular layers, which express involucrin, and loricrin as well as filaggrin, 
respectively. Terminally differentiated cells are then enucleated and form the outermost cornified layer. 
(Adapted from Wilson and Radtke, 2006) 
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2.3 Four murine hair types 
The mouse pelage consists of four different hair types defined by size, shape and internal 
structure: zigzag, awl, auchene, and guard (or tylotrich). The zigzag constitutes the majority 
of the hairs of the pelage (approximately 70%), has two or more bends, and one single row of 
air spaces. The second most abundant hair type is the awl (approximately 28%) which is small 
(0.5cm) and straight, consisting of two or more rows of air spaces. The auchene and guard 
hair types are less frequently observed. The auchene has one bend and two or more rows of 
air spaces while the guard is straight and long (1cm) with two rows of air cells (Fig.6) 
 
 
2.4 Structure of the hair follicle 
In the embryo, the hair follicle (HF) is produced by epithelial stem cells that grow 
downward at a region called the placode, contiguous with the epithelium and assuming the 
shape of a rod. The inner layers differentiate into concentric cylinders forming the central hair 
shaft (HS) and the inner root sheath (IRS). The HS consists of the hair cortex surrounded by 
the hair cuticle. The IRS can be sub-divided into three layers based on structure, pattern of 
keratinization and incorporation of trichohyalin, which stains an intermediate filament-
associated protein: the cuticle, the Huxley and Henle layers. Surrounding the IRS is the 
outermost layer, the outer root sheath (ORS). The ORS is continuous with the epidermis and 
extends into the sebaceous gland (Fig.7). 
Figure 6. Three of the four hair types of the mouse pelage. (A) Stereomicroscope picture of a zigzag, an awl, 
and an auchene hair from a wild-type mouse back pelage. (B) Higher magnification of a zigzag and an awl 
hair shows 1 and 2 rows of air spaces, respectively. 
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At the base of the HF, a mesenchymal cluster called the dermal papilla (DP) becomes 
enveloped by the hair bulb. Once fully mature, at postnatal day 6 (P6) in mouse back skin, the 
proliferative matrix cells at the follicle base produce daughter cells that terminally 
differentiate to form the growing hair that exits the skin surface. Throughout life, the HF is 
renewed and cycles through growth (anagen), regression (catagen), and rest (telogen). 
2.5 The hair growth cycle 
During anagen, the proliferative matrix cells produce progeny cells that move upwards 
and differentiate into one of the six lineages, from outermost to innermost: Henley, Huxley 
and cuticle layers of the IRS, and cuticle, cortex and medulla layers of the HS. When the HS 
cells terminally differentiate, they become tightly packed with bundles of cross-linked 
keratins, which allow strength and flexibility. The continued proliferation and differentiation 
of matrix cells, which are transit-amplifying cells that undergo a limited number of cell 
divisions, determines the duration of anagen and the length of the hair. 
As the supply of matrix cells declines, the follicle enters the destructive phase. The first 
catagen begins in a wave, from head to tail, at P14 at the upper back to P18 near the tail. The 
onset does not only vary from one skin region to another, but also between mouse strains. 
During catagen, the hair follicle regresses entirely by apoptosis of epithelial cells in the bulb 
Figure 7. Structure of the hair follicle. (A) The HF is divided into three regions (from bottom to top): the 
bulb and suprabulb, the isthmus (from the attachment of the erector pili muscle to the entrance of the 
sebaceous gland duct), and the infundibulum (from the sebaceous gland duct to the follicular orifice). (B) A 
longitudinal cut of a HF shows the different layers from the dermis to the center of the hair cortex. (Adapted 
from Wikipedia) 
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and the outermost layer, the ORS. The HS seals off and forms a club, which remains anchored 
to the permanent non-cycling upper follicle. 
HF lie dormant during telogen until one or two quiescent stem cells at the base of the 
follicle, near the DP, are activated. Rapid proliferation produces transit-amplifying cells that 
will form the new HF by a new anagen phase. The new hair emerges from the orifice of the 
old one, and the club hair is eventually shed (exogen). The complete hair cycle, starting from 
the follicular morphogenesis, is depicted in Fig.8. 
 
 
Figure 8. The hair cycle. During embryogenesis, the follicular morphogenesis is initiated by epithelial-
mesenchymal interactions which occur at the ectodermal placode. After invagination into the dermal layer, 
the newly formed hair follicle (HF) will enter a cycle consisting of three phases: anagen, catagen, and 
telogen. Anagen is the growing phase of the HF, when proliferative transit-amplifying (TA) cells (matrix) 
migrate upwards and differentiate into the six layers of the HF. As the supply of matrix cells declines, the 
hair enters catagen, which is the destructive phase. The HF regresses by apoptosis of cells in the bulb and 
the outer root sheath. Finally, the club hair forms and lies dormant during the resting phase, or telogen. 
Activation of epithelial stem cells at the base of the follicle, which will produce a new pool of TA cells, 
resets the hair cycle. (Reviewed in Fuchs, 2007)  
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2.6 Factors involved in hair formation 
The hair morphogenesis and subsequent hair cycle is a complex process bringing into play 
many different signaling pathways. Examples of factors involved in various aspects of the HF 
formation are the families of fibroblast growth factor (FGF), hedgehog (Hh), transforming 
growth factor- (TGF)-related bone morphogenic protein (BMP), and Wnt signaling 
molecules. 
FGF5, for example, is expressed in the ORS during anagen to catagen transition and was 
shown to be involved in inhibition of hair elongation. FGF5 null mice developed abnormally 
long hair identical to mice carrying the spontaneous mutation angora, which is a mutant allele 
of FGF5 (Hebert et al., 1994). Another member of the FGF family, the keratinocyte growth 
factor (KGF or FGF7), is expressed in the dermis and exerts its mitogenic activity on the 
epidermal cells. By ectopically expressing KGF in murine epidermis, growth and 
differentiation of keratinocytes were impaired, resulting in an epidermal thickening, while 
hair follicle morphogenesis and adipogenesis were suppressed (Guo et al., 1993). 
Sonic hedgehog (Shh) is an important signaling molecule involved in epithelio-
mesenchymal interactions as it is expressed in epithelial cells in the placode of the developing 
hair and whisker, and later in the hair bulb surrounding the dermal papilla (Iseki et al., 1996). 
In agreement with this expression pattern, Shh knockout mice failed to evolve any dermal 
papilla, and, consequently, hair follicle morphogenesis was arrested (Chiang et al., 1999). 
In mature hair follicles, BMP4 is expressed in the dermal papilla, and both BMP2 and 
BMP4 are expressed in hair shaft precursors (Wilson et al., 1999). Ectopic expression of 
BMP4 in the ORS inhibited proliferation of the matrix cells and disturbed the expression 
pattern of cytokeratins during differentiation of the shaft cells (Blessing et al., 1993). The role 
of BMPs in the HF formation was consolidated by investigations using the BMP inhibitor 
Noggin. Transgenic mice expressing Noggin in matrix cells showed defects in differentiation 
of the hair shaft cortex and cuticle, as well as an inhibition of the second wave of placode 
formation (Botchkarev et al., 2002; Kulessa et al., 2000). 
Activation of the Wnt signaling pathway involves formation of nuclear complexes 
between -catenin and Tcf/Lef proteins to induce transcription of target genes (Fig.9). Both 
signaling molecules were found to be important in the formation of hair follicles. Lymphoid 
enhancer factor 1 (LEF1) is expressed in the matrix and in the developing dermal papilla cells 
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(Zhou et al., 1995). Confirming the role of Lef1 in hair morphogenesis,  Lef1 knockout mice 
were completely devoid of hair (van Genderen et al., 1994). Moreover, conditional 
inactivation of -catenin in the mouse embryo blocked placode formation. Deletion after 
formation of the HF caused a complete loss of hair, after the first cycle, and concomitant 
development of cysts with epidermal differentiation characteristics (Huelsken et al., 2001). 
 
 
 
2.7 Epidermal stem cells 
The constant self-renewal of the epidermis and of the hair follicle is due to adult 
epidermal stem cells (SC). All three epidermal lineages, i.e. interfollicular epidermis, hair 
follicles, and glands are thought to have their own niches of epidermal stem cells (Reviewed 
in Ambler and Maatta, 2009).  
A hair follicle region, called the bulge, was identified as a reservoir of epidermal SC by a 
label-retaining technique using 3H-thymidine (Cotsarelis et al., 1990). The transcriptional 
profile of the SCs of the bulge was determined by a genetic approach to generate label-
Figure 9. Canonical Wnt signaling pathway. Left scheme: In the absence of Wnt signaling molecules, -
catenin is phosphorylated by the GSK3/axin/APC complex and subsequently degraded. Wnt target genes 
are repressed by Tcf/Lef proteins interacting with co-repressors. Right scheme: In the presence of Wnt 
molecules, LRP and Frizzled receptors are activated, thereby relieving-catenin degradation. Consequently, 
the stabilized -catenin can translocate to the nucleus and bind to the Tcf/Lef family of transcription factors. 
This interaction activates transcription of the formerly repressed target genes. (Wormbook.org) 
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retaining cells (LRC). A transgenic mouse strain was engineered to express a GFP-tagged 
protein histone H2B in epidermal cells, and the transgene can be silenced by feeding the mice 
tetracycline (Tet-Off system). Consequently, slow-cycling cells continue on expressing the 
GFP transgene while the rapidly dividing cells dilute the fluorescent protein out (Tumbar et 
al., 2004).  
The second reservoir of epidermal SC was identified in the IFE by lineage tracing 
experiments. As previously described, Shh is expressed in the epidermal placode of the HF 
and, once the HF formed, is restricted to the cycling portion of the follicles in the skin. 
Consequently, the follicular stem cells in adult mice are descendants of Shh-expressing cells. 
By labeling these daughter cells, it was shown that the follicular SCs of the bulge do not 
contribute to the epidermis, implying another stem cell pool in the IFE (Levy et al., 2005). 
Retroviral transduction of the lacZ gene into mouse skin labeled IFE keratinocytes in spatially 
distinct epidermal proliferative units (EPU; (Allen and Potten, 1974)) independent from 
follicles (Ghazizadeh and Taichman, 2001). 
Another population of SCs was identified in a region between the bulge and the sebaceous 
gland, called the upper isthmus (UI). Cells in this zone expressed the surface marker MTS24 
and possessed higher clonogenic potential in vitro than MTS24-negative cells. Furthermore, 
transplanted UI cells were able to give rise to all three epidermal lineages, a characteristic of 
multipotency (Jensen et al., 2008; Nijhof et al., 2006). The various SC reservoirs described 
above are depicted in Fig.10. 
 
 
 
Figure 10. Locations of epidermal stem and progenitor cells 
in the mammalian skin. Stem cells (purple) are located in the 
bulge of the hair follicle and amongst the basal layer of the 
interfollicular epidermis. Interfollicular stem cells support 
the interfollicular epidermis (arrows) and bulge stem cells 
migrate to the hair follicle bulb (yellow) during the anagen 
(dashed line). Contribution of epidermal progenitor cells 
(lavender) has still to be defined. IFE, interfollicular 
epidermis; UI, upper isthmus; SG, sebaceous gland. (Ambler 
and Maatta, 2009) 
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2.8 Stem cell markers 
The mechanisms by which epidermal stem cell are maintained are not fully understood. 
An interesting candidate is the cell-cycle regulator c-Myc (myelocytomatosis oncogene) since 
elevated expression in transgenic mice lead to hyperproliferation and depletion of SCs 
without loss of differentiation, as well as hair loss and impaired wound healing (Arnold and 
Watt, 2001; Waikel et al., 2001). 
A member of the p53 family of transcription factors called p63 is expressed in basal stem 
cells and down-regulated in progenitor cells of the epithelium (Pellegrini et al., 2001). The 
p63 knockout mice are completely devoid of epidermis and skin appendages, suggesting an 
essential role for maintenance of the epidermal SC population necessary for epithelial 
morphogenesis and renewal (Yang et al., 1999). 
Recently, leucine-rich repeats and immunoglobulin-like domain protein 1 (Lrig1) was 
shown to be expressed in the junctional zone between the sebaceous gland and the 
infundibulum of the HF. However, Lrig1 null mice did not exhibit any impairment of the 
sebaceous gland nor of the HF, but had an increase in IFE proliferation. These results 
suggested that Lrig1 is required for stem cell quiescence in adult mouse epidermis. In 
addition, c-Myc positively regulated Lrig1 expression, thereby consolidating the link between 
c-Myc activity and stem cell maintenance (Jensen et al., 2009). 
Stem cells can be characterized by expression of specific markers. The hematopoietic 
stem and progenitor marker CD34 co-localized with LRCs in the bulge region. Isolated 
CD34-positive keratinocytes expressed high levels of 6-integrin, and were positive for K14 
and K6 (Trempus et al., 2003). Another used marker is the bulge-specific keratin 15 (K15). 
By generating K15-EGFP transgenic mice, bulge SCs could be isolated and subsequently 
shown to have a high proliferative property in vitro, and to be able to generate all cutaneous 
lineages in vivo (Morris et al., 2004). More recently, the marker of intestinal stem cells called 
leucine-rich G protein-coupled receptor 5 (Lgr5) was shown to be expressed in actively 
proliferating, but yet multipotent hair follicle stem cells by generating knockin mouse models 
(Jaks et al., 2008). 
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2.9 Wound healing 
Epidermal stem cells are not only essential during skin homeostasis but are also 
immobilized during the wound repair process. In response to injury, stem cells from both the 
interfollicular epidermis and the bulge rapidly respond by migrating into the damaged area. 
Epidermal SCs, TA cells and early differentiated cells have the ability to form fully 
differentiated epidermis both in vitro and in vivo (Li et al., 2004). The whole healing process 
comprises of three stages (Fig.11) (Reviewed in Gurtner et al., 2008).  
The first response to occur is inflammation and lasts about 48h. Upon mechanical injury, 
the first signal is the release of pre-stored interleukin-1 (IL1) by the keratinocytes, which 
activates and alerts the surrounding area of the wounding. The activation cascade consists of 
many extracellular signals, such as tumor necrosis factor- (TNF) and transforming growth 
factor- (TGF) (Jiang et al., 1993; Komine et al., 2000). Theses signaling molecules induce 
a change in expression of keratins, such as K6, providing the keratinocytes with plasticity and 
flexibility for migration (Komine et al., 2001; Wong and Coulombe, 2003) The damage also 
induces components of the coagulation cascade and of the immune system to protect the body 
from losing fluids as well as from invading bacteria. Platelets form a plug in which a fibrin 
matrix becomes the scaffold for infiltrating neutrophils and macrophages.  
In the next 2 to 10 days following injury an eschar, or scab, closes the surface of the 
wound and new tissue forms underneath by the inwards migration of surrounding epithelial 
cells. In order for keratinocytes to migrate, hemidesmosomes must be dissolved by changes in 
junction and adhesion proteins. Thus, activated keratinocytes produce different membrane 
molecules: vitronectin, fibronectin receptors and integrin 51 (Cavani et al., 1993). During 
re-epithelialization new capillaries associated with fibroblasts and macrophages replace the 
fibrin clot with a perfused extracellular matrix tissue called granulation tissue. 
The last stage is tissue remodeling and can last for more than 1 year. Fibroblasts migrate 
into the wound, some of them differentiate into myofibroblasts, and both types of cells 
interact to produce extracellular matrix, mainly collagen, which forms the bulk of the scar and 
causes a slight bump at the surface of the skin. Keratinocytes are eventually deactivated and 
resume their normal differentiation program. However, no normal appendages, hair follicles 
or glands, can be found in re-epithelialized healed regions. 
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3. Notch signaling in the epidermis… 
An important pathway in epidermal stem cell differentiation is the Notch signaling 
pathway. Expression patterns of Notch receptors and their ligands give a first insight into their 
role. In human epidermis, Notch1 is expressed in all epidermal layers whereas Notch2 is only 
seen in the basal layer. In contrast, in the murine epidermis, Notch2 is not found in the basal 
layer, and both Notch1 and Notch2 are expressed most strongly in the spinous layer. As for 
Notch ligands, they are expressed in overlapping patterns in both human and mouse epidermis 
(Lowell et al., 2000; Rangarajan et al., 2001). 
Notch1 induces differentiation of keratinocytes by stimulating expression of early 
differentiation markers such as keratin1 and involucrin (Blanpain et al., 2006). Notch1 
signaling directly induces expression of the cell-cycle regulator p21 (Waf/Cip1) which 
promotes cell cycle arrest in keratinocytes and thereby initiating terminal differentiation 
(Rangarajan et al., 2001). Notch1 also activates p21 indirectly, through Hes1 and the 
calcineurin/nuclear factors of activated T cells (NFAT) pathway. Hes1 down-regulates 
calcipressin, the negative regulator of the serine/threonine phosphatase calcineurin, which in 
turn dephosphorylates NFAT proteins (Mammucari et al., 2005). 
Several other cross-talks occur between Notch and important signaling pathways, such 
as p63, Wnt and Shh. Notch signaling suppresses p63 expression, while sustained p63 
function inhibits Notch-induced differentiation (Nguyen et al., 2006; Okuyama et al., 2007). 
Figure 11. The three stages of skin wound healing. 1) Inflammation: a fibrin clot forms within 24-48h after 
the injury. Bacteria, neutrophils and platelets are abundant. 2) New tissue formation: a scab forms and 
epithelial cells migrate into the wound. Formation of new blood vessels occurs. 3) Remodelling: fibroblasts 
migrate into the wound and lay down collagen. The healed wound contracts and no normal skin appendage 
can be found in that area. (Adapted from Gurtner et al., 2008) 
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Figure 12. Notch1 signaling in the murine 
epidermis. Notch1-mediated differentiation 
of keratinocytes into the stratified layers of 
the epidermis involves several pathways, 
such as calcineurin/NFAT, Wnt and Shh. 
Notch1 also regulates early (K1, K10, 
involucrin) and late (filaggrin, loricrin) 
differentiation markers. (Adapted from 
Wilson and Radtke, 2006) 
Wnt and Shh signaling pathways are involved in epidermal homoeostasis since Notch1 acts as 
a tumor suppressor notably by repressing both molecules. Notch1 deletion in murine skin 
activates both tumorigenic regulators resulting in basal cell carcinoma and squamous cell 
carcinoma (Nicolas et al., 2003). The Notch1-mediated regulation of the differentiation 
process in the epidermis is schematically summarized in Fig.12. 
 
 
3.1 …and in the hair follicle 
Thus, Notch signaling promotes epidermal differentiation in post-natal epidermis. A 
similar function might be assigned to Notch1 expression in the ORS of the hair follicle and 
the matrix cells. Its ligands Jagged1 and -2 are expressed in complementary patterns in the 
follicle bulb and ORS. Delta-like1 is only expressed during embryonic follicle development 
and is exclusive to the mesenchymal cells of the pre-papilla located beneath the follicle 
placode (Powell et al., 1998). An inhibitory role for Notch signaling in hair formation was 
described upon inactivation in mice of presenilin-1 (Psen1), a proteolytic enzyme of the -
secretase complex. Psen1 null keratinocytes accumulate cytosolic -catenin and have 
increased Lef1-mediated signaling (Xia et al., 2001). The Wnt pathway, through Lef1, was 
previously associated with hair differentiation. 
4. Notch, skin and disease 
In order to study the role of Notch in skin and the consequences of signaling 
deregulation, several genetic mouse models were generated. However, conventional gene 
targeted mice for Notch1, Notch2, RBP-J, Jagged1 and Jagged2 are embryonic lethal 
(Hamada et al., 1999; Jiang et al., 1998; Oka et al., 1995; Swiatek et al., 1994; Xue et al., 
1999). Therefore, conditional knockout strategies are necessary to study Notch signaling 
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during adulthood. Specific deletion in a given tissue can be achieved by the Cre/loxP 
technology. Firstly, the allele of interest is engineered to have two loxP sites, in the same 
orientation, flanking a region of the gene, exons and/or introns, which is crucial for its 
function. Secondly, inactivation is induced by excision of the flanked region by a Cre 
recombinase, which expression depends on its specific promoter.  
4.1 Gene inactivation in the skin 
To specifically inactivate a gene in the epidermis, K14 or K5 promoters are used to 
drive the Cre recombinase in basal and ORS cells. The K14Cre transgenic mice express the 
Cre during embryogenesis, when the K14 promoter is activated, at E12.5 (Dassule et al., 
2000). To study the inactivation of a gene at later stages of development and during 
adulthood, an inducible Cre recombinase called CreERT is used. The mutated ligand-binding 
domain of the human estrogen receptor is fused to the Cre recombinase, which allows 
conditional recombination dependant on the estrogen receptor antagonist 4-hydroxy-
tamoxifen, and not on endogenous estradiol (Feil et al., 1996). The synthetic 4OH-tamoxifen 
displaces heat shock proteins by binding to the ERT, which causes translocation of the Cre 
into the nucleus where it exerts its recombination activity. Thus, the K5CreERT mice have an 
inducible expression of the Cre recombinase only upon 4OH-tamoxifen injection (Indra et al., 
1999). 
4.2 Mouse models of Notch inactivation in the skin 
Inactivation of the Notch1 floxed allele, either embryonic (K14Cre) or induced 
(K5CreERT), results in the excision of the leader peptide and, consequently, in Notch1 
deficiency. The Notch1 conditionally deleted mice gradually lost their hair after birth and the 
remaining 10% were short, probably due to premature entry into catagen, and resembled no 
known hair type (Vauclair et al., 2005). In addition, mice with Notch1-deleted epidermis 
spontaneously developed basal cell carcinoma-like tumors within 9 months after inactivation. 
Furthermore, tumorigenicity was facilitated after chemical-induced carcinogenesis treatment 
(Nicolas, 2003; Nicolas et al., 2003). 
Inactivation of the Notch2 floxed allele is due to a loss of reading-frame, thereby 
inducing expression of a truncated Notch2 protein. Notch2 conditional deletion in the 
epidermis did not give rise to any skin abnormality, hence the generation of Notch1Notch2 
double-deficient mice. Loss of both receptors in the epidermis resulted in a severe skin 
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phenotype. Mice completely lost their hair, and their skin became dry, crusty and wounded 
(Vauclair, 2006). Double-deficient mice died rapidly after developing a myeloproliferative 
disorder in addition to an atopic dermatitis-like disease. Furthermore, epidermal inactivation 
of RBP-J recapitulated the phenotype (Dumortier et al., 2010). 
Inactivation of the Jagged1 floxed allele results in the excision of the two first exons 
encoding the leader peptide. Conditional Jagged1 deleted mice developed a similar, though 
more severe, phenotype than the Notch1-deficient mice. Jagged1-deficient mice completely 
lost their hair and developed a hyperproliferative epidermis. These mice also developed 
tumors, but more rapidly, within 6 months after gene inactivation (Estrach et al., 2006; 
Vauclair, 2006). 
In addition, a double-deficient Notch1Jagged1 mouse was generated to study the 
cumulative effect of loss of both receptor and ligand in the epidermis. These mice completely 
lost their hair in several waves of growth/loss and had a thickened epidermis, similarly to both 
single-deficient mice. Double-deficient Notch1Jagged1 mice also developed tumors, after 6 
months, which were mainly cysts derived from degenerated hair follicles (Vauclair, 2006). 
Another method to study Notch signaling in vivo is by overexpressing Notch1 
intracellular domain (NIC) in the skin. Transgenic mice with activated NIC driven by the K14 
promoter developed clumped hair follicles, thus unevenly spaced, that were mainly in telogen. 
The data suggested that Notch activation was not sufficient to induce hair follicle growth and 
triggered expansion of the base of the hair follicle (Estrach et al., 2006). 
4.3 Notch in human skin disorders 
The mouse models described for investigating Notch signaling in the skin confirm its 
role as an important tumor-suppressor and its implication in skin and hair disorders. Whether 
Notch plays a similar role in human skin has still to be confirmed. A study investigating 
human diseased skin, by in situ hybridization of several members of the Notch family, 
suggested a tumor-suppressive role. Indeed, expression of Notch1-3, Jagged1 and Delta-like1 
were close to non-existent in hyperproliferative keratinocytes from basal cell carcinoma, 
psoriasis, and during the first step of re-epithelialization in wounds. Conversely, non-lesional 
skin exhibited high transcription of the Notch genes in the basal cell layer (Thelu et al., 2002). 
Furthermore, expression of Notch receptors was observed in suprabasal layers of human 
unaffected skin samples whereas lesional skin from atopic-dermatitis patients showed reduced 
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protein expression. Notch receptor regulation was specific to the disease as two other 
hyperproliferative skin disorders showed strong expression of Notch receptors (Dumortier et 
al., 2010). 
5. Rho GTPases 
The retrovirus-associated DNA sequences (Ras) superfamily of GTP-hydrolyzing 
enzymes consists of more than 150 members and can be divided in several subfamilies. The 
Rho (Ras homologue) GTPase subfamily is characterized by its regulation of the actin 
filament system and thereby the morphogenic and migratory properties of vertebrate cells. 
Rho GTPases can be subdivided into 8 subfamilies, including RhoA, Rac, Cdc42 and atypical 
GTPases (Aspenstrom et al., 2007). The small G proteins cycle between an inactive GDP-
bound and an active GTP-bound form. The latter interacts with effectors to mediate the 
cellular functions of the Rho GTPases. 
5.1 Functions of Rho GTPases in the skin 
In addition to the pathways linked to keratinocyte differentiation and/or stem cell 
potential described earlier, the family of small Rho GTPases was identified as a potential 
player (Benitah et al., 2005; Wu et al., 2006). Keratinocytes in the basal layer of the epidermis 
constitutively express a variety of integrin extracellular matrix (ECM) receptors, including 
α2β1 (collagen receptor), α3β1 and α6β4 (laminin receptors), and αvβ5 (vitronectin receptor). 
The β1 integrins associate with the actin cytoskeleton in focal adhesions, whereas α6β4 
associates with intermediate filaments at junctions known as hemidesmosomes (Watt et al., 
1993). Thus, it is not surprising that Rho GTPases are important for the dynamic cell-cell 
contact of epithelial cells by apical junctional complex assembly/disassembly (Fig.13) 
(Fukata et al., 1999; Samarin and Nusrat, 2009). 
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The role of Rho GTPases in the skin in vivo was investigated by conditional deletion of 
Rac1 in the epidermis. Rac1 deficiency led to epidermal stem cell depletion by disrupting 
adhesive interactions between stem cells and their niche (Benitah et al., 2005). Another 
example is Cdc42, which deletion in the skin caused epithelial progenitor cells of the hair 
follicle to change their fate into keratinocytes of the epidermis (Wu et al., 2006). 
5.2 Rho GTPases and skin tumorigenesis 
Due to their multiple roles in affecting cell morphology, Rho GTPases are potential 
candidates in cancer promotion (Fig.14) (Reviewed in Karlsson et al., 2009). Many Rho 
GTPases were deregulated in several types of human cancers. Focusing on skin disorders, 
RhoC was up-regulated in squamous cell carcinomas (SCC) while Rac2 was overexpressed in 
both non-melanoma cancers, SCC and basal cell carcinoma (BCC) (Marionnet et al., 2003).  
Figure 13. Rho GTPases during focal adhesion assembly/disassambly. Active Rho, i.e. the GTP-bound 
form, acts upon focal adhesion assembly by interacting with kinases and the myosin-binding subunit (MBS) 
of myosin phosphatase. The antagonistic effect of active Rac1/Cdc42 is due to the interaction with PAK 
effectors to disassemble the stress fibers. (Adapted from Fukata et al., 1999) 
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Even though the expression of Rho GTPases was deregulated in several cancer types, 
transgenic animal models for the role of the small G proteins in skin tumorigenesis are scarce. 
Nonetheless, RhoB null mice had an increased susceptibility to skin tumor formation by 
induced carcinogenesis (DMBA/TPA treatment) (Liu et al., 2001). It is interesting to note that 
the carcinogenic chemical DMBA predominantly induces a mutation in the H-Ras gene, an 
early event in transformation of keratinocytes into a SCC. 
5.3 Rho GTPases and Notch signaling 
Investigation of the Notch-mediated tumor-suppressive mechanism in human 
keratinocyte cancer cell lines and SCCs revealed Notch1 to be a p53 target, and a negative 
regulator of Rho effectors ROCK1/2 and MRCK kinase. The combined knockdown of these 
kinases counteracted the effects of Notch suppression in keratinocytes both in vitro and in 
vivo (Lefort et al., 2007). These results suggested an inverse relationship between Notch and 
Rho signaling in control of stem cell potential and tumorigenesis. 
Figure 14. Potential functions of Rho GTPases during tumorigenesis. Different Rho GTPases have 
functions in cell cycle, epithelial cell polarity, migration, apoptosis, and angiogenesis. Any of these 
properties could lead to tumorigenic transformation of a cell when deregulated. (Karlsson et al., 2009) 
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Aims 
 
I. RhoV as a potential Notch target gene in the skin 
The exact mechanism by which Notch mediates its effects in the skin, where it functions 
as a tumor suppressor, is currently unknown. For this purpose, potential key target genes 
identified by gain and loss of function assays, using murine primary keratinocytes, were 
validated by real-time RT-PCR. Among thirteen candidate genes, we decided to focus on 
RhoV, which showed robust deregulation under both conditions. Its role in differentiation of 
keratinocytes, during epidermal homeostasis as well as during wound healing, was 
investigated by the generation of skin specific transgenic mice expressing dominant active 
and dominant negative forms of the gene. 
II. Generation of Jagged2 floxed mice  
In the skin, Notch receptors interact with their ligands Jagged1 and Jagged2. The 
precise role of Jag2 in the epidermis can be investigated by generating floxed Jag2 mice that 
allow a conditional loss of function approach to determine its role in vivo. In this system, Jag2 
can be deleted by crossing Jag2lox/lox mice with transgenic mice expressing a tissue specific 
Cre recombinase. This chapter describes both the generation of Jag2lox/lox mice and the 
subsequent experiments undertaken to determine the integrity of the targeted allele. 
III. Generation of Notch2-mediated signaling reporter mice 
Even though Notch signaling is important in the development of many organs and is 
linked to various diseases and cancers, there is no tool allowing in vivo visualization of 
endogenous Notch signaling in a specific tissue at any given time point. Therefore, we sought 
to generate a Notch2-mediated signaling reporter mouse to identify Notch2 signal-receiving 
cells in vivo.  For this purpose, we generated a chimeric Notch2 fused to a transactivating 
domain and a secondary reporter consisting of response elements driving a red fluorescent 
protein. We demonstrated that both transgenes were functional in vitro, and thus suitable to 
generate transgenic mouse lines. Once generated, the mice will be crossed to obtain double 
transgenic animals in which cells receiving a Notch2 signal can be identified and traced in 
vivo. 
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I. RhoV in the skin 
 48 
 49 
I. Characterization of the small Rho GTPase RhoV as a potential Notch 
target gene in the skin 
 
1. Introduction 
The development and the homeostasis of the skin involve a tightly-regulated 
coordination between epidermal cell proliferation and differentiation. Notch signaling 
mediates these complex processes through many downstream targets such as Hes1 and p21 
(Blanpain et al., 2006; Rangarajan et al., 2001). During epidermal development Hes1 
expression in suprabasal cells was shown to be directly regulated by Notch1 and loss of 
canonical Notch signaling, via conditional deletion of RBP-Jwhich resulted in decreased 
Hes1 expression in newborn skin (Blanpain et al., 2006). Correspondingly, overexpression of 
Notch1 intracellular domain in transgenic NICD1 epidermis showed a dramatic increase in 
Hes1 throughout the epidermal layers. Loss of Hes1 by targeted deletion of its basic helix-
loop-helix domain (Ishibashi et al., 1995) disrupts the spinous layers of the interfollicular 
epidermis, resulting in a thinner epidermis at E18.5. In addition, the proliferative potential of 
the basal epidermal cells is impaired in the absence of functional Hes1 (Moriyama et al., 
2008).  
Despite the role of Hes1 during epidermal development, conditional deletion during 
embryogenesis of Hes1lox/lox, mediated by K14Cre, does not impair skin homeostasis in adult 
mice (Fig.1 and data not shown). Thus, in adult interfollicular epidermis, other downstream 
Notch target genes are involved. One mechanism by which Notch1 promotes terminal 
differentiation is through cell cycle withdrawal of basal keratinocytes by directly activating 
the expression of p21(Cdnk1a) (Nguyen et al., 2006; Rangarajan et al., 2001). The expression 
of cyclin-dependent kinase inhibitor p21WAF1/Cip1 was up-regulated upon infection of 
keratinocytes with an adeno-virus expressing NIC. Moreover, the RBP-J protein was shown 
to directly bind to the endogenous p21 promoter in a luciferase assay.  
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In addition, Notch1 deficient epidermis showed elevated levels of free -catenin, the 
effector of canonical Wnt signaling, thus suggesting a link between the Notch and Wnt 
signaling pathways in epidermal keratinocytes (Nicolas et al., 2003). Furthermore, the 
signaling-competent form of -catenin was highly expressed in the basal cell carcinoma 
(BCC)-like tumors which developed in the induced deleted Notch1 mice. Notch signaling in 
the skin thus plays a tumor-suppressive role. 
Links between Notch signaling and pathways involved in epithelial cell fate 
determination, cell-cycle arrest and tumorigenesis suggest many unknown target genes. In an 
attempt to determine these important downstream players, Affymetrix microarray analyses 
were performed on murine primary keratinocytes with both a gain and a loss of function 
assays (Vauclair, 2006).  Several hundred differentially regulated genes were categorized by 
fold change and significance of pathways. Among thirteen candidate genes further analyzed 
by quantitative reverse transcription PCR (qRT-PCR), three showed robust up-regulation 
during forced Notch signaling, as well as down-regulation upon loss of Notch1. These three 
candidate genes were DEPP, Prickle2, and RhoV.  
Figure 1. Conditional Hes1 deletion in the skin. (A) Skin morphology of both control (Hes1) and deleted 
(Hes1K14) skins show no overt phenotype by haematoxylin/eosin staining. (B) The Southern analysis of 
Hes1 deletion efficiency consists of a PstI digestion (arrows) of DNA from scraped epidermis and 
hybridization with a probe at the 5’UTR. By densitometric analysis of the phosphorimager scan we 
measured a deletion efficiency of 90%. Arrows show the 1.84kb wt and 1.4kb deleted bands. 
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The first candidate gene to be confirmed was DEPP (decidual protein induced by 
progesterone), also known as fasting-induced gene (FIG) or fat-specific expressed gene 
(FSEG). DEPP modulates the effects of progesterone during decidualization of endometrial 
stromal cells, which is a crucial event for embryo implantation and placentation (Watanabe et 
al., 2005). Experiments done on 293 cells suggest that DEPP increases the level of 
phosphorylated Erk and activates the transcription factor Elk-1 (Watanabe et al., 2005). DEPP 
was also described as an arterial-specific gene expressed in endothelial cells of peripheral 
tissues, which was up-regulated in subsets of vessels in tumors and wounded skin. 
Nevertheless, DEPP knockout mice develop normally and show no apparent physiological 
defects, as well as no difference in vessel development or patterning (Shin and Anderson, 
2005). The knockout mouse strain was cryopreserved and, as no skin phenotype was 
observed, we decided not to pursue the investigation of this gene further. 
The second potential target gene robustly deregulated was Prickle2. Prickle2 was first 
identified in silico in the mouse (Katoh and Katoh, 2003). The Drosophila homolog Prickle 
plays a role in epithelial planar cell polarity (PCP). Briefly, Prickle competes with the 
ankyrin-repeat protein Diego for binding to the cytoplasmic protein Disheveled. Prickle 
thereby prevents the recruitment by Frizzled of Disheveled to the cell membrane. In the fly 
PCP signaling regulates the orientation of the ommatidial arrangement in the compound eye 
and the hair orientation in wing cells (Jenny et al., 2005). More recently, Prickle2 was shown 
to be highly expressed in the adult murine brain and lung. Knockdown assays by siRNA in a 
neuroblastoma cell line suggest a role for Prickle2 in neurite outgrowth (Okuda et al., 2007). 
Mouse Prickle2 cDNA consists of 8 exons for a total of 2.5kb-long coding sequence, which 
renders it difficult to clone. For this reason, and since the next candidate gene discussed 
below had a shorter cDNA sequence, we decided not to pursue investigations for Prickle2. In 
the meantime, a group reported cloning of the full-length murine Prickle2 cDNA together 
with an eGFP tag and studied the polarization of vestibular sensory epithelial cells of the 
inner ear. Prickle2 was localized asymmetrically at cell boundaries throughout the hair cell 
differentiation and polarization of the inner ear from mouse embryos (Deans et al., 2007). 
The third candidate gene which showed robust deregulation under Notch gain and loss 
of function conditions was RhoV. This small Rho GTPase belongs to the Wrch (Wnt-
regulated Cdc42 homolog) branch of the mammalian Rho GTPase family and is also known 
as Wrch2 or Chp. The murine RhoV gene is located on chromosome 2 and consists of 3 exons 
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for a 712bp-long coding sequence. It possesses additional sequences at both termini which 
distinguishes it from the classical Rho GTPase members (Cdc42, RhoA, and Rac1).The latter 
contain a carboxy-terminal CAAX (C, cysteine; A, aliphatic acid; X, terminal amino acid) 
motif that signals post-translational modifications crucial for their association to plasma and 
other cellular membranes, and, consequently, for their biological function. Although RhoV 
shares sequence and functional similarities with Cdc42, they diverge significantly in their 
mode of membrane association due to the lack of the CAAX-motif in RhoV (Chenette et al., 
2005; Chenette et al., 2006). Its localization to membranes depends on the palmitoylation of 
its carboxy terminus in vitro, which is distinct from the prenylation critical for the association 
of the other Rho GTPases (Chenette et al., 2005; Shutes et al., 2006).  
There are 23 mammalian genes encoding Rho GTPases which function as molecular 
switches for a multitude of tasks, including cytoskeleton remodeling and modulation of gene 
expression (Reviewed in Jaffe and Hall, 2005). As regulatory GTPases they cycle between an 
inactive GDP-bound state and an active GTP-bound state. Once activated the Rho GTPases 
control remodeling of the cytoskeleton, by formation and organization of actin filaments and 
microtubules, and, consequently, contribute to cell morphogenesis and migration. They also 
regulate gene expression through many signaling pathways as well as cell cycle progression. 
Since RhoV is potentially downstream of Notch1 and can induce a variety of cellular 
alterations important in the differentiation process of epithelial cells, we decided to 
characterize the role of RhoV in the skin. Thus, the potential role of RhoV in differentiation 
of keratinocytes and its relation with Notch1 was investigated by in situ hybridization, in vitro 
luciferase assays and by generation of skin specific transgenic mice expressing dominant 
active and dominant negative forms of the gene. 
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2. Results 
2.1 Gain and loss of function assays 
Three different conditions for gain and loss of function of Notch signaling were set up. 
Firstly, primary keratinocytes carrying floxed Notch1 alleles were cultured for 24 hours. 
These cells were then infected with adeno-viruses to efficiently deliver a specific gene into 
the primary keratinocytes, which will thus be highly expressed. In the first instance, Notch 
signaling was up-regulated by infection with an adeno-NIC-GFP. In the second instance, the 
loss of function assay, we used an adeno-Cre-GFP to induce Notch1 deletion of the floxed 
keratinocytes. In both cases adeno-GFP was used as infection control. RNA was isolated 12h 
after adeno-NIC infection, the time at which the Notch signaling activity was most potent, or 
24h post adeno-Cre infection when complete Notch1 deletion was achieved. Quantitative 
analysis of potential Notch1 direct target genes was performed by TaqMan® real-time PCR 
(Fig.2). 
 
 
It is important to note that keratinocyte differentiation is dependent on a calcium 
gradient in vivo as well as in vitro. Epidermal calcium gradient can be mimicked in culture by 
increasing the concentration of calcium ions in the medium, which causes the cells to 
differentiate (Yuspa et al., 1989). Therefore, a third condition was tested by adding calcium to 
the medium of adeno-Cre infected cells to induce differentiation in absence of Notch1. 
Figure 2. Experimental procedure for gain and loss of function conditions on murine primary keratinocytes 
involved 4 steps. First, Notch1lox/lox 2-day old pups were sacrificed and their skin isolated. Primary 
keratinocytes from the epidermis were then taken into culture. Adeno-viruses, either adeno-NIC or adeno-
Cre, or control adeno-GFP, were added to the culture media and RNA was isolated after 12h and 24h, 
respectively. Total RNA was used as template for cDNA synthesis and subsequent TaqMan® real-time PCR 
analysis. A third condition consisted in the addition of Ca2+ to the medium to induce differentiation of the 
primary keratinocytes after adeno-Cre infection. Total RNA was isolated 24h later. 
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Three candidate genes, namely DEPP, Prickle2 and RhoV, were confirmed to be up-
regulated during NIC signaling and decreased upon loss of Notch1 in primary keratinocytes in 
three independent experiments (Fig.3A and B). In addition, the RNA expression of all three 
candidate genes showed a slight increase during calcium-induced differentiation and a strong 
decrease when this differentiation process was induced after Notch1 deletion (Fig.3C and D). 
These observations strongly suggest a role for DEPP, Prickle2 and RhoV as downstream 
targets of Notch signaling in murine keratinocytes. 
 
 
We first decided to focus on DEPP and RhoV for cloning as they have short coding 
sequences, 618bp and 712bp, respectively. Their cDNAs were amplified from murine NIC-
overexpressing keratinocytes and were subsequently cloned into the pBluescriptSK+ backbone 
Figure 3. TaqMan® real-time analysis of the three potential candidate genes DEPP, Prickle2 and RhoV. 
Fold change in RNA expression upon gain of function (A), loss of function (B), differentiation (C) and 
differentiation after loss of function (D) represents strong up- and down-regulation depending on the 
condition applied. (E) RhoV RNA expression graph summarizes the differential regulation of the potential 
candidate gene upon all three main conditions. All bar graphs are representative of three independent 
experiments. Relative fold change was normalized to GAPDH expression. 
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via NotI/HindIII. The sequences were controlled by sequencing with the T7 primer, which is 
localized upstream of the ligated cDNA. 
DEPP primer set:  5’ATCTGCGGCCGCCAGCACATCGTCCTGACTGTCC 3’ 
5’ATCAAGCTTCTAGGAATTGCCCAGTCCCTGC 3’ 
NotI HindIII DEPP cDNA 
RhoV primer set: 5’ AACTGCGGCCGCGAACCTGCTTCCCCGAGTGCC 3’ 
 5’ CATAAGCTTCCCTGCCAGTACCCGATGTCTC 3’ 
NotI HindIII RhoV cDNA 
Due to the wide array of potential functions of RhoV in keratinocyte differentiation, the 
small GTPase was chosen for further analysis and characterization in the skin. 
2.2 RhoV as a potential direct Notch target gene 
In silico analysis of the promoter region of RhoV revealed three putative RBP-J 
transcription binding sites as well as two such sequences in its second intron (Fig.4A). Both 
regions were cloned into a luciferase reporter plasmid: one including the three putative 
binding sites upstream of the transcription start site (RhoVprom) and the other reporter 
containing the two sites found within intron 2 (RhoVint2). The relative luciferase units were 
recorded in transfection assays using Hela cells. These cells were also transfected with 
different amounts of a NIC-expressing plasmid. Notch signal induction efficiency was tested 
in parallel with a 12RBP-luciferase reporter which was strongly activated by NIC expression 
(data not shown). Upon NIC transfection with each RhoV reporter plasmid a slight activation 
of both luciferase reporters was observed, with a higher increase when using the RhoVprom 
(Fig.4B). Although the increase of the latter was quite low, representing less than a 2-fold 
change, it was nonetheless observed in three independent experiments. 
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In order to study the role of RhoV in vivo, we first investigated RhoV expression in 
wild-type (wt) epidermis. We could discriminate between genomic DNA and mRNA by using 
PCR primers flanking introns 1 and 2 of RhoV. The PCR amplification identified an 836bp 
band from genomic DNA and a 468bp product from cDNA. The difference in product sizes 
allowed discrimination of any contaminating genomic DNA. 
RhoV RT primer set: 5’CAGCCTCATCGTCAGCTACA 3’ 
   5’ CCGAGTCGAACACCTCCTT 3’ 
The RT-PCR results on a sample from scraped wt epidermis indicated that transcription 
of RhoV does occur in wt skin (Fig.5A). In addition, to get a view of the localization of 
mRNA within the epidermis, we performed an in situ hybridization (ISH) on P1 and adult 
skin sections. Hybridization of the antisense probe, specific to RhoV mRNA, revealed 
expression in the lower layers of the epidermis as well as in the bottom region of the cortex of 
hair follicles (Fig.5B).  
Figure 4. Luciferase assay on putative RhoV RBP-J binding sites. (A) Three consensus RBP-J binding 
sequences (blue arrows) are represented upstream of the RhoV transcription start site (black arrow). Their 
exact locations are indicated (blue numbers). Two putative sites are also situated within the 2nd intron (green 
arrows and numbers). Pink boxes: exons. (B) The bar graph represents the luciferase assay in transfected 
Hela cells of putative RBP-J binding sites of RhoV cloned upstream of a luciferase reporter gene. When 
two increasing amounts of a NIC-expressing plasmid (250ng and 400ng) were co-transfected, a slight 
increase in luciferase expression was induced. RLU: relative luciferase units normalized to renilla luciferase. 
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Moreover, we hypothesized that if RhoV is a downstream target of Notch signaling, the 
ISH signal should be stronger in mice over-expressing NIC in the epidermis and, conversely, 
lower in skin from mice with loss of Notch signaling. For this purpose, we used either the 
RosaNIC transgenic mouse line or the Notch1lox/lox homozygous mice. The RosaNIC allele 
consists of a Neo/Stop cassette, flanked by loxP sites, upstream of the intracellular domain of 
Notch1 and targeted to the Rosa26 locus. Cre-mediated deletion of the Stop sequence 
removes the transcription blockade resulting in tissue-specific NIC expression (Murtaugh et 
al., 2003). In order to over-express NIC in the skin, RosaNIC mice were crossed with K14Cre 
mice, which express the Cre recombinase in the basal layer of the epidermis. ISH on skin 
from NIC K14Cre P1 mice showed an increase in signal compared to the NIC control 
(Fig.5C). The signal in the control is barely detectable because the amount of antisense probe 
was decreased from 100ng to 50ng to lower the background in the NIC K14Cre sample. As 
for down-regulating the Notch pathway, K14Cre mice were also crossed with Notch1lox/lox 
homozygous mice. However, ISH results on Notch1-deleted skin sections were inconclusive 
(data not shown). 
 
 
Figure 5.  RhoV transcriptional expression in the skin. (A) RhoV cDNA is amplified in wt scraped 
epidermis when reverse transcriptase is added to the reaction (+RT vs –RT). L: 1kb DNA ladder. (B) ISH 
for RhoV mRNA on P1 and adult wt skin sections. (C) RhoV ISH signal increases in NIC K14Cre P1 skin. 
Bar: 50m. 
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Taken together, the RT-PCR and ISH data demonstrate expression of RhoV, at the 
transcriptional level, in wild-type murine skin. 
2.3 Generation of RhoV transgenic mouse lines 
In the last section we have shown the expression of RhoV in the skin, although in vitro 
data did not confirm the small GTPase to be a direct downstream target gene of Notch 
signaling. We thus decided to investigate its function in vivo by generating skin-specific gain- 
and loss-of-function mutant mice. For this purpose two different constructs were used: a 
dominant active and a dominant negative form of RhoV. The constitutively active RhoV 
(RhoVAc) is characterized by a valine substitution at glycine 40 (G40V) which blocks GTP 
hydrolysis by GTPase-activating proteins (GAP) (Aronheim et al., 1998). The dominant 
negative version (RhoVDn) has its serine at position 45 substituted by asparagine (S45N). 
This mutation locks the Rho GTPase in a GDP-bound inactive form which stays bound to 
guanine nucleotide exchange factors (GEF) (Aronheim et al., 1998). As a result the GEF are 
no longer available to interact with endogenous RhoV, which are then forced to stay inactive 
as well (Fig.6). Both constructs were shown to be functional by RhoV-induced ubiquitin-
mediated degradation of one of the Rho GTPase’s direct effectors p21-activated kinase 1 
(Pak1) (Weisz Hubsman et al., 2007). 
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Dr. Aronheim kindly provided us with the pCEFL-Chp plasmids which consist of a 
myc-tagged RhoV (Chp) cDNA cloned from rat. The rat RhoV cDNA sequence shares 96% 
homology with murine RhoV. In order to track cells expressing the transgene, the wt as well 
as both mutated forms, RhoVAc and RhoVDn, were first subcloned into pcDNA3.1+ and 
subsequently coupled to an internal ribosome entry site (IRES) upstream of a GFP reporter 
cloned from the retroviral vector MigR1. The green fluorescence was tested by transfection of 
each plasmid into 293T cells and, indeed, expression of the GFP was observed using 
fluorescence microscopy 24h later (Fig.7). Specific mutations for the active and negative 
forms of RhoV, i.e. G40V and S45N respectively, were confirmed by sequencing reactions of 
the plasmids using the T7 primer located upstream of the transgene. 
.  
Figure 6. Schematic representation of a Rho GTPase’s activity cycle. (A) Rho GTPases (pink) are found in 
an inactive GDP-bound form, as they bind to guanine nucleotide dissociation inhibitors (GDI), and in an 
active GTP-bound state. Guanine nucleotide exchange factors (GEF), upon external stimuli (red arrow), 
activate the Rho GTPases by exchanging the GDP for a GTP. Once in an active state the Rho GTPase can 
interact with effectors, thereby inducing the cell to respond, depending on the type of stimulus and the 
GTPase involved. GTPase-activating proteins (GAP) then catalyze the hydrolysis of the GTP, which 
inactivates the Rho GTPase. (B) Constitutive active form of RhoV stays bound to its GTP which can no 
longer by hydrolyzed by the GAP. (C) Dominant negative form of RhoV binds to the GEF permanently, 
thereby titrating out the GEF and blocking other RhoV molecules in a GDP-bound inactive state. 
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Thereafter, according to the mRNA pattern of RhoV obtained by ISH, and knowing that 
Notch1 is mainly expressed in the suprabasal layers of the epidermis, we designed three 
different strategies to counteract Notch signaling during skin development and keratinocyte 
differentiation. Since our data suggest an induction of RhoV through Notch signaling, we 
cloned the RhoVDn transgene downstream of the involucrin promoter. This promoter will 
drive expression of the RhoV dominant negative form in the suprabasal layers (Fig.8A), 
where the Notch receptors are normally expressed, and in the inner root sheath of the hair 
follicle (Uyttendaele et al., 2004). Conversely, the RhoVAc transgene is expressed under the 
control of the human keratin14 promoter (Fig.8A), which is induced in the basal layers of the 
epidermis (Vassar et al., 1989).  
Additionally, ISH results strongly suggest RhoV expression in the matrix region of the 
hair follicle. Moreover, Notch1 expression has been shown in matrix cells and precursor cells 
of the cortex and inner root sheath (Lin et al., 2000). Therefore, the third transgenic mouse 
generated comprises of the RhoVDn transgene driven by the mouse hair keratin A1 
(MHKA1) promoter (Fig.8C). MHKA1 and Notch1 RNA expressions overlap (Lin et al., 
2000) allowing investigation of the role of RhoV in hair development and homeostasis and its 
potential link to Notch signaling. 
 
Figure 7. Expression of mutated forms of RhoV. 
(A and B) Cultured 293T cells were transfected 
with either RhoVAc (A) or RhoVDn (B) plasmids 
which express GFP after an internal ribosome 
entry site sequence.  
 61 
 
 
After several cloning steps to generate the corresponding transgenes, each one was cut 
out of the backbone (Fig.8B and D) and given to the transgenic animal facility for pronuclear 
injections. All mice generated were screened by PCR for presence of the transgene. A total of 
141 potential transgenic mice were screened as follows: 60 RhoVAc (hereafter HKRAB), 28 
RhoVDn with the involucrin promoter (hereafter IRNB) and 83 for the RhoVDn driven by 
MHKA1 (hereafter HairKRNB).  
Genotyping primer set:  5’CGCCTGGAGAAGAAACTGAA 3’ 
    5’ACACCGGCCTTATTCCAAG 3’ 
Figure 8. Schematic expression of the three different transgenes and their linearization. (A) RhoVDn driven 
by the involucrin promoter is expressed in the spinous layer of the epidermis and the RhoVAc driven by the 
human K14 promoter is expressed in basal cells. Restriction enzymes used for linearization are given by 
arrows and the subsequent fragment size is noted. Epidermis taken from review (Wilson and Radtke, 2006). 
(B) Agarose gel picture of linearized plasmids for corresponding digested transgenes. (C) RhoVDn driven 
by MHKA1 promoter shows expression in cortex and matrix cells of the hair follicle. Hair follicle adapted 
from (Fuchs and Raghavan, 2002). (D) Agarose gel picture of linearized PvuI/XbaI transgene. SmartL: 
DNA Smart ladder; L: 1kb DNA ladder. 
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Potential positive transgenic mice were confirmed by Southern blot analysis. Genomic 
DNA was digested with NcoI restriction enzyme and the RhoV cDNA was used as a probe to 
hybridize to the 3.8kb wt band and to the transgenic 1.8kb fragment. There were 5 HKRAB, 5 
IRNB and 7 HairKRNB transgenic (Tg) mice confirmed by Southern blot hybridization 
(Fig.9). The Tg mice were then bred with C57Bl/6 mice to assess germline transmission. 
 
 
 
Each founder line was then analyzed by RT-PCR for expression of the transgene in the 
epidermis. Western blot analysis was also performed to investigate protein expression. 
Finally, transgenic mice were sacrificed at several time points and their skin analyzed by 
immunohistochemistry for various proliferation and differentiation markers 
Figure 9. Screening of RhoVAc and RhoVDn transgenic founder lines by Southern blot analysis. RhoVAc 
transgene is driven by the human keratin14 promoter (A) while the RhoVDn is driven either by the 
involucrin promoter (B) or the MHKA1 promoter (C). After NcoI digestion of genomic DNA from the 
various potential transgenic mice, hybridization with RhoV cDNA as a probe (red bar) identified five (one 
not shown), five and seven founders bearing the 1.8kb transgene, respectively. The 3.8kb wt band was 
present in all mice. 
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2.4 Analysis of the active RhoV-expressing transgenic mouse line 
After pronuclear injection of the RhoVAc transgene controlled by the human keratin14 
promoter, 60 mice were first screened by PCR. Potential positive mice were then confirmed 
by Southern blot hybridization for presence of the transgene (Fig.9A). Five transgenic 
HKRAB founders (F0) were backcrossed into C57Bl/6 to generate offspring for each line. 
Four of these F0 breeders conferred germline transmission. To verify the expression of the 
constitutive active RhoV, several mice from each F0 line were sacrificed and their skin 
isolated. The epidermis was then scraped for subsequent RNA extraction. RT-PCR for 
RhoVAc and for GFP on samples from transgenic and littermate control mice revealed 
transcription of the transgene in one single founder line F0 26151 (Fig.10). The F0 26151 line 
also had the highest copy number of the transgene, 208 copies, as measured by densitometry 
of the phosphorimager scan of the Southern blot (Fig.9A). 
 
 
 
Since the RT-PCR for RhoVAc and eGFP both confirmed expression of the transgene 
in one founder line, we sought to analyze the phenotype of F0 26151 offspring. Skin was 
isolated from 2-day old (P2) and 18-day old (P18) HKRAB transgenic mice and their 
littermate controls. After 4% PFA fixation, skin sections were immunostained for several 
proliferation and differentiation markers. No overt skin morphology abnormality was 
observed by haematoxylin/eosin (H&E) staining. Proliferation was not impaired as detected 
by staining for the proliferation marker Ki67 on P2 sections. Immunostainings for basal cell 
specific K14 and spinous layer marker K1 were similar (Fig.11). 
Figure 10. Expression of the RhoVAc transgene in 4 founder lines. The first panel represents the transgene-
specific PCR (HKRAB), while the second panel is the GFP reporter PCR (eGFP). F0 line number 26151 
expresses both transgenes, compared to the three other F0 lines (26145, 26312 and 26327). The bottom panel 
is the -actin control PCR. One control and one or two transgenic mice are shown for each F0 line. Genomic 
DNA was used as positive control for each PCR reaction (last lane). 
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The immunological stainings suggest that overexpression of the RhoVAc in the basal 
layer of the epidermis does not effect skin homeostasis. Nonetheless, Rho GTPases are 
involved in cytoskeleton remodeling and regulation of cell migration. Moreover, RhoV was 
shown to induce lamellipodia in porcine endothelial cells (Aronheim et al., 1998). Thus, we 
hypothesized that RhoV might play a role during re-epithelialization processes such as during 
wound repair. The healing process can be divided into three stages. The first reaction is 
inflammation when a fibrin clot forms with neutrophils and platelets to protect from incoming 
bacteria. Secondly, from 2 to 10 days after injury, a scab has formed at the surface and new 
tissue forms with new blood vessels and inward migration of epithelial cells. The final stage 
can last from several months to a year when the tissue is remodeled by disorganized collagen 
from fibroblasts and extracellular matrix proteins. A typical feature of healed skin is the 
absence of normal appendages such as hair follicles and sweat glands (Gurtner et al., 2008). 
The role of RhoV during tissue repair was investigated by wounding control and Tg 
adult mice by means of 5mm biopsy punches on their formerly-shaved back skin. Wounds 
Figure 11. Histological analysis of HKRAB transgenic mice. H&E, Ki67, K14 and K1 stainings were 
performed on skin sections from a control (Ctrl) and a HKRAB transgenic (Tg) mouse isolated 2 days (P2) 
and 18 days (P18) after birth. Bar 100m. 
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were monitored and isolated 4 days and 12 days post-wounding. Stainings for morphology 
and proliferation were conducted on sections from the 4% PFA-fixed wounds. Both control 
and Tg mice showed similar healing efficiency by 4 days with strong cell proliferation at the 
edges of the wound (Fig.12A). After 12 days the wounds of both HKRAB Tg and control 
were closed and barely visible by eye (Fig12B). 
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Figure 12. Wound healing in HKRAB transgenic mice. (A) Picture of an HKRAB Tg next to a littermate 
control represents the back wounds 4 days after injury. Similar healing processes are observed by 
morphology (H&E) and proliferation (Ki67 staining) where the proliferative edge of the wound is shown by 
an arrowhead. Immunofluorescence staining for basal layer marker K14 is marked in red. E: epidermis; Es: 
eschar; G: granulation tissue; HE: hyperproliferative epithelium; Star: unspecific staining of the scab. (B) 
Pictures from back wounds after 12 days show complete closure. 
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Taken together these results suggest that constitutive activation of RhoV in K14-
expressing cells of the skin does not impair homeostasis or tissue re-epithelialization such as 
the wound healing process. However, we can not exclude that the transgene was not 
expressed at the protein level since Western blot analysis on scraped Tg epidermis, with an 
antibody against GFP, did not detect any reporter expression. We also cultured primary 
keratinocytes from HKRAB Tg newborns, hypothesizing that this would enrich for GFP 
expressing cells driven by the K14 promoter. Yet again, no green fluorescence was detected 
under the microscope after 24 and 48h in culture. Therefore, we conclude that the 
constitutively active RhoV protein is either not expressed in the Tg mice or that it is expressed 
at undetectable levels, which might not suffice to impede on skin homeostasis. 
2.5 Analysis of the involucrin-driven dominant negative RhoV-expressing transgenic 
mouse line 
Similarly to the generation of HKRAB Tg mice, the linearized involucrin-driven 
RhoVDn was injected into pronuclei by the transgenic animal facility. Thereby 28 mice were 
generated and 5 showed integration of the transgene (Fig.9B). Backcrossing into C57Bl/6 
identified four founder lines as germline transmitters. In order to detect expression of the 
transgene skin was isolated from their offspring and the epidermis was scraped. The RNA 
was extracted and cDNA was synthesized as template for RT-PCR for the RhoVDn. One 
founder line F0 1807 expressed RhoVDn and the GFP reporter at the RNA level (Fig.13). 
 
 
 
Figure 13. Expression of the RhoVDn transgene driven by involucrin in 4 founder lines. The first panel 
represents the transgene-specific PCR (IRNB), while the second panel is the GFP reporter PCR (eGFP). F0 
line number 1807 expresses both transgenes, compared to the three other F0 lines (2008, 2018 and 2019). 
The bottom panel is the -actin control PCR. One control and one or two transgenic mice are shown for 
each F0 line without (-RT) and with (+RT) addition of reverse transcriptase during cDNA synthesis. 
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As for the HKRAB Tg mouse line, the expressing F0 IRNB transgenic mouse showed 
the highest transgene copy number in its genome. 165 copies were measured by densitometry 
of the phosphorimager scan of the Southern blot (Fig.9B). Expression of the protein was 
investigated by Western blot analysis using an anti-GFP antibody which recognizes the 
27kDa monomeric protein. Scraped epidermis from 13 and 15 days old IRNB Tg and 
littermate control mice were used as lysates. The RhoVDn-ires-GFP, previously cloned in the 
expression vector pcDNA3.1+, was transfected into 293T cells and used as positive control for 
GFP expression. The GFP protein was detected in both Tg samples as opposed to the wt 
controls, thereby confirming the expression of the transgene in the IRNB Tg mice (Fig.14). 
Green fluorescence was confirmed in IRNB Tg primary keratinocytes taken into culture, 
though at a low level (data not shown). 
 
 
 
 
Since IRNB Tg mice did express GFP at the protein level, we further analyzed the mice 
for skin morphology and proliferation status of their keratinocytes. Control and IRNB Tg 
mice were sacrificed at two time points, P5 and P15, and their skin was fixed in 4% PFA prior 
to paraffin embedding. Skin sections were then stained for H&E, Ki67 and BrdU. The latter 
was injected into the mice intraperitoneally two hours prior to sacrifice. Skin morphology and 
proliferation status of Tg mice showed no difference compared to littermate controls (Fig.15). 
Figure 14. GFP protein expression. Top panel: 
Western blot using an anti-GFP antibody on scraped 
epidermis from P15 and P13 mice detects the 
protein in transgenics (Tg+). The last lane (+) is on 
cell lysate from 293T cells transfected with the 
RhoVDn-ires-GFP plasmid. Bottom panel: anti-
tubulin Western blot for loading control. 
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Morphology and proliferation of keratinocytes were indistinguishable between IRNB 
Tg and control mice. Since Notch signaling is crucial during the differentiation process of the 
basal cells into the upper more differentiated cells of the epidermis, we performed 
immunostainings on the skin sections for K14, expressed in the basal layer, and K1, expressed 
in the spinous layer. At both time points P5 and P15, the Tg mice and their littermate controls 
showed similar expression patterns of both differentiation markers (Fig16). 
Figure 15. Morphology and proliferation state of IRNB Tg mice. (A and B) Skin sections of IRNB Tg 5 day 
old (P5; A) and 15 day old (P15; B) mice are undistinguishable from controls (Ctrl) by H&E, Ki67 and 
BrdU stainings. Arrowheads show BrdU positive cells at P15. Bar: 100m. 
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These results imply that RhoV, through its dominant negative form, does not affect skin 
morphology, proliferation and differentiation during homeostasis. If RhoV plays a role during 
skin remodeling, the dominant negative form RhoVDn would impair the healing process after 
injury. This hypothesis was investigated by performing 5mm biopsy punches on the formerly-
shaved back skin of IRNB Tg mice. The wounds were isolated 4 days post-injury and sections 
were stained for morphology, proliferation by Ki67 and for the basal cell marker K14. 
Morphology and proliferation at the margins of the IRNB Tg wound are similar to control. 
Even though K14 staining was detected under the scab in the control mouse, this was not 
observed in other wt mice, suggesting that the wound of this particular mouse was not as deep 
(Fig17A). Wounds were also isolated 12 days post-wounding and were completely closed in 
both mice (Fig.17B). Thus, the healing process occurred equally well in both the IRNB Tg 
and littermate control mice. 
Figure 16. Immunofluorescence of the differentiation markers K14 and K1. (A and B) Skin sections of 
IRNB Tg 5 day old (P5; A) and 15 day old (P15; B) mice are undistinguishable from controls (Ctrl). Top 
panels: K14 (in red); Bottom panels: K1 (in red). 
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Figure 17. Wound healing in IRNB transgenic mice. (A) Picture of an IRNB Tg next to a littermate control 
represents the back wounds 4 days after injury. Similar healing processes are observed by morphology 
(H&E), K14 immunofluorescence (red) and proliferation (Ki67 staining) where the proliferative edge of the 
wound is shown by an arrowhead. Immunofluorescence staining for basal layer marker K14 is marked in 
red. E: epidermis; Es: eschar; G: granulation tissue; HE: hyperproliferative epithelium; Star: unspecific 
staining of the scab. (B) Picture of closed wounds 12 days after injury and H&E staining show complete 
healing in both IRNB Tg and control mice. Arrows point to the healed region. 
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Taken together, the data imply that the RhoV dominant negative form does not impair 
homeostasis and does not delay the re-epithelialization of the skin. In conclusion, the active 
and negative forms of RhoV do not impede the differentiation process of keratinocytes in the 
murine epidermis.  
2.6 Analysis of the MHKA1-driven dominant negative RhoV-expressing transgenic 
mouse line 
The role of RhoV in the hair follicle was studied by generating transgenic mice in two 
rounds. The first pronuclear injection of the MHKA1-driven RhoVDn generated 53 mice 
from which only 1 showed transgene integration. The transgenic animal facility thus injected 
a second round of pronuclei and generated 30 mice from which 6 had integrated the transgene 
(Fig.9C). By backcrossing into C57Bl/6 mice all HairKRNB founder lines displayed germline 
transmission. Transgene expression was assessed by RT-PCR on scraped skin of their 
offspring. The RNA was extracted and cDNA was synthesized as template for RT-PCR for 
the RhoVDn. Two founder lines, F0 2298 and 2331, had amplified the RhoVDn band 
confirming the expression of the transgene (Fig18.). 
 
 
The two expressing founder lines, 2298 and 2331, were then analyzed for skin 
morphology of their offspring. Hair follicles follow a life cycle of three phases: anagen, 
catagen and telogen. HairKRNB Tg mice were thus sacrificed at different ages corresponding 
to the various phases. Anagen starts during embryonic life and continues to P17 after birth. 
Skin was isolated from transgenic and littermate control mice for each founder at P9 or P12. 
Figure 18. Expression of the RhoVDn transgene driven by MHKA1 in 6 founder lines. The first panel 
represents the transgene-specific PCR (HairKRNB). F0 lines 2331 and 2298 both express the transgene, 
compared to the non-expressing F0 2333. The bottom panel is the -actin control PCR. One control and one 
transgenic mice are shown for each F0 line without (-RT) and with (+RT) addition of reverse transcriptase 
during cDNA synthesis. 
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Skin sections were stained for H&E, for proliferation marker Ki67 as well as for basal cell 
marker K14 and no significant difference was observed in either transgenic line (Fig.19). 
 
 
The first catagen starts at P18 and the subsequent telogen lasts up to P26. Transgenic 
and littermate control mice were injected with BrdU two hours prior to sacrifice and their skin 
was isolated. Morphology, proliferation and K14 immunostainings were undistinguishable 
between the mice for both founder lines (Fig.20). 
Figure 19. Morphology and proliferation state of HairKRNB Tg mice during anagen. Skin sections of 
HairKRNB Tg mice at P9 for founder 2298 and at P12 for F0 2331 are undistinguishable from controls 
(Ctrl) by H&E, Ki67 and basal cell marker K14 (red). Bar: 100m. 
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Adult mice at around P35 have hair follicles which are between the second anagen and 
the second telogen phase. Adult P35 or P37 transgenic and littermate control mice were 
injected with BrdU. Two hours later their back skin was isolated and fixed in 4% PFA before 
paraffin embedding. Morphology, BrdU and K14 immunostainings were performed on the 
sections and were undistinguishable between the control and Tg mice for both founder lines 
(Fig.21). 
 
Figure 20. Morphology and proliferation state of HairKRNB Tg mice at P22. Skin sections of HairKRNB 
Tg mice for both founders 2298 and 2331 are undistinguishable from controls (Ctrl) by H&E, BrdU and 
basal cell marker K14 (red). Bar: 100m. 
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The data of the various hair cycle phases suggest no phenotypic difference in hair 
follicle growth when the dominant negative form RhoVDn was expressed by the MHKA1 
promoter. Moreover, no overt phenotype was observed in either one of the generated founder 
lines. However, RhoV might be involved in the generation of one or more of the four murine 
hair types (auchene, zigzag, awl, guard). To address this question we plucked approximately 
100 hairs from the back pelage of two Tg mice for each founder line. Phenotypically the hairs 
were similar to hairs from littermate controls (Fig.22A and B). We then counted the different 
hair types using a stereo microscope. The three main hair types were identified in both Tg and 
control mice (Fig22C). Preliminary results suggest no hair abnormality and a distribution of 
hair types comparable to wt (data not shown). 
Figure 21. Morphology and proliferation state of adult HairKRNB Tg mice. Skin sections of HairKRNB Tg 
mice for both founders 2298 and 2331 are undistinguishable from controls (Ctrl) by H&E, BrdU and basal 
cell marker K14 (red). Bar: 100m. 
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In conclusion, all hair types were generated and no gross hair growth abnormality was 
observed by immunohistochemical analyses of HairKRNB Tg mice. Therefore, if protein 
expression of the dominant negative RhoV is confirmed, its expression in the cortex of the 
hair follicle does not hamper normal development of any hair type. 
Figure 22. Different hair types of HairKRNB Tg mice. (A and B) Pictures of hairs visualized under the 
stereo microscope for founder 2298 (A) and founder 2331 (B) are undistinguishable from control (Ctrl). (C) 
Picture of three hair types found in all mice, Tg and ctrl: zigzag, awl and auchene. 
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3. Discussion and perspectives 
In an attempt to decipher the mechanisms of Notch signaling in the skin, we have 
identified and confirmed by quantitative RT-PCR three potential downstream Notch1 target 
genes. DEPP, Prickle2 and RhoV were up-regulated upon NIC-overexpression and down-
regulated after Notch1 deletion in cultured murine primary keratinocytes. 
As briefly mentioned in the introduction, the DEPP knockout mice were generated by 
targeting an eGFP-Cre fusion gene into the DEPP locus, thereby replacing the entire predicted 
coding sequence of the gene. This strategy allowed visualization of DEPP expression in 
subsets of endothelial cells and in settings of adult neo-vascularization, such as during 
tumorigenesis and skin wound healing. Even though DEPP was expressed in several organs, 
e.g. kidney, lung and liver, homozygous mutant mice develop normally and do not exhibit any 
physiological defect (Shin and Anderson, 2005). Since the DEPP knockout mice were 
cryopreserved and that no skin phenotype was observed, we decided not to investigate this 
gene further. 
The second potential target gene Prickle2 was identified as an antagonist of the planar 
cell polarity (PCP) pathway involved, for example, in polarization of vestibular sensory cells 
of the inner ear (Deans et al., 2007). The PCP pathway was characterized in Drosophila and is 
conserved in vertebrates. PCP signaling is triggered by non-canonical Wnt proteins which 
interact with the Frizzled family of seven-transmembrane receptors to transduce signaling to 
the c-Jun-N-terminal kinase (JNK) pathway, possibly via Rho/Rac GTPases (Reviewed in 
Jenny and Mlodzik, 2006). The potential link between Notch and PCP signaling was 
investigated in cell fate determination of photoreceptors of the Drosophila eye. Experiments 
with dominant negative and dominant active forms of several components of the Rho/Rac 
GTPases and JNK cascade did not alter Notch signaling in the R3/R4 cells (Strutt et al., 
2002). These investigations suggested that the PCP pathway was not sufficient to regulate 
Notch signaling in the fly photoreceptors. These observations, in addition to the fact that the 
murine Prickle2 cDNA was difficult to clone, prompted us not to pursue the characterization 
of this potential Notch target gene. 
The focus of this study was the role of the potential Notch target gene RhoV in the skin. 
We first demonstrated the expression of the mRNA in wt murine epidermis by RT-PCR and 
by ISH. The ISH results detected RhoV mRNA in the epidermis as well as in the hair follicle 
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matrix region. In addition, we conducted luciferase assays in vitro to investigate a potential 
direct interaction of the NIC/transcription factor RBP-J complex with putative binding sites 
localized upstream of the transcription start site and within the 2nd intron. The slight increase 
in luciferase activity observed opens the question of RhoV as a direct vs. indirect target gene. 
To test if direct binding to a site within the RhoV genomic sequence occurs upon Notch 
activation, a chromatin immunoprecipitation should be performed. In addition, RT-PCR of 
RhoV mRNA from cells treated with an inhibitor of protein synthesis, e.g. cyclohexamide, 
could also indicate if de novo proteins are necessary for its transcription. Furthermore, in 
silico analysis revealed another RBP-J putative binding site in the 3rd exon as well as a RBP-
Ebox-RBP motif localized 212bp downstream of the 3rd exon, which should be investigated. 
We have shown RhoV expression in wild-type skin and hence decided to generate three 
different transgenic mice to study the role of RhoV in vivo. We expressed either constitutively 
active or dominant negative RhoV in various parts of the skin by using different promoters. 
The RohVAc form was driven by the K14 promoter and we generated the HKRAB Tg mice. 
The RhoVDn form was either driven by the involucrin promoter or the MHKA1 promoter, 
thereby generating the IRNB Tg and the HairKRNB Tg mice, respectively. 
The generated transgenic lines were first backcrossed into C57Bl/6 to assess germline 
transmission. Skin samples from the offspring were then analyzed by RT-PCR for transgene 
expression. One HKRAB Tg, one IRNB Tg and two HairKRNB Tg mice expressed the 
corresponding mutated form of RhoV, RhoVAc or RhoVDn. Protein expression was then 
investigated by Western blot analysis for GFP as readout of transgene expression.  
HKRAB Tg mice were first tested for protein expression. No GFP was detected in 
scraped epidermis samples from the HKRAB Tg mouse line. Moreover, no green 
fluorescence was observed in HKRAB Tg primary keratinocytes taken into culture to enrich 
for K14-expressing non-differentiated cells. The GFP expression was also investigated by 
directly observing, by fluorescence microscopy, sections of skin fixed in OCT, or by 
immunostaining for GFP. Both methods were inconclusive and could be explained by a level 
of protein expression below detection. However, we can not rule out the possibility that the 
RhoVAc protein is not expressed in the HKRAB Tg mice. 
In contrast to HKRAB Tg mice, GFP expression was detected in scraped epidermis 
from IRNB Tg offspring. Green fluorescence was confirmed in primary keratinocytes in 
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culture, though at a low expression level. RhoV expression was also investigated directly by 
Western blot analysis with an anti-RhoV. This polyclonal antibody was generated against a 
peptide from a unique region at the carboxyl terminus of RhoV (Aronheim et al., 1998). The 
36kDa protein was detected in 293T cells transfected with a RhoV-expressing plasmid, but no 
protein could be detected in lysates from epidermis. Consequently, the conditions for the anti-
RhoV using epidermal samples need to be improved. 
Finally, HairKRNB Tg mice were analyzed for protein expression. Western blot 
analysis on hair follicles was hindered by the highly keratinized structure of the hair, which 
contains a large amount of hard -keratins. To increase the protein extraction yield a non-
detergent lysis, described as the Shindai method (Nakamura et al., 2002), was tested on hairs 
plucked from the back pelage of transgenic mice. The first extraction following this protocol 
was non-conclusive and needs to be repeated.  
Once the expression of the transgene confirmed by RT-PCR, and by Western blot 
analysis for the IRNB Tg mouse line, all three strains of transgenic mice were investigated by 
histological analyses of their skin at several ages. Morphology by H&E and proliferation state 
by Ki67 or BrdU stainings showed no developmental abnormalities. Differentiation was not 
impaired in any of the Tg as investigated by K14 and K1 immunostainings. Immunostainings 
for more differentiation markers, such as loricrin and filaggrin, could be performed in order to 
confirm the absence of differentiation defects. 
Histological analyses suggested that disruption of RhoV does not impair homeostasis of 
the skin, implying that the small GTPase may play a role in challenged conditions. This 
hypothesis was tested by wounding both HKRAB and IRNB Tg mice and following the 
healing process. No overt defect in morphology and re-epithelialization of the epidermis of 
the wound was observed after 4 and 12 days post-wounding in any of the Tg lines. Further in 
vitro characterization of the migratory capacity of the keratinocytes should also be 
undertaken. Migration can be estimated by a scratch assay on primary keratinocytes. The cells 
in culture are treated with mitomycin C, to inhibit DNA synthesis and thus proliferation, and 
monitored after 24 hours for potential migratory defects. 
Furthermore, the immediate reaction to injury is an inflammatory response, consisting 
of inward migration of platelets at the wound and subsequent formation of new blood vessels. 
We can thus also investigate the inflammation and angiogenesis responses induced by the 
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wounding in RhoVAc- and RhoVDn-expressing mice. For this purpose, CD31 expression was 
analyzed on wound sections. The CD31 glycoprotein is expressed on endothelial cells as well 
as in platelets and is involved in cell signaling and adhesion. The CD31 immunostaining on 4 
days post-wounding skin sections, from both HKRAB and IRNB Tg mice, were not 
conclusive. The immunostaining can be repeated by changing the conditions and another 
specific staining for neutrophils, for example, can be performed. 
In order to verify if RhoV is indeed downstream of Notch signaling, HKRAB and IRNB 
transgenic mice were crossed with Notch1lox/lox K14Cre mice. As Notch1-deleted mice lose 
their hair and spontaneously develop BCC tumors, the triple transgenic mice were monitored 
for either a rescue or an increased severity of the phenotype. Preliminary observations of 
HKRAB Tg Notch1lox/lox K14Cre mice suggest similar phenotypes since they exhibit a hair 
loss comparable to their Notch1-deleted littermates. However, the mice analyzed range from 6 
to 8 months old, and thus have not developed any skin cancer, yet. Monitoring of the 
phenotype progression, as well as IRNB Tg crosses with Notch1lox/lox K14Cre mice, are 
ongoing. 
Taken together, the data suggest a non-essential role of RhoV during skin homeostasis 
and wound healing. Active and negative forms of RhoV did not impair skin development and 
tissue remodeling even though RhoV was expressed in the epidermis and hair follicle. 
Therefore, a deeper understanding of the potential roles of the candidate target gene should be 
characterized by more gain- and loss-of-function assays.  One method is overexpression of the 
gene in vitro, which can be induced by infection of cultured murine primary keratinocytes. 
The adeno-virus specifically expressing RhoV can be generated by cloning the cDNA into an 
adenoviral vector. Infected cells can then be analyzed for their differentiation status by 
investigating the expression levels of markers such as K1 or loricrin. Deciphering the 
pathways activated or down-regulated by this potential Notch downstream target gene can be 
undertaken by Western analysis of proteins involved in keratinocyte differentiation and 
migration, or of proteins which are potentially downstream of Rho GTPases. 
In combination with overexpression, another method to analyze the function of the 
candidate gene is siRNA knock-down. After transfection into primary keratinocytes of the 
siRNA specific for RhoV, potential downstream signaling pathways can be investigated by 
Western blot analysis or microarray studies. 
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One hypothesis for the non-essential role of RhoV in the skin, suggested by this project, 
is a partial or complete compensatory effect of other Rho GTPases. In mammals, the Rho 
GTPase family is composed of 23 genes. The best-characterized members of the small Rho 
GTPase family are RhoA, Rac1 and Cdc42. Phylogenetic studies have revealed a remarkable 
conservation among the Rho GTPases throughout evolution, from yeast to humans. Gene 
duplication and divergence has expanded the family to several closely related subfamilies 
with each gene playing slightly different roles (Wherlock and Mellor, 2002). RhoV and 
RhoU, also known as Wrch1, are the two members of a subfamily sharing over 50% amino-
acid sequence identity with Cdc42. RhoV and RhoU differ by additional unique sequence 
extensions at both N- and C-termini and they share a 54% amino-acid sequence identity. 
RhoU was first described as a gene increased in response to Wnt1-mediated signaling, 
such as in Wnt1 transgene-induced mouse mammary tumors and Wnt1 retrovirus infected 
cells. Infection of Swiss 3T3 cells with a recombinant RhoU-expressing adenovirus induced 
filopodia and stimulated quiescent cells to reenter the cell cycle (Tao et al., 2001). 
Furthermore, RhoU was shown to regulate focal adhesion formation and cell migration in 
vitro. Indeed, RhoU siRNA knockdown in HelaS3 cells increased focal adhesion formation 
and inhibited cell migration in response to wound healing (Chuang et al., 2007). In order to 
test redundancy between RhoU and RhoV, RhoU expression should first be investigated in 
murine skin by RT-PCR and ISH. If both expressions do overlap, deleting both RhoV and 
RhoU in the epidermis might impair skin development and/or homeostasis. However, 
deregulation of RhoU was not detected in the Affymetrix microarray analysis conducted 
originally.  
Several studies investigated the involvement of Rho GTPases in adhesion and migration 
of keratinocytes (Benitah et al., 2005; Lock and Hotchin, 2009). Most recently, RhoA was 
shown to signal through ROCK effectors in human keratinocytes and thereby regulate cell 
adhesion to fibronectin and terminal differentiation (Lock and Hotchin, 2009). In mouse 
epidermis, Rac1 was expressed in undifferentiated cells of the basal layer, in the bulge and the 
bulb of the hair follicle. Conditional deletion of Rac1 led to epidermal stem cell depletion by 
disrupting adhesive interactions between stem cells and their niche. Consequently, basal cells 
lacking Rac1 divided and underwent terminal differentiation inducing partial or complete loss 
of the IFE cell layers (Benitah et al., 2005). In fact, Rac1 was identified during the Affymetrix 
gene chip analysis in two conditions, the gain- and the loss-of-function with calcium-induced 
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differentiation. Nonetheless, quantitative RT-PCR in both settings did not determine Rac1 as 
a robustly deregulated potential downstream target gene of Notch1. Rac1 expression was 
slightly increased by 1.4 fold upon NIC-adenovirus infection of primary keratinocytes and a 
modest 0.8 fold change was detected upon adeno-Cre infection with Ca2+ addition (data not 
shown). No significant change in mRNA expression was detected upon loss of Notch1 alone. 
Hence, if the effects of RhoVAc and/or RhoVDn in the transgenic mice were rescued by 
another Rho GTPase, Rac1 may be a minor but not the sole contributor. 
In addition, the Rho GTPases share common downstream effectors such as the 
serine/threonine protein kinase family known as p21-activated kinases (PAK). PAK proteins 
specifically interact with Cdc42, Rac (Manser et al., 1994; Zhao and Manser, 2005) and RhoV 
(Aronheim et al., 1998). The activated forms of the Rho GTPases bind to a p21 binding 
domain which induces autophosphorylation of PAK and subsequent kinase activity. Whereas 
Rac1 was shown to negatively regulate c-Myc through phosphorylation of PAK2 in mouse 
epidermis (Benitah et al., 2005), RhoV and Cdc42 triggered autophosphorylation-dependent 
degradation of PAK1, 2 and 3 in vitro (Weisz Hubsman et al., 2007). Common characteristics 
in effector-binding and in signaling potential might contribute to the redundancy among Rho 
GTPases. As Cdc42 was detected during the Affymetrix microarray analysis, it might also be 
a Notch1 target gene and have overlapping functions with RhoV. Nevertheless, Cdc42 
deregulation upon Notch signaling needs to be confirmed by qRT-PCR. 
In summary, RhoV is dispensable during skin homeostasis and re-epithelialization 
during wound healing, but its function might be more complex due to interplay with other 
small Rho GTPases and effectors. In order to investigate its effects in a more direct setting, 
one could generate RhoV straight knockout mice or conditionally delete the RhoV allele in 
the epidermis. 
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II. Generation of Jagged2 floxed mice 
1. Introduction 
Notch signaling is initiated through the direct interaction of the Notch receptors with 
their specific ligands. All four Notch receptors are activated by either the Delta-like (Dll) 
family of ligands and/or the Jagged (Jag) ligands. The Jagged2 gene encoding the 
transmembrane protein was cloned in mammals in 1996 (Shawber et al., 1996) and was 
shown to be expressed during rat embryogenesis. Co-expression of both Jag2 and Notch1 in 
the apical ectodermal ridge, as early as embryonic day 12.5 (E12.5), suggests a receptor-
ligand interaction during limb development (Shawber et al., 1996). Interaction of Jag2 and 
Notch1 was also suggested to play a role at a later stage in other tissues such as the 
developing thymus, the epidermis and hair follicles as shown by immunohistochemical co-
expression (Luo et al., 1997). A few years later, the mouse Jag2 gene was isolated from a 
multipotent hematopoietic cell line. The full-length Jag2 promoted survival of bone marrow 
progenitors in vitro through direct cell-to-cell contact (Tsai et al., 2000), even though the 
receptor to which it bound was not described. 
 In adult mice, the interplay between Notch receptors and their ligands has also been 
investigated through their differential expression patterns. For example, Notch receptors 1 to 
3 exhibit differential expression patterns not only during thymus development, but also in 
adult thymocyte subpopulations (Felli et al., 1999). The investigators also characterized the 
expression of the Jagged ligands. Whereas Jag1 mRNA expression decreased in the post-natal 
thymus, expression of Jag2 was stable. In addition to the thymus, expression of members of 
the Notch signaling pathway has been well described in the skin. Both Notch1 and Notch2 are 
expressed in the suprabasal layers of the epidermis. While Notch1 is also expressed in the 
basal cells, Notch2 is absent (Rangarajan et al., 2001).  Three Notch ligands were shown by in 
situ hybridization to be expressed in murine epidermis and developing hair follicles, Jag1 and 
2, and Dll1, the latter being only detectable in embryonic skin exclusively in mesenchymal 
cells of the pre-papilla (Powell et al., 1998). More precisely, in the interfollicular epidermis 
(IFE), both Jag1 (Nicolas, 2003) and Jag2 (Fig.1) are primarily found in the suprabasal layers. 
As for the hair follicle, Jag1 is expressed in the upper outer root sheath (ORS) and bulb pre-
cortex while Jag2 shows a complementary expression pattern in the follicle bulb and basal 
layer of the ORS (Watt et al., 2008). 
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Gene targeting in mice further validated the importance of Notch ligands in skin 
development and homeostasis. Specifically, inactivation of Dll1 in embryonic epidermis 
caused increase proliferation and thickness of the IFE (Estrach et al., 2008) whereas loss of 
Jag1 in the mouse epidermis inhibited hair growth and induced conversion of hair follicles 
into cysts (Estrach et al., 2006). The Jag1 conditional knockout mice developed skin tumors 
within 6 months after gene inactivation confirming the tumor-suppressor activity of Notch 
signaling in this self-renewing tissue (Vauclair, 2006). Jag1 inactivation in the skin did not 
phenocopy conditional deletion of Notch1. Gene targeting of Notch1 lead to a gradual hair 
loss and only 10% of hairs remained (Rangarajan et al., 2001; Vauclair, 2006) while Jag1 
deficient mice lost all hairs within a few months. The conditional inactivation of both Notch1 
and Notch2 caused a much stronger phenotype since the mice developed an atopic dermatitis 
(AD)-like disease (Dumortier et al., 2010). The N1N2 inducible inactivation rapidly caused 
severe skin abnormalities, such as complete and irreversible hair loss and hyperproliferative 
epidermoid cysts, and the mice died within 7 weeks post deletion (Dumortier et al., 2010; 
Vauclair, 2006). This premature death and AD-like disease was not recapitulated by the 
inactivation of Jag1 alone, as previously mentioned. This discrepancy suggested a non-
redundant role for Jag2 in the skin. 
Although Jag2 is suggested to play a complementary role to Jag1 in the skin, this Notch 
ligand has not been extensively characterized during epidermal homeostasis. Investigating the 
Figure 1. Jagged2 expression in murine skin. (A and B) Jag2 immunofluorescence (red) shows Jag2 
expression in murine epidermis of a 2-day old newborn (A) and of a 7-week old adult (B), when expression 
is also seen in the hair follicle. Bar: 100m 
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function of Jag2 in the adult skin is hampered by the fact that conventional gene targeting of 
Jag2 is embryonic lethal. Mice that died at or shortly after birth, due to craniofacial 
morphogenesis defects, were homozygous for a targeted mutation which removed the DSL 
domain of the Jag2 protein (Jag2DSL). This domain is required for receptor interaction (Jiang 
et al., 1998). Jag2DSL homozygous mice exhibited fusion of the tongue with the palatal 
shelves and thus were unable to breathe or accumulated air in their stomach and intestines. 
Jag2DSL/DSL mutant mice also exhibited syndactyly of the fore and hind limbs.  
Moreover, the Jag2 gene was mapped near the spontaneous missense mutation sm. 
Jag2sm homozygous mice displayed a similar phenotype, such as fusion of the digits, 
hyperplastic apical ectodermal ridge at the limb buds and postnatal mortality (Gruneberg, 
1956; Sidow et al., 1997). Interestingly, epidermal hyperplasia, producing excessive thickness 
of epidermal cells, was observed in circumscribed areas of the limb epidermis. Additionally, 
premature keratinization, or parakeratosis, occurred from E13 onwards. The latter 
observations suggest a function of Jag2 in keratinocyte proliferation.  
In order to investigate the role of Jag2 at later stages of development and during 
adulthood, we focused on generating floxed Jag2 mice. Homozygous Jag2lox/lox mice could 
then be crossed with specific Cre transgenic mouse strains to conditionally delete the Notch 
ligand in targeted tissues, such as in the hematopoietic system or in the skin. 
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2. Results 
2.1 Generation of the floxed Jag2 targeting vector 
Floxed Jag2 mice are generated to investigate the role of the ligand in a loss of function 
context during adulthood. Generation of the Jag2 floxed mouse line was originally outsourced 
to the company Nucléis (Lyon, France). Nucléis went bankrupt in 2006 and we received the 
targeting vector for the Jag2 gene, which is schematically shown in Fig.2. Briefly, the 
targeting vector consists of the 5’homologous arm upstream of the deletion arm and the 
3’homologous arm was cloned downstream. The deletion arm, flanked by loxP sites, consists 
of exons 1 and 2 of the Jag2 gene which code for the leader peptide and the conserved N 
terminus of Notch ligands (MNNL). It also contains sequences 551bp upstream of the ATG 
and 1443bp within the 2nd intron, summing up to 2.6kb in total. Additionally, a neomycin 
resistance cassette, itself flanked by two 34bp FLP recognition target (FRT) sites, was 
inserted for positive selection and a diphtheria toxin A-chain (DTA) cassette for negative 
selection (Fig.2).  
 
 
Figure 2.  Inducible targeting of the Jag2 gene. (A) The Jag2 gene consists of 26 exons of which the two 
first ones code for a leader peptide and an N terminus common to Notch ligands (MNNL). Also encoded 
are the DSL region which interacts with the Notch receptors, 16 calcium-binding EGF-like repeats and the 
transmembrane domain (TM). (B) The targeting vector consists of the neomycin cassette (pink), flanked by 
FRT sites (red), and exons 1 and 2 (blue) flanked by two loxP sites (green triangles). The homologous Jag2 
regions are depicted as the short arm (grey) and the long arm (orange). HindIII and EcoRI cutting sites are 
indicated by arrows. The red bar corresponds to the localization of the 3’ probe used for Southern blot 
hybridization during the screening of homologous recombination events. 
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The targeting construct was then electroporated into mouse embryonic stem (ES) cells 
by the transgenic animal facility. Subsequently, 480 clones were screened by Southern blot 
for the floxed allele. Double digestion of the DNA with HindIII/EcoRI allowed identification 
of a 9.3kb wild-type band or a 6.7kb band for the correctly targeted locus (Fig.2B and 3). This 
analysis revealed one positive clone (Fig.3) that was confirmed to carry the most 3’loxP site 
by  PCR, using primers within the 2nd intron of the deletion arm and upstream of the long arm 
(Fig.3C). 
3’loxP primers: 5’CTTTTGGTTAGGGGGTCAGG 3’  
 5’GGGCTGCAGGAATTCGATC3’  
 
 
Figure 3.  Southern blot analysis of Jagged2 gene targeted ES cell clones. (A) Representative 
phosphorimager scan from 12 of the 480 clones analyzed by the Southern blot strategy shown in Fig.2B. 
DNA from ES cell clones was hybridized with a probe downstream of the 3’end after double digestion with 
HindIII/EcoRI. One positive clone (arrow) shows the correct recombined 6.7kb band in addition to the 9.3kb 
wt band.  (B) The recombined clone was further confirmed by an independent Southern blot analysis. (C) 
PCR of the most 3’loxP site amplifies a 524bp band as shown schematically on the left. PCR amplification 
on DNA from the positive clone (+) compared to a negative one (-) confirms the presence of the most 
3’loxP site. Green triangles: loxP sites; red boxes: FRT sites; SA: short arm; Neo: neomycin cassette; Ex1/2: 
exons 1 and 2; LA: long arm; L: 1kb DNA ladder with two band sizes given in bp. 
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2.2 Jag2lox/lox founder lines 
The correctly targeted ES cell clone described above was injected into blastocysts by 
the transgenic animal facility and subsequently implanted into pseudopregnant recipients. 
Eight chimeras were born and crossed to C57Bl/6 mice to identify germline transmitters. 
Since the ES cell lines were derived from SV129 substrains, two of the founder lines (F0) 
displayed germline transmission by virtue of the brown coat color of their offspring. The F1 
generations of both founders were intercrossed and genotyped by PCR for the most 3’loxP 
site. Genotyping PCR resulted in only heterozygous lox/+ and wt animals determined by the 
392bp lox band and 200bp wt band (Fig.4B). 
Genotyping primers: 5’GCTCCAAATCGCTACCTGAG 3’ 
 5’GTCCCCAAGACCAAGTACCA 3’ 
 
 
 
Since no homozygote Jag2lox/lox mice could be generated after several litters from 
intercrosses of both founder lines, we hypothesized that the Neo cassette, still present in the 
original targeting construct, might interfere with the endogenous Jag2 gene. This interference 
could induce hypomorphism, i.e. by reducing the level of gene activity, which could explain 
why no homozygote mice were born. Therefore, we decided to set up timed pregnancies and 
investigated three embryonic time points, namely E12.5, E13.5 and E14.5, for embryonic 
lethality. By examining the embryos using the stereo microscope we found no phenotypic 
difference among siblings and no syndactyly was observed, as previously described for 
Jag2DSL  homozygous mice (Jiang et al., 1998). E12.5 and E13.5 embryos were genotyped by 
Southern blot and several mice were indeed Jag2lox/lox homozygotes. Surprisingly, the 
genotypes by PCR on genomic DNA from the very same mice indicated that the mice were 
Figure 4. Southern blot analysis and 
PCR genotyping for floxed Jag2 gene 
do not correlate. Phosphorimager scan 
of Southern blot (A) and 
corresponding PCR (B) for J2lox/lox 
(lane 1), J2+/+ (lane 2) and J2lox/+ (lane 
3). 392bp: lox band; 200bp: wt band; 
L: 1kb DNA ladder. 
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heterozygotes (Fig.4). The discrepancy between results obtained by Southern blot analysis 
and by PCR amplification suggested an incomplete homologous recombination of the 
targeting vector into the Jag2 gene, unless the PCR amplified an unspecific product of the 
same size as the wt band. 
In order to rule out the possibility of an unspecific band instead of the wt band, we 
decided to verify the specificity of the amplified products. We thus isolated the two PCR 
bands, wt and most 3’loxP site, amplified from genomic DNA of a founder, a C57Bl/6 wt 
mouse and from the plasmid containing the original Jag2 targeting vector. Several digestion 
patterns were tested for diagnosis of the correct sequences (Fig.5A). Digestion of the wt and 
3’loxP PCR products with three restriction enzymes, namely AflIII, HindIII and XhoI, 
produced distinct band patterns when analysed by electrophoresis on a high percentage 
agarose gel. This analysis not only revealed the expected digestion patterns for both wt and 
3’loxP site PCR products, but more importantly the patterns of the wt sequence were identical 
(Fig.5B and C). Similar results were obtained for the digestion patterns of the 3’loxP site 
isolated from a J2lox/+ mouse (data not shown). Therefore, we concluded that the products 
amplified by the genotyping PCR were the correct sequences and hence, that the wt allele of 
the Jag2 gene was indeed present in the samples genotyped by this method. 
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2.3 Incomplete homologous recombination of the floxed Jag2 allele 
We have shown that the failure to generate Jag2lox/lox homozygous mice was neither due 
to hypomorphism of the floxed Jag2 allele, nor to the integrity of the most 3’loxP site. We 
thus decided to delete the Neo sequence and to further investigate whether correct 
homologous recombination had occurred in the floxed Jag2 mice.  
As previously described in Fig.2B, the Neo sequence is flanked by FRT sites which 
enable recombination through flipase activity. Excision of the intervening Neo cassette by 
FLP-mediated recombination was tested on the targeting vector by transformation into the 
294-FLP E.coli strain. The bacteria were specifically engineered to express flipase and 
therefore efficiently recombine plasmids containing FRT recognition sites (Buchholz et al., 
1996). Isolated potentially recombined vector DNA was subsequently digested with the 
Figure 5. Specificity of wt and 3’loxP site PCR products verified by digestion patterns. (A) Genotyping 
PCR on founder (F0) and C57Bl6 DNA as well as on the plasmid of the original targeting vector (J2 vector) 
amplifies both products: the wt 200bp (boxed in blue) and the 3’loxP site 392bp (boxed in red). L100: 
100bp Plus ladder. The table displays the values in bp of the diagnostic digestion pattern for each band for 
the three restriction enzymes used. (B and C) Isolated wt band (B; blue) and 3’loxP site band (C; red) are 
digested with enzymes AflIII, HindIII or XhoI. Restriction sites cutting in the PCR products are shown 
schematically above the corresponding agarose gel pictures. A: AflIII; H: HindIII; X: XhoI; L: 1kb DNA 
ladder; L100: 100bp Plus ladder. 
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HindIII restriction enzyme to assess complete excision of the Neo cassette. Three HindIII 
restriction sites are located within the targeting vector, one in the Neo sequence and two in the 
backbone plasmid. Consequently, HindIII digestion of the targeting vector produces two 
fragments instead of three upon Neo deletion by FLP-mediated recombination (Fig.6A). 
Digestion patterns indeed resulted in two bands instead of three after transformation into the 
FLP-bearing bacteria (Fig.6B) demonstrating efficient excision of the Neo cassette from the 
Jag2 targeting vector. 
 
 
Since efficient FLP-mediated recombination of the Jag2 targeting vector occurred in 
vitro, we focused on excision of the Neo cassette in vivo. For this purpose, the J2lox/+ mice 
were crossed with a deleter mouse strain (Flpe+ mice) harboring the enhanced thermostable 
FLPe recombinase gene under the human ACTB promoter. These mice express the FLPe 
recombinase variant in tissues such as the brain, the heart and in germ cells of adult testes and 
ovary (Rodriguez et al., 2000). The F1 J2lox/+ Flpe+ mice were then intercrossed in order to 
obtain hetero- and homozygous mice for the FLPe transgene for efficient expression of the 
recombinase. Complete deletion of the Neo cassette was analyzed by PCR with the upstream 
primer in the short arm region and the downstream primer within the Neo sequence (Fig.7A).  
Figure 6. FLP-mediated efficient recombination of Jag2 targeting vector. (A) Efficient FLP-mediated 
recombination is tested by HindIII digestion (restriction sites represented by arrows) which cuts three times 
in the Jag2 targeting vector. After excision of the Neo sequence (dotted lines) one HindIII restriction site is 
lost resulting in a single 2.8kb fragment instead of the two 571bp and 3.7kb portions. (B) Agarose gel 
electrophoresis of the HindIII digested Jag2 targeting vector after (Rec) and before (original) transformation 
into 294-FLP bacteria. Diagnostic bands are highlighted by arrows with their corresponding sizes. L: 1kb 
DNA ladder. 
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Neo deletion primers:  5’CACTCACTCCCAGGCTGTTT 3’ 
 5’GGGGTGCCTAATGAGTGAGA 3’ 
As deletion of the Neo cassette resulted in the absence of the 188bp band, DNA from 
both founder lines was used as positive controls for its presence (Fig.7B). Not only do these 
PCR results confirm efficient Flp-mediated excision of the Neo sequence in vivo but they also 
prove the presence of the 5’loxP site of the targeting vector in the floxed Jag2 founders. 
We have shown that floxed Jag2 Flpe+ mice carried the FLPe transgene and that the 
Neo cassette was efficiently deleted. However, the wt band was still amplified during the 
genotyping PCR and Southern blot analyses on these same mice again revealed the presence 
of Flpe+ homozygote Jag2lox/lox mice. This observation suggested an incomplete homologous 
recombination. 
We thus investigated whether the presence of the wt Jag2 allele was due to a 
homologous integration of the targeting vector at its 5’end. In other words, we hypothesized 
that only the 3’end had recombined correctly. This incomplete homologous recombination 
would explain the PCR amplification of the wt band since the endogenous gene segment 
would not be replaced by the floxed Jag2 allele at its 5’end. To test this hypothesis we 
designed a Southern blot strategy consisting of an EcoRI digestion and subsequent 
hybridization with a 2.65kb fragment of the deleted region. If exons1 and 2 were correctly 
replaced by the targeting deletion arm, expected bands would be the wt 22kb and the 2.65kb 
from the targeting construct (Fig.7A). Both bands were indeed detected in J2lox/+ and wt 
genomic DNA samples. However, an extra band at about 12kb was identified in both J2lox/+ 
and J2lox/lox mice (Fig.7C) thereby confirming the presence of a third segment containing Jag2 
exons 1 and 2. 
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In an attempt to interpret this unexpected 12kb band and to corroborate a partial 
integration of the targeting vector, we designed a Southern blot strategy to investigate the 
5’loxP region. We have previously shown the presence of the 5’loxP site indirectly, in the 
founders, by the Neo deletion PCR. However, a Southern blot analysis using a probe at the 
boundary of the short arm with the Jag2 genomic sequence would confirm or refute the 
correct homologous recombination event. Double digestion of the genomic DNA with 
DraIII/HindIII would then result in a 2kb band for the targeting construct and a 9.7kb wt band 
Figure 7. Efficient Neo cassette deletion and control of homologous recombination. (A) Primers designed 
for the PCR amplification of the 5’loxP site and Neo cassette are shown by black arrows delimiting a 188bp 
region. The Southern blot strategy for the integration of the deleted region (red bar represents the probe) 
gives a 2.65kb band for the targeting construct and a 22kb wt band after EcoRI digestion (arrows). (B) PCR 
amplification on genomic DNA from floxed Jag2 mice bearing the FLPe transgene shows efficient deletion 
of the Neo sequence. Both founders are shown as positive controls. (C) Phosphorimager scan of Southern 
blot on 10g of genomic DNA from hetero-and homozygote Jag2 mice hybridized with a fragment of the 
deleted region as probe gives an unexpected extra band at about 12kb (violet box). Expected bands are 
shown by arrows with their respective sizes. Bl6wt: DNA from a C57Bl/6 wild-type mouse. 
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(Fig.8A). Surprisingly, not only was the 2kb band not identified on the Southern blot scan but 
an unexpected band about 1 to 2 kb higher than the 9.7kb wt band was detected (Fig.8B). 
 
 
In parallel, several PCR amplifications for both the 5’ and the 3’ loxP sites were 
designed (Fig.9A). The PCRs were performed on genomic DNA from E13.5 embryos of the 
three different genotypes, i.e. wt J2+/+, J2lox/+ and Jag2lox/lox. 
Primer set 1/2:  5’GCTCCAAATCGCTACCTGAG 3’ 
 5’CCAAAGAGCGGAAATACCAA 3’ 
Primer set 3/4: 5’CTAGGCTCCTGCTCCATACG 3’ 
 5’GTCCCCAAGACCAAGTACCA 3’ 
Figure 8. Southern blot analysis of the 5’loxP region of the Jag2 targeting construct. (A) Southern blot 
strategy for 5’loxP region uses a probe (red bar) at the boundary of the short arm with the Jag2 genomic 
sequence. Two restriction enzymes, DraIII and HindIII (arrows), are used in a double digestion of the DNA. 
Dotted lines represent the 2kb targeting construct band and the 9.7kb wt band, respectively. SA: short arm; 
LA: long arm; green triangles: loxP sites; red box: FRT site; Ex1/2: exons 1 and 2. (B) Phosphorimager scan 
of the 5’loxP region Southern blot on 10g of DNA digested HindIII/DraIII from a wt Jag2+/+, a homozygote 
Jag2lox/lox and a heterozygote Jag2lox/+ mouse. The 9.7kb wt band is detected in the wt and Jag2lox/+ lanes as 
expected, but no 2kb band appears in either homo- or heterozygote mice. However, an extra band at about 
11kb is visible in both lanes (question mark). Ladder: 1kb DNA ladder. 
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Primer set 5/6: 5’TGTGCAGCAGGCAGTATCTC 3’ 
 5’GCACAGAACCAGTAGCAGCA 3’ 
Primer set 7/8: 5’GACAGGGAAGCTGAATTTGC 3’ 
Primer set 8/9: 5’ATCGATACCGTCGAAACAGC 3’ 
 5’ACCTACCCTACCTGCGTGTG 3’ 
 
 
As depicted in Fig.8B, PCR amplifications for the two sets of primers in the 3’loxP 
region (1/2 and 3/4) still identified the wt band in the homozygous Jag2lox/lox genomic DNA. 
The 5’loxP site was present downstream of the short arm as amplified by the primer set 8/9 
even though the two PCR reactions that did not work were within the 5’loxP region (5/6 and 
7/8; Fig.9A). 
Taken together, these results suggest an efficient homologous recombination event at 
the 3’end of the targeting construct, but not at its 5’end. An integration of the Jag2 floxed 
Figure 9. PCR amplification strategies for 5’ and 3’loxP sites. (A) Schematic representation of the targeting 
vector shows the emplacement of the primers (arrows) designed for 5 different PCR amplifications. The 
primer sets are designated by numbers which can be found in the table below with their corresponding 
product sizes in bp (wt band and lox band). The PCR strategies that did not give any results are highlighted 
in red (twp rows). (B) Agarose gel pictures show products of expected sizes for the three PCR 
amplifications 1/2, 3/4 and 8/9, respectively. Genomic DNA from embryos of a wt +/+, a J2lox/+ and a J2lox/lox 
genotype were used as templates. L: 1kb DNA ladder. 
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allele in its 5’region has most likely occurred instead of a complete replacement of the 
endogenous Jag2 gene as the wt Jag2 allele was still present in Jag2lox/lox mice. 
2.4 Efficiency of Jag2 inactivation 
The hypothesis of integration in the 5’UTR of the 5’ short arm of the targeting 
construct, instead of its homologous recombination, was further investigated by analyzing the 
inactivation efficiency of the floxed Jag2 allele. In order to recombine the loxP sites flanking 
the deletion arm, Jag2lox/lox homozygote mice were crossed with mice bearing the Cre 
recombinase, such as the MxCre or K14Cre mouse strains. If the hypothesis of partial 
homologous recombination is correct the generated Jaglox/lox MxCre, or K14Cre, mice would 
have their floxed Jag2 allele efficiently excised but nonetheless continue to transcribe a wt 
Jag2 allele. Consequently, the Cre-recombined Jaglox/lox mice would still express a functional 
Jag2 protein (Fig10).  
 
 
Figure 10. Hypothesis of Jag2 transcription and protein expression after Cre-mediated deletion. (A) 
Excision of exons 1 and 2 of correctly recombined Jag2 deletes the translation start site of the gene. 
Consequently, Cre-mediated deletion through MxCre or K14Cre blocks Jag2 protein expression. (B) In the 
case of a partial recombination event, deletion of Jag2 would cause a 5.6kb insertion (red bar) in the 
endogenous gene. As the wt Jag2 gene is still present, the deletion arm excision might not affect Jag2 
protein expression. SA: short arm; LA: long arm; green triangles: loxP sites; red box: FRT site; Light blue 
boxes: exons 1 and 2 which also correspond to the deletion arm (Del Arm); black arrow represents the Jag2 
translation start site (ATG). 
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Jag2 deletion efficiency was first studied in thymocytes, since it was previously shown 
that Jag2 mRNA is expressed in the thymus (Felli et al., 1999). Efficient deletion in the 
lymphoid organ can be achieved by the inducible MxCre mouse strain. The MxCre transgene 
expresses Cre recombinase under the Mx1 (myxovirus influenza resistance 1) promoter. The 
Mx1 promoter is inducible upon interferon (IFN)- or – treatment. Another method to 
induce this promoter is by administration of a synthetic double-stranded RNA (called pI-pC, 
polyinosinic-polycytidylic acid) which stimulates endogenous IFN production. Upon MxCre 
induction floxed alleles are efficiently deleted in many organs, such as the liver, the spleen, as 
well as the thymus (Kuhn et al., 1995). Thus, homozygously floxed Jag2 mice were crossed 
with MxCre mice and offspring were injected 5 times with pI-pC in order to inactivate Jag2 in 
the hematopoietic system. 
To confirm efficient excision of the Jag2 deletion arm Cre recombinase expression was 
induced in a Jag2lox/+ MxCre mouse and its littermate control by administering pI-pC every 
other day for a total of five times. One week after the last injection the Jag2lox/+ MxCre and the 
control mice were sacrificed and genomic DNA was subsequently extracted from their bone 
marrow cells. Cre-mediated excision of the floxed Jag2 deletion arm was revealed by PCR 
amplification (Fig.11A). The deletion PCR correctly amplified the excised region of bone 
marrow DNA derived from the Jaglox/+ MxCre mouse (Fig.11B). 
Deletion primers: 5’TGTGCAGCAGGCAGTATCTC 3’ 
 5’GTCCCCAAGACCAAGTACCA 3’ 
To further confirm the correct excision of the floxed Jag2 deletion arm Southern blot 
analysis was performed. The same DNA as for the deletion PCR was digested with the 
restriction enzyme BamHI and hybridized as indicated in Fig.11A. The probe was located 
downstream of the targeting vector, towards the 3’end, and expected fragments were the wt 
6.64kb, the floxed 6.07kb and the deleted 8.4kb bands (Fig.11A). The wt 6.64kb band was 
indeed identified in DNA derived from the heterozygote mouse, and the floxed 6.07kb band 
was detected in DNA derived from the control Jag2lox/lox mouse. However, instead of the 
8.4kb deleted band, an unexpected band above 12kb was detected in the DNA from the 
Jag2lox/+ MxCre mouse (Fig.11C). 
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Overall, both strategies proved the efficient excision of the floxed Jag2 allele in the 
bone marrow of the Jaglox/+ MxCre mouse. Intriguingly, the Southern blot analysis also 
revealed a higher band instead of the expected deleted band. These data further suggested an 
integration of the 5’short arm of the targeting vector. In order to test if transcription of the 
Jag2 gene occurred despite the partial homologous recombination Jag2 heterozygote mice on 
the MxCre background were intercrossed. The offspring were genotyped by Southern blot 
analysis to generate homozygous Jag2lox/lox MxCre mice. It has been previously shown that 
double negative (DN) thymocytes, as well as CD4 and CD8 single positive T cells, express 
Figure 11. Excision of the floxed Jag2 allele confirmed by PCR and Southern blot analyses. (A) The 
deletion PCR amplifies a 456bp band (dotted lines) after Cre-mediated excision of Jag2 deletion arm (Del 
Arm). The Southern blot strategy consists in a BamHI digestion of the genomic DNA (arrows) and 
subsequent hybridization with a probe located downstream of the targeting vector (red bar). Expected 
fragments are the wt 6.64kb band, the 6.07kb band for the targeting construct and, after excision of the 
deletion arm, the 8.4kb band. (B) Deletion PCR on DNA derived from bone marrow of injected Jag2 control 
and Jag2lox/+ MxCre mice amplifies the 456bp product. L: 1kb DNA ladder. (C) Phosphorimager scan of the 
Southern blot analysis for the excision of the floxed Jag2 allele was performed as depicted in A. 7g of bone 
marrow DNA derived from control Jag2lox/lox (first lane), Jag2lox/+ MxCre (second lane) and C57Bl/6 wt 
(third lane) mice were used for digestion and subsequent hybridization. The unexpected band above 12kb is 
highlighted (pink box). Ladder: 1kb DNA ladder. 
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Jag2 mRNA (Felli et al., 1999). Therefore, Jag2 mRNA expression was assessed in the 
deleted Jag2lox/lox MxCre mice by RT-PCR on extracted total RNA from sorted DN 
thymocytes.  
The sorted DN thymocytes were pooled from 11 Jag2lox/lox MxCre and from 6 Jag2lox/lox 
mice sacrificed 2 weeks after last pI-pC injection. RNA was extracted from the sorted DN 
cells and, after genomic DNase treatment, cDNA was synthesized. The Jag2 transcript was 
PCR amplified by using primer sequences which span from exon 22 to exon 25 (Felli et al., 
1999). The RT-PCR thus amplified a 592bp band if Jag2 mRNA was present in the samples. 
Any genomic DNA which might have contaminated the cDNA was not detected as it would 
have been too long (2.2kb). 
Jag2 RT-PCR primers: 5’GTCCTTCCCGCATGGGAGTT 3’ 
 5’GTTTCCACCTTGACCTCGGT 3’ 
RT-PCR performed on cDNA derived from FACS purified Jag2lox/lox DN cells 
successfully amplified the 592bp product (Fig.12A). To test the Jag2 deletion efficiency 
spleens were also isolated from the same mice and their DNA was extracted. Excision of the 
floxed Jag2 allele was confirmed in each sample by the previously mentioned deletion PCR 
(data not shown). In addition, DNA was extracted from lin+ bone marrow (BM) cells isolated 
from the same mice and used as template for the deletion PCR amplification (Fig.12B). Jag2 
genotyping PCR amplification of the same DNA samples identified the wt product in both 
samples as expected, whereas the floxed allele was only amplified from the Jag2lox/lox control 
DNA (Fig.12C). These results indicated that the Jag2lox/lox MxCre mice did express the Jag2 
mRNA, even though efficient Cre-mediated recombination of the floxed Jag2 allele had 
occurred. 
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In conclusion efficient Cre-mediated recombination of the floxed Jag2 allele did occur 
when Jag2lox/lox mice were crossed with the inducible MxCre mouse strain. Nevertheless, Jag2 
mRNA expression was detectable in the deleted homozygous mice. 
Figure 12. Jag2 expression by RT-PCR and deletion efficiency. (A) Top panel: Jag2 RT-PCR amplification 
of cDNA derived from sorted DN thymocytes identifies a 592bp product in both control (ctrl) and deleted 
(MxCre) samples. Bottom panel: -actin PCR amplification. (B) The deletion PCR of DNA derived from 
the lin+ BM cells of the Jag2lox/lox MxCre mice identifies the 456bp deletion band. (C) Jag2 PCR of same 
DNA as (B) amplifies the lox and the wt products in control samples, but only the wt product in the deleted 
sample (MxCre). Last lane: Jag2lox/lox tail DNA control. L: 1kb DNA ladder. 
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3. Discussion and perspectives 
The aim of this project was to generate a floxed Jag2 mouse strain in order to study 
Notch signaling, via the Jagged2 ligand, in an in vivo loss-of-function context. Therefore, ES 
cells carrying a floxed Jag2 allele were used to generate homozygous Jag2lox/lox mice. 
Successful excision of the Neomycin cassette from the Jag2 recombined targeting vector was 
also shown. However, a discrepancy between the PCR genotyping and the Southern blot 
analysis was observed. Several strategies of PCR amplifications and Southern blot analyses 
have confirmed an incomplete homologous recombination of the targeting vector. These 
results suggested an integration of the 5’short arm within the 5’UTR of the endogenous Jag2 
gene without the replacement of the genomic Jag2 sequence. 
Despite the partial recombination event, we further demonstrated efficient Cre-mediated 
excision of the deletion arm by crossing the Jag2 floxed mice with MxCre transgenic mice. 
Nevertheless, the Jag2 gene was still expressed in the deleted tissues, as proven by RT-PCR. 
Since Jag2 mRNA is present in deleted DN thymocytes, its protein should also be expressed. 
To confirm this hypothesis we performed Western blot analysis on dendritic cells (DC). Jag2 
was shown to be expressed in DC, though at higher level when stimulated by mesenchymal 
stem cells (Zhang et al., 2009). We thus expanded DC isolated from Jag2lox/lox MxCre mice in 
culture for one week before harvesting and lysing the cells. Jurkat cells were used as a 
control. Although the Jag2 protein was detected in the Jurkat lysate, no expression could be 
identified in any of the DC samples. The Western blot conditions were also tested on scraped 
epidermis from a wt mouse with no result. These experiments need to be repeated and 
conditions improved. 
Alternatively, Jag2 protein expression can also be investigated by crossing Jag2 floxed 
homozygous mice with K14Cre mice. Immunostaining for Jag2 could then be performed on 
sections from the skin of Jag2lox/lox K14Cre mice. In parallel, Jag2lox/lox mice could also be 
crossed with Jag1lox/lox K14Cre mice thereby generating double mutant Jag1lox/loxJag2lox/lox 
K14Cre mice. The double knockout mice would be monitored for the severity of their 
phenotype compared to Jag1lox/lox K14Cre mice. These experiments are ongoing. 
In conclusion, the Jag2 mRNA expression in the deleted Jag2lox/lox mice could not be 
effectively abolished. Consequently, these mice were unsuitable for loss-of-function 
investigations. Therefore, in order to analyze the role of Jag2 in vivo by conditional deletion 
 104 
in the hematopoietic system or in the skin, floxed Jag2 mice were obtained from the Jackson 
laboratory in collaboration with Dr. Thomas Gridley. The targeting vector strategy designed 
by Jingxia Xu is similar to the one described in this chapter. Briefly, the deletion arm flanked 
by loxP sites also consists of the ATG translation start site and exons 1 and 2 of the Jag2 
gene. Efficient excision, which creates a null allele, was confirmed by crossing the floxed 
homozygous mice with Meox2-Cre mice. The Meox2-Cre mouse strain expresses Cre 
recombinase in the germline (Tallquist and Soriano, 2000), thus generating embryos bearing a 
Jag2 null allele. Hence, homozygous Jag2 null mutant mice exhibited an identical phenotype 
to the null mutant Jag2DSL/DSL (Jiang et al., 1998). The mice died at birth and exhibited 
syndactyly as well as palate-tongue fusion (Xu, 2009). 
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III. Notch2 reporter 
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III. Generation of a Notch2 reporter mouse 
1. Introduction 
Notch signaling is an essential pathway in intercellular communication involved in cell 
fate determination, stem cell maintenance and differentiation in a variety of tissues during 
development and homeostasis. The second Notch receptor to be identified in mammals was 
Notch2 from a rat cDNA library (Weinmaster et al., 1992). In situ hybridization analyses of 
E16 rat embryos have revealed both overlapping and differential expression of Notch1 and 
Notch2. For example, Notch2 mRNA was highly expressed in the spleen compared to 
Notch1. Furthermore, Notch1 and Notch2 were expressed in different cell types and at 
different time points during brain development in rat and in mouse, suggesting that Notch1 
and Notch2 may have complimentary roles (Higuchi et al., 1995; Weinmaster et al., 1992). 
Several other organs were shown to express both receptors, such as the eye, the kidney, the 
intestine and the skin (Rangarajan et al., 2001; Riccio et al., 2008; Weinmaster et al., 1992). 
Moreover, Notch2 expression was shown to be indispensable for post-implantation 
development in mice by the generation of Notch2-/- mice. A mutation replacing 5 out of 6 
ankyrin repeats of the Notch2 receptor by the -galactosidase gene resulted in embryonic 
lethality, in homozygous mutants, prior to E11.5. The Notch2-deficient mice died due to the 
widespread onset of apoptosis throughout the embryo at E9.5 (Hamada et al., 1999). 
Since Notch2 knockout mice do not survive into adulthood, a Notch2 conditional 
mutant mouse was generated to study tissue-specific deletion of the receptor (Saito et al., 
2003). Notch2 conditional deletion in the hematopoietic system revealed a role during cell-
fate decision in B cells. Loss of Notch2 blocked B cell differentiation during commitment to 
marginal zone B-cells. The function of Notch2 was restricted as no other B cell lineage was 
affected by the loss of Notch2 (Saito et al., 2003). Even though Notch2 was shown to be 
expressed in thymocytes by semi-quantitative RT-PCR (Kaneta et al., 2000), no T cell 
development defect was observed in the Notch2-deficient mice (Saito et al., 2003). Similarly, 
although Notch2 is expressed in the murine epidermis its specific deletion in the skin during 
embryogenesis did not impair skin development and deletion in the adult mouse only resulted 
in a minor hair phenotype (Rangarajan et al., 2001; Vauclair, 2006). 
The function of Notch2 in several organs was also investigated by a hypomorphic 
Notch2 mutation. The targeted disruption of Notch2 resulted in alternatively spliced 
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transcripts which had one or two EGF-like repeats deleted. Mice homozygous for the 
mutation died perinatally from defects in glomerular development in the kidney. The mutant 
mice also exhibited heart and eye vasculature defects (McCright et al., 2001), thereby 
suggesting a role for Notch2 in these tissues. 
 The importance of the Notch2 receptor in many different organs is reflected by its 
implication in various diseases. As described earlier, Notch2 is crucial during B cell 
differentiation into marginal zone B cells in mice. Thus, it is not surprising that high Notch2 
expression was linked to splenic marginal zone lymphoma (Troen et al., 2004), thereby 
suggesting that Notch2 might also function as a cell-fate switch in human B cells. 
Additionally, Notch2 was overexpressed in B-cell chronic lymphocytic leukemia and 
involved in the overexpression of the glycoprotein CD23, a hallmark of this disease 
(Hubmann et al., 2002). Notch2 deregulation was also observed in human skin diseases, as its 
expression was down-regulated in psoriatic plaques and in human basal cell carcinoma (Thelu 
et al., 2002). 
A well-documented illness in which Notch2 plays a role is the Alagille syndrome 
(AGS). AGS is a dominant highly variable disorder characterized by hepatic bile duct paucity, 
kidney, cardiac, skeletal and ophthalmologic manifestations. Although mutations in the 
Jagged1 ligand are associated with 94% of patients suffering from AGS (Li et al., 1997; Oda 
et al., 1997), the majority of the other 6% of AGS cases have alterations in the Notch2 gene 
(McDaniell et al., 2006). Accordingly, the described mouse model for AGS is heterozygous 
for the Jag1 null allele and for a Notch2 hypomorphic allele. The double heterozygous mice 
exhibited bile duct differentiation defects as well as cardiac, ocular and renal deficiencies 
(McCright et al., 2002).  
Expression and targeted deletion studies of Notch2 suggest diverse roles as well as a 
complex interplay of receptor-ligand interactions. In spite of its importance in the 
development and homeostasis of several organs, and of its role in diseases, a precise in vivo 
tool for visualization and identification of Notch2 signaling activity is still lacking. Even 
though two reporter mice for Notch signaling have recently been described, both transgenic 
mouse lines respond to canonical Notch signaling mediated by all four receptors.  
The first example of a Notch reporter mouse is the Notch activity sensor mouse (NAS). 
The reporter transgene harbors 12 multimerized head-to-tail RBP-J binding sites upstream of 
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the lacZ gene. This TP1 promoter is transactivated in a RBP-J dependant manner by all four 
mammalian Notch receptors. Due to the artificial structure of multiple transcription binding 
sites, NAS transgenic mice do not display -galactosidase staining in several tissues known to 
depend on Notch signaling, such as lymphoid organs (Souilhol et al., 2006). 
The second transgenic Notch reporter mouse (TNR), or Tg(Cp-EGFP)25Gaia/J, bares 
an enhanced green fluorescent protein (EGFP) reporter driven by four tandem copies of the 
RBP-J binding site consensus sequence. The transgene was used to read out canonical Notch 
signaling in the hematopoietic and nervous systems. The study reported Notch signaling 
activity in hematopoietic stem cells in vivo and Notch down-regulation upon differentiation 
(Duncan et al., 2005). Additionally, Notch activity was detected in the epidermis and in 
regions of the hair follicle (Estrach et al., 2006). These results demonstrate the efficiency of 
the TNR transgenic mouse line to study Notch signaling in vivo. However, similarly to the 
NAS reporter mouse previously described, the TNR reporter responds to all four Notch 
receptors through RBP-J binding to an artificial promoter. 
In addition to canonical Notch signaling reporter mice, other reports described 
alternative approaches. The first strategy takes advantage of a Notch target gene promoter, to 
drive a reporter gene, instead of multimerized RBP-Jbinding sites. Accordingly, the Hes5 
promoter was used to express a GFP reporter gene. The promoter region amplified for the 
Hes5-reporter was a 3kb fragment, which also included repressor elements and potential 
binding sites specific for transcription factors other than RBP-J. This method successfully 
identified multipotent progenitors in the embryonic nervous system but only upon Hes5 
expression (Basak and Taylor, 2007). This reporter system is limited due to the need of 
Notch-induced Hes5 expression and, consequently, is a useful tool in tissues where Hes5 
expression correlates with Notch-signaling, such as in the central nervous system (CNS). 
Following a similar strategy, two different reporter mice were generated with a GFP-
expressing transgene driven by either Hes1 or Hes5 promoters. In this study, a 2.5kb promoter 
region was used for the Hes1 reporter and less than 1kb for the Hes5 reporter. Both Hes1 and 
Hes5 are Notch target genes expressed in the developing CNS, although in distinct patterns in 
different brain regions, suggesting differential regulation. Moreover, their complementary 
expression pattern was enhanced in the reporter mice (Ohtsuka et al., 2006). Consequently, 
these results cannot be assimilated to a direct Notch signaling read-out. 
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The third approach is dependant on Notch1 proteolysis to follow descendants of cells 
having undergone Notch1 activation. The N1IP (Notch1 intramembrane proteolysis)-Cre 
reporter (Notch1tm3(cre)Rko/J) consists of a Cre recombinase replacing the intracellular domain 
of Notch1, which is released upon interaction with a ligand (Vooijs et al., 2007). Crossing 
these reporter mice with the Rosa26R mouse line allows lineage tracing investigations. The 
Rosa26R mouse line carries a loxP-flanked neo sequence (STOP cassette) which prevents 
expression of a lacZ reporter gene (Soriano, 1999). Consequently, when crossed with N1IP-
Cre mice, the STOP cassette is recombined upon Notch1 signaling-induced Cre. The 
recombined allele is then inherited in all descendants. A major disadvantage of this system is 
that -galactosidase staining does not correspond to the precise timing when the Notch1 
signal occurred. Furthermore, because the recombined allele lacking the STOP cassette is 
inherited by all daughter cells irrespective of an ongoing Notch signaling, Notch1 activation 
at later time points, such as in the adult, cannot be investigated by this method. 
Even though several different Notch signaling reporter mice do exist, none of them 
specifically responds to Notch2-specific signaling. Therefore, we sought to generate a 
valuable tool to follow cells which have specifically received a Notch2 signal. The Notch2 
reporter strategy consists of two complementary transgenes: a chimeric Notch2 receptor and a 
secondary reporter. The chimeric Notch2 consists of the extracellular domain of the receptor 
fused in frame with a DNA binding and a transactivating domain (TAD). Once the chimeric 
Notch2 receptor is cleaved by interaction with its specific ligand, the intracellular domain, 
consisting of the DNA binding domain and the TAD, translocates to the nucleus. The Notch2-
mediated signal is then conveyed by binding of the intracellular domain to specific response 
elements of a secondary reporter, which subsequently induces expression of a red fluorescent 
protein (Fig.1). 
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This strategy will detect Notch2-mediated signal receiving cells in any tissue at any 
given point in time. Thus, the genetic design for the Notch2-specific reporter is different in 
very specific ways than for the previously described reporter mice. 
Figure 1. Schematic design of Notch2 reporter signaling activity. A specific ligand, i.e. Jagged or Delta-
like, binds to the extracellular domain of the Notch2 receptor, thereby activating the consecutive proteolytic 
cleavages by TACE and -secretase complex which release the DNA binding and transactivating domains 
(TAD). The TAD of the chimeric construct replaces the intracellular domain of Notch2 and is consequently 
translocated to the nucleus where it binds to its response elements. The interaction with the response 
promoter in turn activates transcription of the reporter gene. The latter is a red fluorescent protein which 
therefore renders the cell receiving a Notch2-mediated signal detectable by becoming red. 
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2. Results 
2.1 Generation of the chimeric Notch2/tTA2 receptor 
As schematicaly shown in Fig.1, the Notch2 reporter strategy consists of two 
complementary elements: the chimeric Notch2 receptor and its specific reporter. The chimeric 
Notch2 plasmid was generated by using components of the Tet-Off technology. The rationale 
behind the system is to replace the cytoplasmic domain of Notch2 with a tetracycline-
controlled transactivator (tTA2) which is fused in frame with the extracellular and 
transmembrane domains of Notch2. The tTA2 transactivator is a fusion protein between the 
repressor (TetR) of the Tn10, the tetracycline resistance operon of Escherichia coli, and a C-
terminal portion of the minimal transcriptional activation domain derived from Herpes 
simplex virus protein 16 (VP16). Compared to the first version known as tTA, tTA2 
comprises of TetR fused to three activation domains and is tolerated in cells at higher 
concentrations for the same activity (Baron et al., 1997). This transactivating domain will 
activate transcription only in the absence of the effector tetracycline, or any of its derivatives 
such as doxycycline, by binding of TetR to tet operator (tetO) sequences upstream of a 
minimal promoter. In contrast, the presence of tetracycline prevents tTA2 from binding to its 
target, thus abolishing transcription (Fig.2). 
 
 
 
Generation of the chimeric Notch2/tTA2 receptor was achieved in several steps. First, 
the tTA2 transactivator was subcloned from the pUHD20-1 plasmid received from Dr. Bujard 
(Baron et al., 1997) into the pBluescriptSK backbone. The tTA2 sequence was then amplified 
Figure 2. Tet-off system. In absence 
of tetracycline the transactivating 
domain tTA2 binds to Tet response 
elements (TRE) upstream of a minimal 
promoter (PCMV) and activates 
transcription of the reporter gene. In 
presence of tetracycline (blue 
diamonds) tTA2 can no longer bind to 
its target thereby abolishing 
transcription. 
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by high-fidelity PCR in order to add the restriction sites PvuI and NotI, up- and downstream 
of the transgene, respectively.  
tTA2 primers with  PvuI and  NotI  restriction sites: 
5’AGTTGACGATCGAGGCGCCATGTCTAGATTAGATAAAAGTAAAGTGATTAA
CAGCG 3’ 
5’GCATCAGCGGCCGCAAGCTTGGTCGAGCTGGATACTTCCC 3’ 
Finally, these restriction enzymes were used for digestion of both the tTA2 PCR 
product and the pTracer-CMV vector containing the full length Notch2 sequence. Subsequent 
ligation resulted in the fusion in frame of the tTA2 transactivator downstream of the 
transmembrane domain of the Notch2 receptor. The restriction enzyme PvuI also cut once in 
the ampicillin resistance cassette of the vector backbone, which is the reason why a three-way 
ligation was performed (Fig.3B). The unique PvuI restriction site within the Notch2 receptor 
is located downstream of the RAM domain, precisely 252bp downstream of the TM, which is 
upstream of the ankyrin repeats (Fig.3A). Ligated clones were tested by two different 
digestion patterns: EcoRI/NotchI double digest, which resolves two fragments of 5.7kb and 
6.6kb in correctly ligated clones, and an HpaI single digest, which is predicted to linearize the 
vector resulting in a single 12.3kb band if the tTA2 gene is present (Fig.3C). One of the 
positive vectors was also partially sequenced by custom up- and downstream primers (T7 and 
BGH rev) as well as by an internal primer designed to sequence the TM region of the 
chimeric transgene. Obtained sequences aligned as expected.  
Internal N2 primer:  5’CAGTGAACTGGAGAGTCC 3’ 
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Once generated, the chimeric Notch2/tTA2 receptor had to be inserted permanently into 
the mouse genome. One method to integrate and express a transgene is the bacterial artificial 
chromosome (BAC) technology, which is a plasmid encompassing 100-300kb of genomic 
DNA. Homologous recombination into a Notch2-containing BAC enables targeted integration 
of the modified Notch2 gene while conserving regulatory sequences found within its genomic 
sequence. This strategy enables a similar expression of the chimeric Notch2/tTA2 to the 
endogenous Notch2 gene.  
For recombination into the corresponding BAC, the chimeric Notch2/tTA2 gene was 
flanked by homologous regions to both the immediate up- and downstream sequences of the 
Notch2 translation start site (i.e. ATG). For this purpose, three different BAC clones, namely 
RP23-268C11, -69J13 and -143I22 (Fig.4A), were purchased from the BACPAC Resources 
Center of the Children’s Hospital Oakland Research Institute (CHORI) and a PCR strategy 
Figure 3. Generation of the chimeric Notch2/tTA2 vector. (A) Plasmid map of the Notch2/tTA2 sequence 
shows unique restrictions sites in blue and both PvuI restrictions sites in red. The Notch2 extracellular 
domain, the transmembrane domain (TM), as well as tTA2 gene are indicated. (B) 0.8% TAE agarose gel 
represents the isolated fragments for the three-way ligation of the chimeric Notch2/tTA2 vector. E/P: EcoRI 
and PvuI double digest; E/N: EcoRI and NotI double digest of the Notch2 full length plasmid. SL: Smart 
ladder. (C) Diagnostic digestion patterns for one correctly ligated clone with EcoRI/NotI double digest 
(E/N) and with HpaI identify the expected band sizes (arrows). L: 1kb DNA ladder. 
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for both regions was designed. The 5’homologous arm is 566bp long and consists of the 
genomic region 400bp upstream of exon1 and the portion of exon1 immediately upstream of 
the initiating ATG. The 3’homologous arm consists of the portion of exon1 immediately 
downstream of the initiating ATG and 853bp of the first intron (Fig.4B). The 5’arm was 
directly inserted via restriction enzymes AflII and EcoRI. However, an oligonucleotide 
sequence containing an AgeI restriction site was added downstream of the Notch2/tTA2 
transgene before ligation with the 3’homologous arm. Orientation of the latter and sequences 
of both homologous arms were confirmed by sequencing with custom primers (CMVfor and 
BGHrev). 
 
 
In addition to the homologous arms, an ampicillin resistance (Amp) cassette flanked by 
34bp FLP1 recombinase target (FRT) sites was cloned between the 5’ homologous box and 
the Notch2/tTA2 gene via the unique EcoRI restriction site (Fig.5A). Ampicillin resistance 
allows subsequent selection of correctly integrated BAC clones. The Amp cassette can be 
removed in a second step by FLP-mediated recombination, which induces excision of the 
intervening sequence and leaves a single FRT site in place. Efficient FLP-mediated 
recombination of the FRT sites was tested by transforming the final construct into the E.coli 
strain 294-FLP (Buchholz et al., 1996). This bacteria strain was engineered to efficiently 
express the FLP recombinase gene. Complete excision of the Amp cassette was confirmed by 
digesting the 294-FLP transformed Notch2/tTA2 vector with the restriction enzyme PvuI. The 
Figure 4. Bacterial artificial chromosomes including the Notch2 genomic sequence. (A) Two BACs, RP23-
143I22 and -69J13, are schematically drawn spanning the Notch2 region of the mouse genome (red arrow). 
Sizes in kb are given up- and downstream of Notch2. (B) Agarose gel electrophoresis of PCR amplifications 
corresponding to the 5’(566bp) and 3’(923bp) homologous arms of Notch2 from two of the BACs (RP23-
143I22 and -69J13). L: 1kb DNA ladder. 
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Amp sequence bears a PvuI restriction site which is thus lost upon flipase recombination of 
the resistance cassette (Fig.5).  
 
 
2.2 Generation of the secondary reporter 
As mentioned earlier, detection of the Notch2-receiving cell is conveyed by binding of 
the TetR domain of the chimeric Notch2/tTA2 to its specific response transgene. Therefore, 
the reporter construct harbors a destabilized DsRed coding sequence which is driven by a 
multimerized Tet Response Element (TRE). The TRE consists of seven tet operator sequences 
upstream of a minimal cytomegalovirus (CMV) promoter. The reporter DsRed is a red-shifted 
protein derived from the marine organism Discosoma (Matz et al., 1999). Several variants of 
DsRed, such as DsRed.T3 and DsRedExpress, were cloned before settling for the most 
destabilized form known as DsRedExpressDR. The latter is a fast-maturing version of the red 
fluorescent protein which is fused to the degradation domain of mouse ornithine 
decarboxylase at its C-terminal end conferring a short half-life to the reporter protein 
(Hansson et al., 2006). 
The original TRE-Tight-DsRed2 vector from Clontech was used for the backbone of the 
secondary reporter. The 2.6kb backbone containing the TRE sequence was isolated after a 
BamHI/NotI digestion. The DsRed2 gene was replaced by the DsRed.T3-c-myc version 
Figure 5. Schematic representation of the chimeric Notch2/tTA2 vector. (A) Homologous boxes to Notch2 
genomic sequences, Hom Box 5’ and Hom Box 3’ (orange), flank Notch2 extracellular (Ext) and 
transmembrane (TM) domains (dark blue) fused in frame with tTA2 (pink). An ampicillin cassette (Amp; 
green) flanked by FRT sites (turquoise) is inserted between the Hom Box 5’ and the ATG of the 
Notch2/tTA2 transgene. The three PvuI cutting sites are indicated by arrows. (C) Agarose gel 
electrophoresis of PvuI digested chimeric Notch2/tTA2 plasmid. FLP-mediated recombination by 
propagation into 294-FLP bacteria identifies two bands (FLP-rec.) compared to three fragments before 
transformation (No rec.). Arrows with the band sizes of the fragments are indicated. 
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kindly provided by Dr. Gérard Eberl. The 700bp transgene was isolated after AscI/NotI 
digestion. The restriction sites BamHI and AscI were blunted with Klenow DNA polymerase 
in order to ligate both fragments. Another DsRed version, the DsRedExpress gene, was also 
cloned into the TRE backbone. The 686bp DsRedExpress gene was isolated from the 
DsRedExpress-N1 vector (Clontech) by EcoRI/NotI digestion. The same digestion was used 
to isolate the 2.6kb TRE-containing backbone from the previously cloned TRE-Tight-
DsRed.T3-c-myc vector.  
The final secondary reporter was cloned in two steps. Firstly, the DsRedExpressDR 
gene was subcloned into pBluescriptSK, via XhoI/EcoRI digestion, from the 12CSL-
DsRedExpressDR vector (kind gift from Dr. Urban Lendahl). The 817bp DsRedExpressDR 
transgene was then isolated by XhoI/NotI digestion (Fig.6A) and the restriction site XhoI was 
blunted by Klenow DNA polymerase. This time the 2.6kb TRE-containing backbone from the 
previously cloned TRE-Tight-DsRed.T3-c-myc vector was isolated by SmaI/NotI digestion. 
Each cloned vector was checked for correct ligation by diagnostic digestion patterns and 
subsequently confirmed by sequencing. The table below summarizes the cloning steps 
performed for the generation of each reporter vector. 
Vectors Restriction enzymes  
([] when blunted) 
Ligated vectors     
(backbone with insert) 
TRE-Tight-DsRed2 
DsRed.T3-c-myc 
[BamHI]/NotI 
[AscI]/NotI 
TRE-Tight-DsRed.T3-c-myc 
2.6kb with 700bp 
TRE-Tight-DsRed.T3-c-myc 
DsRedExpress-N1 
EcoRI/NotI 
EcoRI/NotI 
TRE-Tight-DsRedExpress 
2.6kb with 686bp 
12CSL-DsRedExpressDR 
pBlueScriptSK 
TRE-Tight-DsRed.T3-c-myc 
pBS-DsRedExpressDR 
XhoI/EcoRI 
XhoI/EcoRI 
SmaI/NotI 
[XhoI]/NotI 
pBS-DsRedExpressDR 
2.9kb with 817bp 
TRE-Tight-DsRedExpressDR 
2.6kb with 817bp 
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The TRE-Tight-DsRedExpressDR was digested by StuI and by XhoI and compared to 
TRE-Tight-DsRed.T3-c-myc digestion patterns. The restriction enzyme StuI excised the 
DsRedExpressDR gene as expected, which was slightly larger than the DsRed.T3 gene. As 
the DsRedExpressDR contained an additional XhoI restriction site, three fragments were 
identified instead of two (Fig.6B).  
 
 
The positive clone was then confirmed by sequencing reactions, which were performed 
by using custom primers (T7 and T3) for the pBS-DsRedExpressDR vector and an internally 
designed primer for the reporter vector. 
Internal DsRedExpress primer:   5’ATGGCCTCCTCCGAGGACGTCATC 3’ 
2.3 Co-culture assays determine the functionality of the Notch2 reporter system 
After generation of both constructs, the complete Notch2 reporter system was tested in 
vitro. Co-cultures of Hela cells expressing a Notch ligand, i.e. Delta-like1 (Dll1), with Hela 
cells transfected with the TRE-DsRedExpress reporter and with or without the chimeric 
Notch2/tTA2 construct were set up. Red Hela cells expressing the DsRedExpress reporter 
were visible when all the elements for the Notch2-mediated signaling were present (Fig.7A). 
Accordingly, the DsRedExpress protein was only detected when Dll1 cells were co-cultured 
with Hela cells co-transfected with both the reporter and the chimeric Notch2/tTA2 
constructs. Furthermore, the signal was specific to the Notch2 activation since no red cells 
were detected when the reporter was transfected alone in co-cultures (Fig.7B). 
Figure 6. Cloning of the TRE-DsRedExpressDR vector. (A) The 817bp DsRedExpressDR gene is isolated 
by a double digest XhoI/NotI (X/N) of the pBS-DsRedExpressDR vector. (B) Agarose gel electrophoresis of 
digestion patterns of a positive clone (+) by restriction enzymes StuI and XhoI identify expected band sizes 
(arrows). L: 1kb DNA ladder. 
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The functionality of the chimeric Notch2/tTA2 transgene, as well as the robustness of 
the reporter, was proven in vitro. However, for the reporter mouse to be a useful tool the 
system must not interfere with endogenous Notch2 signaling. As described earlier, the tTA2 
gene is fused downstream of the RAM domain. The RAM domain was shown to bind, in 
conjunction with the ankyrin repeats, to the RBP-J transcription factor in stromal cells 
isolated from murine bone marrow in vitro (Deregowski et al., 2006). Consequently, the 
presence of the RAM domain in the chimeric Notch2/tTA2 vector could potentially interfere 
with endogenous Notch2 signaling. This potential interference, although unlikely due to the 
absence of the ankyrin repeats, was nonetheless analyzed by luciferase co-culture experiments 
using a Notch signaling reporter. This reporter consisted of 12 multimerized RBP-J binding 
sites upstream of the firefly luciferase gene. Expression of the luciferase was highly induced 
when Hela cells are co-transfected with a plasmid containing the Notch1 intracellular domain. 
Figure 7. Co-cultures of Dll1-expressing Hela cells with the chimeric Notch2/tTA2 receptor and the 
DsRedExpress reporter. (A) Schematic representation of the Notch2/tTA2 chimeric receptor (blue) 
interacting with a specific ligand, e.g. Delta-like 1 (Dll1;green), on the surface of a neighboring cell. This 
ligand-receptor binding induces proteolytic cleavages which subsequently release the transactivating domain 
tTA2 (pink). tTA2 binds to the Tet response elements (TRE; light pink) in the nucleus and activates 
transcription of the reporter gene DsRedExpress (red). (B) Top panel: Co-culture of Hela cells expressing 
the Dll1-eGFP ligand (green) with co-transfected cells for Notch2/tTA2 and TRE-DsRedExpress proves 
interaction occurrence by subsequent expression of DsRedExpress protein (red). Bottom panel: Negative 
control co-culture of Dll1-eGFP Hela cells with Hela cells transfected with the reporter plasmid TRE-
DsRedExpress alone. 
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When the chimeric Notch2/tTA2 was co-transfected together with the 12RBP-J luciferase 
reporter the signal was similar to basal level (Fig.8B). These results verify that the chimeric 
Notch2/tTA2 receptor does not induce Notch signaling.  
Moreover, the Notch2/tTA2 construct had to be specific to ligand-induced Notch 
proteolytic cleavages. To inhibit Notch signaling, Hela cells co-cultures were treated with the 
-secretase inhibitor DAPT, or N-[N-(3,5-difluorophenacetyl)-l-alanyl]-S-phenylglycine t-
butyl ester. Compared to control DMSO treated cells, no red fluorescent protein was 
detectable upon DAPT treatment (Fig.8A). This data demonstrates that specific inhibition of 
Notch signaling impedes on DsRed expression and hence on Notch2/tTA2 cleavage. 
Verification of the reporter system also included testing the Tet-off technology. As 
schematized in Fig.2, the tTA2 domain can be inactivated by addition of the tetracycline 
derivative doxycycline. Therefore, Hela co-cultures of Dll1-expressing cells with 
Notch2/tTA2 transfected cells were treated with 2g/ml of doxycycline, which indeed hinders 
the expression of the red fluorescent protein as expected (Fig.8A). 
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Since the DsRedExpressDR protein is fast-maturing and rapidly degraded, this “real-
time” detection does not allow a long-term lineage tracing of cells which have received a 
Notch2 signal. Therefore, we decided to combine the above strategy with a system to track 
cells that have once received a Notch2-mediated signal, and which may not signal any longer. 
For this purpose we focused on an inducible Cre/loxP-based lineage strategy. This method 
takes advantage of the mutated ligand-binding domain of the human estrogen receptor fused 
to the Cre recombinase (CreERT). The CreERT recombinase gene allows conditional site-
specific recombination dependant on the estrogen receptor antagonist 4OH-tamoxifen, and 
not on estradiol (Feil et al., 1996). Lineage tracing is then possible by crossing the reporter 
mice bearing the CreERT with Rosa26R mice (129S-Gt(ROSA)26Sortm1Sor/J; JAX 
stock#003310). This Rosa26R mouse line carries a loxP-flanked neo sequence (STOP 
cassette) which prevents expression of a -galactosidase (lacZ) reporter gene (Soriano, 1999). 
Figure 8. The Notch2/tTA2 reporter system is inhibited by DAPT and by doxycycline. (A) Co-cultures of 
Notch2/tTA2 and TRE-DsRedExpressDR co-transfected Hela cells (red) with Dll-1 expressing cells (green) 
were treated with 1mM DAPT or 2g/ml doxycycline. Equivalent amount of DMSO was added in control. 
As co-culture negative control the Notch2 full length construct was transfected into Hela cells instead of the 
chimeric Notch2/tTA2.  (B) Luciferase reporter assay was performed on Hela cells co-transfected with 
12RBP-Jk-luciferase (12RBP) and Notch2/tTA2 chimeric constructs. NIC: Notch1 intracellular domain; 
N2full: Notch2 full length; RLU: relative luciferase units normalized to renilla luciferase. 
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Consequently, when crossed with a Cre-expressing mouse strain the STOP cassette is 
recombined thereby removing the block for expression of the lacZ reporter (Fig.9B). 
 
 
 
Therefore, the tamoxifen-inducible CreERT recombinase gene, together with an internal 
ribosome entry site (IRES), was cloned downstream of the DsRedExpressDR gene (Fig.9A). 
The TRE-DsRedExpressDR-ires-CreERT vector was tested in Hela cell culture experiments in 
vitro to prove the functionality of the system. In order to visualize correct recombination 
mediated by the CreERT recombinase, the reporter construct is co-transfected with a CMV-
driven plasmid containing eGFP downstream of a loxP-flanked Stop cassette (Fig.10A). The 
TRE-DsRedExpressDR-ires-CreERT was expressed by co-transfecting with CMV-tTA2, and the 
inducible Cre ERT recombinase was subsequently activated by addition of 4OH-tamoxifen 
directly to the medium for 24 hours. As expected for a successful recombination event, Hela 
cells expressed the eGFP reporter when induced with tamoxifen as opposed to the ethanol 
control (Fig.10B). 
Figure 9. Schematic representation of the secondary reporter and lineage tracing principle. (A) The Tet 
response element (TRE; light pink) controls the expression of the DsRedExpressDR reporter gene (red) and 
an internal ribosome entry site (IRES) upstream of the CreERT recombinase gene (light blue). (B) Lineage 
tracing approach involves crossing the Notch2 reporter mouse with a Rosa26R mouse and injecting 
tamoxifen to the offspring. 4OH-tamoxifen induces expression of the lacZ reporter by removal a STOP 
cassette. The box below represents the lacZ expression of the Notch2-signaling descendent cells with and 
without 4OH-tamoxifen injection. DsRedExpressDR expression is in red and lacZ expression is in blue. 
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2.4 BAC homologous recombination 
We have shown that the Notch2 reporter system, i.e. the chimeric Notch2/tTA2 together 
with the reporter TRE-DsRedExpressDR-ires-CreERT, induced expression of the red 
fluorescent protein upon ligand interaction and was specific to Notch2 signaling in vitro. The 
data indicated that the constructs were suitable to use for the generation of transgenic mouse 
lines to study Notch2-signaling in vivo. 
Figure 10. Tamoxifen induced CreERT-mediated recombination. (A) The CreERT recombinase was tested by 
using a plasmid containing a CMV promoter and the eGFP reporter separated by a loxP-flanked (full 
triangles) Stop cassette. 4OH-Tamoxifen addition induces CreERT-mediated recombination to remove the 
Stop sequence, thereby allowing eGFP expression. (B) Hela cells were co-transfected with three plasmids: 
the response plasmid TRE-DsRedExpressDR-ires-CreERT, the CMV-tTA2 plasmid to induce expression of 
the reporter as well as of the inducible CreERT recombinase, and the CMV-Stop-eGFP plasmid. 4OH-
tamoxifen (TAM) to a final concentration of 2M, or an equivalent amount of ethanol as control, was added 
to the culture medium. Pictures were taken 24h after addition. 
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To generate Notch2/tTA2 transgenic mice, we sought to generate BAC clones 
containing the Notch2/tTA2 transgene within the Notch2 regulatory sequence. Two 
alternative methods were available. The first consisted of electroporation of the linearized 
chimeric construct into EL250 bacteria, which were previously electroporated with a Notch2-
containing BAC. The EL250 bacteria contain recombination proteins controlled by a 
temperature-sensitive repressor as well as an arabinose-inducible flpe gene (Lee et al. 2001). 
The 9.25kb Notch2/tTA2 transgene was isolated after linearization by the restriction enzyme 
PmeI (Fig.11B). Homologous recombination was induced by a temperature shift at 42°C for 
15min before chilling the cells on ice for the electroporation step. As the BAC backbone 
contains a chloramphenicol (chlor) resistance gene, recombined clones containing both BAC 
and Notch2/tTA2 were selected by double-resistance to ampicillin and chloramphenicol 
(Fig.11A).  
The flpe recombinase expression was then induced by incubating the cultures in 0.1% 
L-arabinose for 1h. This FLP-mediated excision of the Amp cassette generated the final 
Notch2/tTA2 transgene. A hundred colonies were picked after chloramphenicol selection and 
digested by the restriction enzyme KpnI. The obtained digestion patterns were compared with 
that of the original RP23-143I22 BAC and should include an extra fragment at 2.8kb. 
Intriguingly, several strong bands appeared after agarose gel electrophoresis, but no expected 
digestion pattern was identified (Fig.11C). Despite several attempts, the chimeric transgene 
could not be correctly recombined into a Notch2-containing BAC. 
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Homologous recombination into the Notch2 genomic sequence was unsuccessful by 
electroporation into EL250 bacteria. Therefore, we settled for a second method which uses a 
shuttle vector called pDelsac for targeted recombination into the BAC (Sparwasser et al., 
2004). Briefly, the pDelsac, modified to contain the transgene of interest, is first integrated 
into the BAC via recombination of one of the homologous arms. A second recombination 
event with the other homologous arm results in excision of the shuttle vector and the 
resolution of the BAC modification.  
Thus, the chimeric Notch2/tTA2 vector, without the Amp cassette, was cloned into the 
shuttle vector (kindly provided by Dr. Gérard Eberl) by a three-way ligation strategy. Two 
fragments were isolated from pDelsac: 5.7kb after NotI/NcoI digestion and 1kb after another 
BamHI/NcoI digestion. The 9.1kb Notch2/tTA2 transgene was isolated from a NotI/BglII 
Figure 11. BAC homologous recombination mediated by EL250 bacteria. (A) Linearized chimeric 
Notch2/tTA2 transgene recombines via the 5’ and 3’homologous boxes (orange) into the Notch2-containing 
BAC. Chlor: chloramphenicol resistance cassette. (B) The 9.25kb chimeric Notch2/tTA2 transgene is 
linearized by the restriction enzyme PmeI (arrow). (C) Left panel: The restriction enzyme KpnI digests the 
BAC RP23-143I22 into more than 25 fragments, from which 3 are shown by arrows. Right panel: Several 
potentially recombined clones (#numbered) are digested by KpnI and compared to the RP23-143I22 original 
BAC. L: 1kb DNA ladder. 
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digestion of the chimeric vector. Since the two restriction sites BamHI and BglII formed 
compatible ends, no blunting was needed (Fig.12A). Correctly ligated clones were identified 
by the digestion patterns of two restriction enzymes PvuI and XhoI. The Amp sequence, as 
well as the Notch2/tTA2 transgene, both contain PvuI restriction sites whereas the restriction 
site XhoI is only present in the Notch2/tTA2 sequence. Consequently, digestion by PvuI 
resolved two fragments of 12.4kb and 3.2kb while digestion with XhoI resulted in the 
generation of a 15.8kb band, which corresponded to the linearized product of correctly ligated 
clones (Fig.12B). 
 
 
The pDelsac containing Notch2/tTA2 was then successfully recombined by a 
postdoctoral fellow of our laboratory, Dr. Nicolas Fasnacht, following the previously 
described protocol (Sparwasser et al., 2004). Clones were first tested for a segment of the 
Notch2/tTA2 to insure integration of the chimeric transgene. An internal PCR amplification 
of an 800bp product was designed to span the fusion region between Notch2 and tTA2 
(Fig.13). 
Internal Notch2/tTA2 primers:    5’CCAACTTGCGCATTAAACAA 3’ 
                                                     5’AGCAAAGCCCGCTTATTTTT 3’ 
 The correctly recombined BAC clones were further verified by two PCR 
amplifications, one for each recombination region, i.e. at the 5’and the 3’homologous arms. 
Figure 12. Notch2/tTA2 ligation into shuttle vector pDelsac. (A) pDelsac-Notch2/tTA2, with both 5’ and 
3’homologous arms (orange boxes), vector is schematically represented with the restriction sites used for 
ligation marked in blue. The restriction enzymes used for diagnostic digestion patterns shown in B are in 
black. R6K: origin of replication; Amp: ampicillin resistance gene; SacB: counter-selection gene; RecA: 
E.coli recombinase gene. (B) Digestion of a positive clone by PvuI and by XhoI identifies expected sizes 
3.2kb and 12.4kb, and 15.8kb, respectively (arrows). pDel: pDelsac shuttle vector. L: 1kb DNA ladder. 
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The expected sizes, 1.3kb and 1.2kb respectively, were indeed amplified in several 
recombined BAC clones (Fig.13). These results strongly suggested correct homologous 
recombination of the Notch2/tTA2 transgene within the Notch2 genomic sequence of the 
BAC. 
BACrec5’ primers:                      5’TCGTAGTTGCCAATTTCGTTC 3’  
                                                     5’CCAAGAAGCCCTCTGGACAT 3’ 
BACrec3’ primers:                      5’CACGCTATCTGTGCAAGGTC 3’ 
                                                     5’AAGACATAGCCCCACTGGAA 3’ 
 
 
 
Verification of the potentially recombined BAC clones by Southern blot analysis will 
further confirm the correct BAC homologous recombination event. Once more, both 
homologous recombination arm regions will be investigated. The 5’homologous arm was 
used as a probe after an EcoRV digestion of the BAC DNA. The 3.37kb wt band was 
identified in the original RP23-143I22 BAC. After recombination, clones should have a 
recombined band at 2.1kb. In addition, the 3’homologous arm was used as a probe after KpnI 
digestion of the BAC DNA and the 14kb wt band was identified in the RP23-143I22 BAC. 
Figure 13. Identification of recombined BAC clones. Top panel: PCR amplifications for three regions of the 
recombined Notch/tTA2 transgene are schematically drawn by dotted lines with the sizes of the products. 
Arrows represent the approximate location of the primers. Bottom panels: The three amplification products 
are shown (arrows) for a potential positive clone by agarose gel electrophoresis. 143I22: RP23-143I22 BAC 
as negative control.  L: 1kb DNA ladder. 
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The tTA2 gene could also be used as a probe in this case, and the recombined band would be 
at 5.5kb (Fig.14). 
 
 
If the BAC clones identified by the PCR amplifications are confirmed by the Southern 
blot analyses described above, then the modified BAC containing the chimeric Notch2/tTA2 
will be given to the transgenic animal facility for generation of the Notch2-specific reporter 
mouse line. 
Figure 14. Scheme representing Southern blot analyses of recombined BAC clones. Either an EcoRV or a 
KpnI digestion (arrows) of the BAC DNA identifies the recombined regions of the 5’or the 3’homologous 
arm, respectively. Sizes of the expected bands are shown above the dotted lines (wt/recombined) and the 
probes used are represented by red bars. 
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3. Discussion and perspectives 
In this section, we have described the successful generation of a Notch2/tTA2 chimeric 
vector and a TRE-DsRedExpressDR reporter. Both transgenes were designed to generate 
Notch2-specific reporter mouse lines in order to study Notch2-mediated signaling in vivo. The 
specificity and robustness of the system using both transgenes was demonstrated in vitro by 
co-culture assays indicating that this is a valid strategy for the generation of Notch2 reporter 
mice. 
In order to generate Notch2/tTA2 “pseudo knockin” mice, the chimeric transgene was 
integrated by homologous recombination into a Notch2-containing BAC. Several clones 
showed correct recombination by PCR amplifications. However, these potentially modified 
BAC clones must be confirmed by the Southern blot analyses discussed at the end of chapter 
2.4. The Notch2/tTA2 BAC clone will then be given to the transgenic animal facility for 
pronuclear microinjection and subsequent generation of the Notch2/tTA2 transgenic mice.  
Co-injection of the Notch2/tTA2 and the secondary reporter transgenes was also 
discussed. This method was used for the generation of a Notch1-specific reporter mouse by a 
postdoctoral fellow of the laboratory, Dr. Emma Smith. The strategy was the same as for the 
Notch2-specific reporter, but with a Notch1/Gal4VP16 chimeric transgene and a Gal4-Venus-
ires-CreERT secondary reporter. After pronuclear injection of both constructs, not only was the 
efficiency extremely low, 6 out 114 mice integrated both transgenes, but more importantly no 
reporter expression, in this case the green fluorescent protein Venus, was observed in any of 
the founder lines. These results prompted us to inject the transgenes separately and to increase 
the efficiency of reporter expression by an alternative method. 
The secondary reporter vector TRE-DsRedExpressDR-ires-CreERT could be directly 
injected into murine pronuclei to generate the transgenic mice. However, in order to 
circumvent variation due to random insertion and copy number, we focused on an alternative 
strategy by homologous recombination into a known location of the genome. The method 
integrates a single transgene copy into the X-linked hypoxanthine phosphoribosyltransferase 
(Hprt) locus, a housekeeping gene, by a directly selectable homologous recombination 
(Bronson et al., 1996). The subsequent targeted embryonic stem cells are selected by 
restoration of a functional Hprt gene and injected into blastocysts to generate the transgenic 
mouse line. A disadvantage of the Hprt targeted integration is the location of the Hprt locus, 
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which is on the X-chromosome. Thus, the transgene might be silenced in several tissues of 
female transgenic mice, thereby potentially generating mosaic expressing transgenic females. 
Additionally, to increase the efficiency of expression of the reporter DsRedExpressDR, 
as well as of the CreERT gene, both genes can also be cloned into a bidirectional vector. IRES-
containing vectors, such as the reporter TRE-DsRedExpressDR-ires-CreERT,  are known to 
induce different levels of expression of the genes located up- and downstream of the IRES 
sequence. Consequently, the DsRedExpressDR protein level is not similar to the level of the 
CreERT recombinase. To circumvent the variation in expression levels, the two reporter genes 
can be divergently oriented to the central TRE DNA binding sequence. Upon binding of the 
tTA2 domain, this bidirectional configuration results in initiation of transcription of both 
transgenes at the same time (Fig.15). Cloning of the bidirectional TRE-DsRedExpressDR-
CreERT vector is currently pursued by a new PhD student in the laboratory. 
 
 
 
Once both transgenic mouse lines are generated, they will be crossed in order to study 
in vivo Notch2-mediated signaling. Any tissue can be observed at any given time to 
investigate Notch2 activation during development, self-renewal and tumorigenesis. To control 
correct reporting of the system red fluorescence can be analyzed at first in organs where 
Notch2 has been reported to be active, such as in the hematopoietic system. As briefly 
mentioned earlier, Notch2 is highly expressed in splenic marginal zone B-cells (Kuroda et al., 
2003; Saito et al., 2003). Notch2 signaling could also be investigated during hair vibrissae 
follicle morphogenesis where it has been shown to be expressed in interfollicular dermis and 
suggested to play a role in dermal papilla formation (Favier et al., 2000). Many other tissues 
could be analyzed as it has been shown more recently that Notch2 is expressed during 
intrahepatic bile duct development when hepatoblasts differentiate into biliary epithelial cells 
(Tchorz et al., 2009). 
Figure 15. Scheme of the bidirectional 
TRE-DsRedExpressDR-CreERT vector. The 
backbone depicted is the pENTR1A vector 
(Invitrogen). 
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Moreover, the native microenvironment of Notch2-receiveing cells can be precisely 
observed by easy detection of red cells in tissue sections. Another application would be to sort 
the red cells from any given tissue at any time point in order to study their gene expression 
profile, by microarray analysis for example. Finally, this Notch2-specific reporter mouse will 
not only allow investigation of Notch2 activation under physiological conditions, but also in 
challenge situations such as during chemically-induced carcinogenesis. The role of Notch2 
signaling can thus be investigated in vivo during the process of tumor formation in the skin. 
This application can also be extended to other disease mouse models by crossing in the 
Notch2 reporter strains. One example is the ApcMin mutants (C57BL/6J-ApcMin/J; JAX 
stock#002020) which spontaneously develop intestinal adenomas (Su et al., 1992). 
Investigating Notch2 in the intestinal tract is of great interest since it is expressed in intestinal 
crypt cells (Sander and Powell, 2004) and, in addition, we have recently shown that it plays 
an important role in the gut self-renewal (Riccio et al., 2008). 
In conclusion, the Notch2 reporter strategy, comprising of the Notch2/tTA2 chimeric 
transgene and the TRE-DsRedExpressDR-ires-CreERT reporter, was shown to be efficient in 
vitro and will shortly be a useful tool for in vivo Notch2-mediated signaling studies. 
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Materials and Methods 
 
Histology, immunohistochemistry and immunofluorescence 
Skin samples were fixed with buffered 4% PFA at 4ºC overnight before embedding in 
paraffin. Skin sections 4μm thick were laid onto slides and dewaxed in three xylene baths 
before gradually hydrating by an alcohol gradient (3x 100%, 1x 96% and 1x 70%). 
Deparaffinized sections were then processed for haematoxylin and eosin staining or for 
immunoreactions. Most immunostainings were set up and performed by the histology core 
facility. All antibodies and their respective dilutions are listed in Table 1. Pictures of 
immunostained slides were taken with either one of the Leica microscopes DM5500 or 
DMI4000. 
H&E 
Skin sections were stained 5 minutes in haematoxylin, washed in water, dripped into an 
acidic alcohol bath and incubated for 10 minutes in water. Sections were stained in eosin for 
30 seconds and rinsed in water. Sections were gradually dehydrated by increasing the ethanol 
concentration of the baths (1x 70%, 1x 96%, 3x 100%) and dripped 3 times into xylene. 
Finally, slides were mounted with Eukitt Solution. 
BrdU and RhoV 
Proliferation of keratinocytes was analyzed in vivo by BrdU (5-Bromo-2’-deoxyuridine) 
incorporation. Mice were injected intraperitoneally 2 hours prior to sacrifice with 0.1mg/g of 
body weight. Back skin samples were isolated and processed as previously described.  
After dewaxing and rehydrating, skin sections were quenched, to remove endogenous 
peroxidases, for 10 minutes in 3% H2O2 in PBS (phosphate buffered saline). Antigen retrieval 
was performed on paraffin slides in tri-sodium citrate buffer (10mM tri-sodium and 10mM 
citric acid in H2O, pH6) at 95°C for 20 minutes. Sections were blocked in 1% BSA (bovine 
serum albumin) in PBS for 30 minutes before incubation with a rat anti-BrdU primary 
antibody overnight at 4°C. Sections were then incubated with a biotinylated donkey anti-rat 
for 40 minutes at room temperature (RT). Streptavidin-HRP treatment for 30 minutes at RT 
was followed by incubation with the enzyme substrate DAB in detection buffer (0.05M 
Tris/HCl pH7.6). The revelation was monitored under a microscope and stopped by washing 
in the detection buffer alone. Slides were washed in PBS and dipped in 1% BSA between 
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each step. Finally, the slides were counterstained with nuclear staining Mayer’s haematoxylin, 
dehydrated, and mounted with Eukitt Solution. 
This protocol was also applied to the immunostaining for RhoV (or Chp) by using an 
anti-RhoV (or anti-Chp) primary antibody. However, the results obtained by this method were 
inconclusive. 
Ki67 and myc-tag 
Slides for immunostaining of the proliferation marker Ki67 were processed as described 
for the BrdU staining with the exception of the blocking step and the antibodies used. 
Blocking of the sections was done in MOM (mouse on mouse) IgG blocking reagent for 60 
minutes. The primary antibody, a mouse anti-human Ki67, was incubated overnight at 4°C in 
MOM diluent. The secondary antibody, an anti-mouse IgG from Envision+ system, was 
incubated for 30 minutes at RT before DAB revelation as previously described. 
The myc-tag immunostaining differs from Ki67 by the antibodies tested. Anti-myc 
9E10.3 prepared in MOM diluent at 1/50 or 1/10 dilutions, whereas anti-myc 9E10 from the 
protein expression core facility was diluted 1/200 or 1/100. However, all dilutions resulted in 
high background. 
K14, K1 and loricrin 
K14, K1 and loricrin immunostainings were performed by two methods: enzymatic 
revelation or fluorescent-labeling. For the first method, the processing of the slides was 
performed as described for the BrdU immunostaining with rabbit anti-K14, rabbit anti-K1, or 
rabbit anti-loricrin as primary antibodies, followed by incubation with a goat anti-rabbit HRP 
as secondary antibody. DAB revelation was then used as previously described. 
Immunofluorescence: K14, K1, loricrin and Jagged2 
In the case of immunofluorescent detection, the secondary antibody was a donkey anti-
rabbit Alex568 while the primary antibodies were the same as for the enzymatic revelation 
described above. Nuclear staining was revealed by incubating the slides in DAPI (1/10.000) 
for 10 minutes at RT, and subsequently mounted with DABCO anti-bleaching solution. 
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GFP 
For direct visualization of GFP, samples were embedded in OCT compound and 
immediately frozen at -80°C. Skin sections 8m thick were cut at -20°C with a cryostat and 
DAPI stained for nuclear detection. Alternatively, immunostaining was also performed as 
previously described for BrdU with the exception of the blocking step and the antibodies. 
Blocking was done in 10% BSA and 0.5% Tween for 30 minutes. Rabbit anti-GFP was 
diluted 1/50 in 10% BSA for incubation overnight at 4°C. The secondary antibody, anti-rabbit 
Alexa568 in 10% BSA, was incubated for 2 hours at RT. Another test for the GFP 
immunostaining was performed with the MOM kit by following the Ki67 protocol. 
Antibody Company Catalog number Dilution 
Anti-BrdU Ab Serotec OBT0030 1/200 
Anti-digoxigenin-AP Roche 11093274910 1/2000 
Anti-GFP Invitrogen A11122 1/50 
Anti-Jagged2 Santa-Cruz sc-5604 1/100 
Anti-K1 Covance PRB-165P 1/500 
Anti-K14 Covance PRB-155P 1/1000 
Anti-Ki67 Novocastra NCL-L-KI67-MM1 1/100 
Anti-Loricrin Covance PRB-145P 1/1500 
anti-mouse Envision+ system 
labeled polymer-HRP 
DakoCytomation K4001 Ready to use 
Anti-myc (clone 9E10.3) 
Anti-myc 
Neomarker (LabVision) 
EPFL/PECF 
MS-139-P0 
9E10 
1/50 or 1/10 
1/200 or 1/100 
Anti-rabbit Alexa568 Invitrogen A21069 1/800 
Anti-rabbit HRP Brunschwig 111-035-003 1/100 
Anti-rat biotinylated Jackson ImmunoResearch 712-065-153 1/200 
Anti-RhoV (anti-Chp) Dr. Ami Aronheim - 1/50 or 1/10 
Streptavidin-HRP Amersham RPN-1231 1/100 
Table 1. List of antibodies with their manufacturer and catalog number. Dilution ratios used are also described. 
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Homologous recombination into a BAC 
BAC DNA isolation 
BAC DNA was purchased from the BACPAC Resources Center of the Children’s 
Hospital Oakland Research Institute (CHORI). The clones were grown in medium containing 
chloramphenicol (12.5g/ml) and DNA was isolated following the maxiprep protocol from 
the Qiagen large-construct kit. In order to extract good quality DNA, resuspension in TE was 
performed overnight. 
For smaller DNA preparations, rapid alkaline lysis minipreps were performed on small 
cultures (2ml) of BAC clones. The bacteria pellet was resuspended in 300l of a filter-
sterilized solution (15mM Tris pH8, 10mM EDTA, 100g/ml RNaseA) chilled at 4°C. 
Bacteria were lysed by addition of 300l of alkaline lysis buffer (0.2N NaOH, 1% SDS) and 
incubated for 5 minutes at RT. 300l of autoclaved, previously chilled 3M KOAc was then 
added, and the mix was incubated on ice for 5 minutes, which resulted in protein and E.coli 
DNA precipitation. After centrifugation at 10.000rpm at 4°C, the supernatant was transferred 
into 800l of ice cold isopropanol and left on ice for 5 minutes. The precipitated DNA pellet 
was washed with 70% ethanol, air-dried, and finally resuspended in 30 to 45 l of TE. 
Method n°1 using EL250 bacteria 
Firstly, the BAC was transformed into EL250 bacteria following a previously described 
protocol (kindly provided by Dr. Friedrich Beermann). Briefly, EL250 bacteria were grown at 
32°C until an OD600 of 0.5-0.8 was obtained. They were washed several times with sterile ice 
cold water before resuspending into 100l. The BAC DNA (50 to 200ng) was then 
electroporated (1.75kV, 25F, 200) using a chilled 1mm gap electroporation cuvette. The 
electroporated bacteria were immediately grown for 1 hour at 32°C in SOC medium and 
incubated on a chloramphenicol selective plate overnight at 32°C.  
The chimeric Notch2/tTA2 targeting vector was then electroporated into the EL250 
bacteria previously transformed with the BAC DNA by the following method. Cultures 
containing the BAC DNA were grown until an OD600 value of 0.5-0.8 had been obtained and 
the recombination machinery was activated by heating the bacterial culture at 42°C for 15 
minutes, before chilling on ice for 20 minutes. The electroporation was then performed as 
described for the BAC DNA, but this time the linearized targeting vector, without the 
 139 
backbone, was electroporated. Transformed bacteria were selected by agar plates containing 
both ampicillin and chloramphenicol. 
Method n°2 using the pDelsac shuttle vector 
The targeting vector cloned into the pDelsac backbone was transformed into 
EC100Dpir+ bacteria, which express the pir gene for replication of R6K origin-containing 
vectors. The shuttle DNA preparation and the BAC homologous recombination were 
performed as previously described (Sparwasser et al., 2004). 
In situ hybridization (ISH) 
RhoV probes were transcribed using the pCMV-SPORT6 plasmid (Table 3) which 
contains mouse RhoV cDNA flanked by two promoters, namely SP6 and T7. The sense probe 
was obtained by linearization with NotI and transcription by SP6 RNA polymerase. For the 
antisense probe the restriction enzyme used was EcoRI and transcription was performed by 
the T7 RNA polymerase (Fig.1).  
 
The linearized plasmid was purified by phenol-chloroform extraction. Briefly, 1/10 
volume of 3M NaAc pH5.2 was added to the DNA before addition of 200l of phenol and 
200l of chloroform. The mix was vortexed and centrifuged for 5min at maximum speed. The 
upper aqueous layer could then be cleaned from phenol traces by adding only chloroform and 
repeating the centrifugation. The DNA was then precipitated with 1ml ice cold 100% ethanol 
and left for at least 20min at -20°C. After 20min centrifugation, the pellet was washed with 
70% ethanol, air-dried, and resuspended in DEPC-treated water. 
Subsequently, 1g of the purified linearized plasmid was used for the labeling reaction. 
The probes were labeled with digoxigenin-UTP following the DIG RNA labeling mix 
Figure 1. Plasmid map of pCMV-SPORT6 
containing the RhoV cDNA sequence. Restriction 
enzymes used for linearization are underlined in 
blue. T7 and SP6 promoters for their respective 
RNA polymerases are depicted in yellow. 
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protocol. Once labeled, the probe can be stored at -80°C for up to a year. In situ hybridization 
was then performed on skin sections fixed overnight in buffered 4% PFA at 4°C and 
embedded in paraffin. Alternatively, skin isolated from newborn pups was fixed in Bouin’s 
fixative solution (30ml picric acid, 10ml 37% formamide, 4ml glacial acetic acid). Briefly, 
samples were fixed overnight at 4°C, washed several times with 1x PBS, washed several 
times in 70% ethanol, and then incubated in 70% ethanol overnight. Skin samples were then 
embedded in paraffin. 8m sections, either from 4% PFA or Bouin fixed paraffin blocks, 
were prepared no longer than 1 week before ISH to avoid RNA degradation of the sample. 
The hybridization was either performed by following a previously described protocol (kindly 
provided by Dr. Hans Clevers), or by an automated ISH instrument.  
For both methods, a pre-treatment of the slides by dewaxing three times in xylene, 
gradual re-hydration (ethanol 100%, 95%, 70% and 1x PBS) and soaking in 0.2N HCl for 15 
minutes was necessary. Pre-treated slides were then incubated with PBS buffered proteinase 
K (30g/ml) at 37°C for 10 minutes. The slides were post-fixed for 10min in 4% PFA then 
incubated for 5min in acetic anhydride solution (1.34% v/v tri-ethanolamine pH8, 0.6% v/v 
acetic anhydride). After two washes in 1x PBS and in 5x SSC (0.75M NaCl, 75mM Na-citrate 
pH7) sections were completely covered by pre-hybridization solution (50% formamide, 5x 
SSC pH4.5, 2% block solution, 5mM EDTA, 0.05% Chaps, 50g/ml heparin, 1g/ml yeast 
total RNA). The slides were kept in a humidified environment (5x SSC, 50% formamide) at 
70°C for at least 1 hour. The DIG-labeled probe was then added at a final concentration of 
1g/ml before incubation at 68-70°C for 12 to 72 hours. 
Post-hybridization were performed in 2x SSC, 50% formamide/2x SSC and TBST (1x 
TBS, 0.1% Tween), prior to immunological detection. The sections were then blocked for 30 
minutes with 0.5% blocking powder using 100l/slide. After subsequent addition of sheep 
anti-digoxigenin-AP (diluted 1/2000 – Table 1), the slides were incubated at 4°C overnight. 
Slides were then washed several times in TBST. Fresh NTMT solution (0.1M Tris pH 9.5, 
0.05M MgCl2, 0.1M NaCl, Tween 1%) was used to wash slides before revelation. NBT/BCIP 
solution was prepared by adding NBT and BCIP to NTMT at 4.5 and 7µl/ml, respectively. 
Slides were then wrapped in aluminum foil, incubated at 37°C, and monitored for revelation. 
The reaction was stopped by rinsing in PBS when the signal was strong enough. Finally, 
slides were mounted with PBS buffered 50% glycerol. 
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Alternatively, ISH was also performed with the automated system Discovery® XT from 
Ventana Medical Systems Inc. This instrument processes several slides rapidly by following a 
protocol set by the user. The amount of the probe added varied from 50ng to 100ng per slide. 
Mice 
Notch1lox/lox (Radtke et al., 1999), Jagged1lox/lox (Mancini et al., 2005), and RosaNIC 
(Murtaugh et al., 2003) mice were crossed with K14Cre transgenic mice (Indra et al., 2000). 
Controls were littermates which lacked Cre recombinase but carried the floxed alleles, or 
were homo- and heterozygous for the RosaNIC transgene. The Jagged2 floxed mice we 
generated were first crossed with Flpe+ deleter mice (Rodriguez et al., 2000), then with 
MxCre (Kuhn et al., 1995), or K14Cre and Jagged1lox/lox mice. 
Genotyping of the mice was done by PCR on genomic DNA extracted from about 5mm 
of tail. Digestion was carried out at 56°C with maximum shaking in a buffer containing non-
ionic detergents (50mM KCl, 10mM Tris-HCl pH8.3, 2.5mM MgCl2, 0.1mg/ml gelatin, 
0.45% v/v Nonidet P40, 0.45% v/v Tween 20) and proteinase K. After 2 hours the digestion 
was heat-inactivated for 10 min at 99°C. Standard PCR conditions were used: 30 seconds at 
95°C before annealing for 30 seconds at a temperature specific for the primer pair, then an 
elongation step of 30 seconds (1min per kb) at 72°C, and this cycle was repeated 30 times. 
Primer sequences for each gene can be found in Table 2. 
Gene Primers’ sequences [5’ to 3’] Annealing 
temperature [°C] 
Band sizes 
[bp] 
-actin TGG GTC AGA AGG ACT CCT ATG 
CAG GCA GCT CAT AGC TCT TCT 
60 591 wt 
Cre CTA GAG CCT GTT TTG CAC GTT C 
GTT CGC AAG AAC CTG ATG GAC A 
60 339 Tg 
eGFP AAG TTC ATC TGC ACC ACC G 
TCC TTG AAG AAG ATG GTG CG 
60 173 Tg 
FLPe CTT TAG CGC AAG GGG TAG GAT 
CAA CTC CGT TAG GCC CTT CA 
60 200 Tg 
 
Jagged1 GCA AGT CTG TCT GCT TTC ATC 
AGG TTG GCC ACC TCT AAA TC 
56 317 lox 
267 wt 
Jagged2 GCT CCA AAT CGC TAC CTG AG 
GTC CCC AAG ACC AAG TAC CA 
60 392 lox 
200 wt 
Notch1 CTG ACT TAG TAG GGG GAA AAC 
AGT GGT CCA GGG TGT GAG TGT 
64 350 lox 
300 wt 
RhoV CGC CTG GAG AAG AAA CTG AA 
ACA CCG GCC TTA TTC CAA G 
60 612 Tg 
RosaNeo AAA GTC GCT CTG AGT TGT TAT 
GCG AAG AGT TTG TCC TCA ACC 
GGA GCG GGA GAA ATG GAT ATG 
60 600 wt 
200 neo 
Table 2. Primer sequences for the PCR reactions. The annealing temperature and the product sizes are noted. 
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Plasmids 
Plasmids used for the generation of the various transgenic mice were kindly provided by 
several sources: the human keratin14 promoter by Dr. Joerg Huelsken, the involucrin 
promoter by Dr. Fiona Watt, and the MHKA1 promoter by Dr. Raphael Kopan. The Jagged2 
targeting vector was generated by the company Nucléis (Lyon, France; bankruptcy in 2006).  
Various plasmids were used for transfection assays, which are described in the 
corresponding paragraphs, and are listed in Table 3. 
Plasmid Source/Company Catalog number 
12RBPJ-luciferase Dr. Freddy Radtke laboratory - 
pAdEasy-1 from AdEasy™ adenoviral vector system Stratagene 240009 
PCMV-Dll1 Dr. Freddy Radtke laboratory - 
pCMV-Notch2 full length Dr. Freddy Radtke laboratory - 
pCMV-Notch1IC Doorbar et al., 2000 - 
pCMV-SPORT6 from SuperScript® plasmid system 
with Gateway® technology 
Invitrogen 19625-011 
pCMV-Stop-eGFP Dr. Friedrich Beermann - 
pGL4.26[luc2/minP/Hygro] Promega E8441 
pGL4.74 [hRluc/TK] Promega E6921 
pRL-CMV-Renilla-luciferase Promega E2261 
pUHD20-1 Dr. Hermann Bujard - 
Table 3. List of plasmids and their respective source. 
Primary keratinocytes 
Primary keratinocytes were prepared from 2-3 day-old Notch1lox/lox mice as previously 
described (Rangarajan et al., 2001). Briefly, newborn mice were decapitated, limb and tails 
were amputated and a longitudinal incision was performed from tail to snout. The skin was 
peeled off the body using forceps and rinsed in 70% ethanol, then in PBS. Each skin was 
carefully deposited with the epidermis facing upwards on the surface of a 0.25% trypsin 
solution and left at 4°C for at least 15 hours. The epidermis was then separated from the 
dermis with forceps, minced and filtered through a sterile 70m nylon cell strainer.  
The culture dishes were coated with 2ml of a solution containing 1ml BSA, 1mg 
fibronectin and 1ml purified collagen (3mg/ml) added to 95ml of DMEM without FCS, and 
left at 37°C for at least 30 minutes before plating the cells. Primary keratinocytes were 
cultured in a minimum essential medium (MEM Eagle with Earle’s BSS calcium-free) 
containing 8% fetal bovine serum (FBS) pretreated with Chelex resin (20g for 500ml) for 
calcium removal. The MEM/8%FBS medium contained a Ca2+ concentration of 0.05mM, 
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which was required to maintain primary keratinocytes in an undifferentiated state. To induce 
differentiation, Ca2+ concentration in the medium was increased to 2mM. The growth medium 
was also supplemented with antibiotics (100 units/ml penicillin, 0.1 mg/ml streptomycin). The 
culture medium was replaced every 2 days or earlier if necessary.  
RT-PCR 
Keratinocytes were scraped from the frozen skin of transgenic and littermate control 
mice and total RNA was isolated using TRIZOL reagent. The working area was previously 
cleaned with RNase AWAY in order to work in an RNase-free environment before handling 
RNA samples. RNA was quantified using a ND-100 NanoDrop spectrophotometer from 
NanoDrop Technologies. 1g of total RNA was reverse-transcribed using the QuantiTect 
reverse transcription kit. For each sample, a reaction with and without reverse transcriptase 
was performed. The resulting cDNA was used for PCRs for RhoV, eGFP and -actin as 
control (primers in Table 2). 
Real-time quantitative RT-PCR 
Primary keratinocytes in culture were washed once with PBS before total RNA was 
isolated following the TRIZOL reagent protocol. The quality of the RNA was tested on a 1% 
TAE (Tris-acetate-EDTA) agarose gel where two sharp bands should appear. The higher 28S 
band should be more intense than the lower 18S band. Moreover, the small 5S band was also 
visible in a few samples. 
For one reverse transcription reaction a mix of 1l of the reverse transcriptase M-MLV, 
4l of the enzyme’s buffer, 2l DTT (0.1M), 1l RNase inhibitor (10U), 1l oligodT (10M) 
and 1l dNTPs (10M) was prepared. Meanwhile, RNA was heated at 65°C for 10 minutes 
and later left on ice for another 5 minutes. The mix was added to the RNA before incubation 
for 50 minutes at 37°C. Once reverse transcription had occurred the reaction was deactivated 
by heating at 95°C for 2 minutes. The resulting cDNA was stored at -20°C until usage. 
The real-time RT-PCR was carried out in optical 96-well fast thermal cycler plates with 
barcodes. For each gene of interest 1l of its specific TaqMan® probe was mixed with 10l of 
TaqMan® Universal PCR master mix and dispensed into the corresponding wells. The cDNA 
was diluted with RNase-free water to a final concentration of 10ng/l, and 9l was added to 
each well. The plate was processed by the Applied Biosystems’ 7500 System. The data were 
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normalized to the housekeeping gene GAPDH and the final fold changes included three 
independent experiments for each gene tested (Table 4). 
Gene name Gene ID Applied Biosystems Number 
BMP receptor 1A 12166 Mm00477650_m1 
Casein kinase 1(CKI) 93687 Mm00521599_m1 
Casein kinase 1(CKI) 27373 Mm00443344_m1 
CyclinD1 12443 Mm00432358_g1 
DEPP 213393 Mm00524329_g1 
Frizzled6 14368 Mm00433383_m1 
Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) 14433 Mm99999915_g1 
Inhibitor of DNA binding 1 (Id1) 15901 Mm00775963_g1 
Mitogen activated protein kinase kinase 1 (MEK1) 26395 Mm00435940_m1 
Prickle2 243548 Mm01182432_m1 
Prostaglandin-endoperoxide synthase 1 (Ptgs1) 19224 Mm00477214_m1 
Ras-related C3 botulinum substrate 1 (Rac1) 19353 Mm01201654_g1 
RhoV 228543 Mm00523731_g1 
SMAD specific E3 ubiquitin protein ligase 2 (Smurf2) 66313 Mm01242752_g1 
Table 4. List of genes and their respective probe numbers from Applied Biosystems. 
Southern blot analysis 
DNA digestion and gel electrophoresis 
A small piece of mouse tail or scraped epidermis from frozen skin was digested 
overnight at 56°C in 400l of proteinase K solution (0.5% SDS, 0.1M NaCl, 50mM Tris pH8, 
7.5mM EDTA and 0.5mg/ml proteinase K). DNA was extracted with 100l of 8M KOAc and 
600l chloroform. After centrifugation, the DNA-containing upper phase was transferred to a 
new tube and mixed with 500l of 100% ethanol. After centrifugation, the DNA pellet was 
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washed with 70% ethanol and resuspended overnight at 37°C in 50l of TE (10mM Tris, 
1mM EDTA, pH8). 
8-10g of DNA was digested overnight with restriction enzymes EcoRI and HindIII for 
Jagged2, and with NcoI for the RhoV transgenic mice. Digested DNA was loaded onto a 
0.8% TAE agarose gel and run overnight at 50 Volts. The gel was then depurinated for 20 
minutes in 0.2N HCl, denatured for 2x 20 minutes in 1.5M NaCl/0.5N NaOH, neutralized 2x 
20 minutes in 1M ammonium acetate/ 20mM NaOH, each time with gentle rocking at RT, 
and was finally soaked 5 minutes in 20x SSC (3M NaCl, 0.3M Na-citrate). The nylon 
membrane was first soaked in water and then in 20x SSC before assembling with the gel on a 
vacuum blotter at 50mbar for 4 hours. The DNA transferred onto the membrane was UV 
cross-linked at 1.200J. 
Probe labeling 
While blotting, the probe was prepared with the High prime DNA labeling kit. Between 
50 and 75ng of template DNA in 8l final volume was denatured for 5 minutes in a heat block 
at 99°C and chilled on ice. After addition of 4l of High prime reaction mixture, 5l of dNTP 
mix (dATP, dGTP, dTTP) and 7l of radioactively labeled (32P) dCTP (3.000Ci/mmol), the 
reaction solution was incubated for 2 hours at 37°C. The probe was then isolated and 
quantified before boiling for 5 minutes. The membrane was incubated in pre-hybridization 
solution (1.5x SSPE (225mM NaCl, 15mM NaH2PO4, 1mM EDTA), 10% PEG, 7% SDS and 
10g/ml salmon sperm DNA) for at least 15 minutes before addition of the probe (about 0.5 
x106cpm per ml of hybridization solution). 
Membrane hybridization 
The membrane was incubated overnight at 65°C, then rinsed in 2x SSC, washed for 20 
minutes in 2x SSC/0.1% SDS (pre-heated at 65°C) and washed another 20 minutes in 0.2x 
SSC/0.1% SDS (also pre-heated at 65°C). The membrane was exposed either on a 
phosphorimager for 5 hours to overnight, or on an X-ray film at –80°C for a few days, 
depending on the intensity of the signal. Copy number was quantified using the 
phosphorimager and the image analyzer software Aida. 
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Thymocytes and dendritic cells 
Adult Jagged2lox/lox MxCre and littermate control (Jagged2lox/lox) mice received 5 
intraperitoneal injections of 2µg/g body weight pI-pC at 2-day intervals. Mice were sacrificed 
2 weeks after the last injection, and RNA was prepared from single cell suspension of sorted 
DN thymocytes. Genomic DNA was isolated from total bone marrow (BM) cells and from 
spleens. mRNA levels of Jagged2 in sorted double-negative (DN) thymocytes cells was 
assessed by RT-PCR and the deletion efficiency of whole BM from control and Jagged2lox/lox 
MxCre was assessed by deletion PCR. BM-derived dendritic cells (DC) were cultured and 
subsequently lysed for protein analysis by Western blot. 
Preparation of sorted DN (DN3 and DN4) thymocytes 
DN thymocytes were prepared from Jagged2lox/lox MxCre and littermate control mice as 
previously described (Wolfer et al., 2001). Briefly, total thymocytes were resuspended in 
Hanks Balanced salt solution (HBSS) supplemented with newborn calf serum (2% NCS) and 
25mM Hepes (staining medium) at 10x106 cells/ml and incubated on ice with antibodies 
directed against CD8 (clone 31M) and CD4 (clone RL172.4). To kill the targeted cells, rabbit 
complement and DNaseI 0.1 % were added and incubated at 37 °C for 1 hour. A 
Lympholyte®-M gradient was performed to eliminate dead cells and debris. DN-enriched 
thymocytes were stained with the indicated antibody cocktail (see table below) and sorted for 
Lin-CD44-CD25+ (DN3) and CD44-CD25- (DN4) fraction by gating out the Lin- 
CD44+CD117- cells using a BD FACSAria™ II cell sorter.  
Antibody Conjugation 
Lin+ cocktail:  CD4, CD8, B220, CD19, CD11b, Gr1 PE-Cy7 
CD44 PE 
CD25 APC-Cy7 
CD117 (c-kit receptor) APC 
Purity of the cell fractions was greater than 98%. The DN3 and DN4 fraction was 
pooled from an individual sample and per sample 1-2x106 cells were sorted. RNA was 
extracted using TRIZOL reagent following standard protocol and RT-PCR for Jagged2 was 
performed. 
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Culture of dendritic cells 
Single cell suspensions of BM cells were isolated and lineage depleted by magnetic cell 
sorting. Bone marrow cells (B6.CD45.1) expressing markers of the myeloid (GR-1, Mac-1), 
lymphoid (B220, CD4, CD8, and CD3), and erythroid (TER-119) lineages were removed 
using sheep anti-rat IgG magnetic beads from Dynabeads® and purified rat antibodies directed 
against the lineage markers. 
The lineage negative fraction was collected, counted and seeded onto 10cm culture 
dishes at a density of 5x106 cells per dish in complete Iscoves medium. Iscoves medium was 
supplemented with gentamicin (100ng/ml), 25mM HEPES, non-essential amino acids, and the 
growth factors SCF (100ng/ml; SCF was removed from the culture medium after 48 hrs), 
GM-CSF (20ng/ml) and IL-4 (10ng/ml). To generate BM-derived DCs, the cultures were 
maintained for 10 days and the supplemented culture medium was exchanged every 3 days by 
gently aspirating 75% of the culture medium and adding back the same amount. On day 10 of 
the culture, DCs were easily observed morphologically and harvested. Cells were further 
processed for whole protein extraction. 
Jurkat cells 
As a control for the Western blot analysis on protein extracts from the cultured DCs, 
Jurkat cells (an immortalized T cell line) were cultured in RPMI/2-mercaptoethanol before 
stimulation of the cells for 1 hour with GM-CSF (25ng/ml). Stimulated and non-stimulated 
cells were harvested 48 hours later for protein lysis and Jag2 Western blot analysis. 
Transient transfection and luciferase assays 
All transient transfections were performed with JetPEI transfection reagent following 
the specific protocol, and in duplicates for each experiment. Transfected cells were lysed 24 
to 48 hours after transfection, and firefly and renilla luciferase values were measured using 
the Dual-Luciferase reporter assay system. Normalized firefly luciferase values were reported 
on the graphs as RLU (relative luciferase units). All studies are representative of at least three 
independent experiments. 
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Cell lines 
 The cell line used for transfection assays was a cervical carcinoma (Hela) cultured at 
37°C with 5% CO2 in 10% FCS/DMEM medium. Another cell line cultured under the same 
conditions was abandoned because of the high background results during the investigations: 
the 293T cells, or human embryonic kidney (HEK) 293 cells containing the SV40 large T-
antigen. 
Notch2/tTA2 assays 
For the chimeric Notch2/tTA2 tests, Hela cells were co-transfected with 1g of 
Notch2/tTA2 plasmid and 1g of 12RBPJ-Luc, together with 200ng of pRL-CMV-Renilla 
luciferase plasmid as an internal control. Transfection controls were cells co-transfected with 
1g 12RBPJ-Luc and 1g pCMV-Notch1IC, or pCMV-Notch2 full length. Inhibition of 
Notch signaling was induced by treating the cells with 1mM -secretase inhibitor DAPT, 
directly added to the medium, or the equivalent amount of DMSO in control. To investigate 
the Tet-off system, 2g/ml of doxycycline, or the equivalent amount of H2O in control was 
added to the culture medium. 
For the assays on the proof of principle of the Notch2/tTA2 transgene, Hela cells were 
co-transfected with 1g of the chimeric plasmid and 1g of the secondary reporter plasmid, 
such as TRE-DsRedExpressDR. The transfected cells were subsequently co-cultured with 
Hela cells transfected with 1g of pCMV-Dll1.  
In order to test the Cre recombinase efficiency, Hela cells were co-transfected with 1g 
TRE-DsRedExpressDR-ires-CreERT together with 1g pUHD20-1, which expressed tTA2, 
and 1.3g pCMV-Stop-eGFP. 4OH-tamoxifen was added to the culture medium at a final 
concentration of 2M, and the equivalent amount in l of ethanol was added to control cells. 
Fluorescence was monitored 24 to 48 hours later by using the Leica microscope DMI4000. 
RhoV promoter analysis 
For the RhoV promoter studies, Hela cells were co-transfected with 1g of one of the 
generated pGL4.26 plasmids containing sequences of potential RBPJ binding sites 
(RhoVprom or RhoVint2), 1g pCMV-Notch1IC, and 200ng of internal control pGL4.74 
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renilla luciferase plasmid. In order to evaluate the transfection efficiency, cells were co-
transfected with 1g 12RBPJ-Luc and 1g pCMV-Notch1IC. 
Viruses 
Generation of recombinant adenoviruses was performed by following the pAdEasy1 
adenoviral vector system (He et al., 1998). Adeno-NIC (gift from Dr. Paolo Dotto) was 
generated by inserting the corresponding cDNA for the constitutively active form of Notch1, 
i.e. amino acids 1852-2125 of human Notch1 (Capobianco et al., 1997) into BamHI-XhoI 
sites of plasmid pAdTrack-CMV and then recombined into the adenoviral vector pAdEasy1 in 
bacteria. The recombinant adenovirus expressing the Cre-recombinase was previously 
generated by the same method after inserting the corresponding cDNA into pAdTrack-PJK 
vector. Both adenoviruses also express GFP to track infection efficiency.  
Each pAd-Track-CMV plasmid was then transfected into 293 cells that were 80% 
confluent. Once the cells started detaching, and before viral-induced lysis, the infected 293 
cells were washed with PBS before recovering them by centrifugation. Viruses were extracted 
by 4 rounds of freeze/thaw using dry ice in methanol and a 37°C water bath. After 
centrifugation, the supernatant containing the virus was titrated and stored at –20°C. Infection 
efficiency was monitored by an estimation of the amount of GFP-expressing 293 cells after 
infection with various quantities of the viral supernatant. 
Once the optimal conditions were determined, Notch1lox/lox primary keratinocytes were 
infected after 24 hours in culture with either adeno-NIC or adeno-Cre in parallel with control 
adeno-GFP viruses. In the gain of function experiment, medium was removed and infected 
cells were scraped and washed with PBS after 12 hours of infection. In the loss of function 
conditions, keratinocytes were scraped after 24 hours of infection or induced to differentiate 
during an additional 24 hours by increasing the medium’s calcium concentration to 2mM. 
Subsequently in all settings, RNA was isolated by TRIZOL extraction for real-time RT-PCR 
analysis. 
Western blot analysis 
Protein extraction 
Whole cell lysate of scraped epidermis or of scraped cells was obtained by washing 
with PBS and incubating on ice for 10 minutes in about 40l of RIPA lysis buffer (1% 
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Nonidet P40, 150mM NaCl, 80mM Tris/HCl pH 7.5, 2mM EDTA, 0.1% SDS, 1% Na 
deoxycholate) containing protease inhibitors (1 tablet of Complete EDTA-free inhibitor 
cocktail in 500l). Supernatant was extracted after 15 minutes centrifugation at maximum 
speed at 4°C and protein concentration was determined by Bradford protein assay. 
Proteins from hair samples were extracted as previously described (Nakamura et al., 
2002). At first, hairs plucked from the back pelage of Tg and control mice were washed with 
ethanol. Then, lipids were removed by adding chloroform/methanol in a 2:1 (v:v) volume 
enough to cover the hairs, and left shaking for 24 hours. Delipidized hair samples were 
weighed and the Shindai mix was added in a ratio of 5ml for 20mg of hair. The Shindai mix 
consists of 25mM Tris/HCl pH8.5, 2.6M thiourea, 5M urea, and 5% 2-mercaptoethanol. The 
samples were incubated on a shaking heating block at 50°C for 2 days. The samples were then 
centrifuged at maximum speed for 20 minutes at RT and the supernatant extracted. Finally, 
protein concentration was determined by Bradford protein assay. 
Gel electrophoresis and protein transfer 
A solution of 2x loading dye (150mM Tris/HCl pH 6.8, 1.2% SDS, 30% glycerol, 15% 
-mercaptoethanol, and 1.8mg per 100ml bromophenol blue) was added to 50g of protein, 
which were subsequently boiled for 5 minutes. The linearized proteins were loaded onto a 
SDS-polyacrylamide gel of 8 to 10%, depending on expected protein size. Electrophoresis 
was performed at 60-70mA without exceeding 180V (SDS-Page running buffer 24.8mM Tris, 
192mM glycine, 0.1% SDS). Subsequently, proteins were transferred onto a nitrocellulose 
membrane for 1 hour at 400mA and 100V maximum voltage (the same solution as the 
running buffer, but with 20% methanol). 
Protein hybridization 
The membrane containing the proteins was blocked with 5% milk in TBST (5mM 
Tris/HCl pH 7.5, 15mM NaCl, 0.1% Tween 20) for 1 hour at RT before adding the primary 
antibody for hybridization overnight at 4°C. After several washes with TBST, the secondary 
antibody was added in 5% milk TBST and incubated for 1 hour at RT. Proteins detected by 
the antibody were revealed by enhanced chemiluminescence using an ECL detection kit. 
Primary and secondary antibodies, as well as their respective dilution ratios, are listed in 
Table 5. 
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Antibody Company Catalog number Dilution 
Anti-GFP (rabbit) Invitrogen A11122 1/3.000 
Anti-Jagged2 (rabbit) Santa-Cruz sc-5604 1/100 
Anti-myc (mouse) 
Anti-myc (mouse) 
EPFL/PECF 
Neomarker (LabVision) 
9E10 
MS-139-P0 
1/5.000 
1/100 
Anti-RhoV (anti-Chp; rabbit ) Dr. Ami Aronheim - 1/1.000 
Anti-tubulin (mouse) Sigma T5168 1/3.000 
ECL Anti-mouse HRP Amersham NA931 1/5.000 
ECL Anti-rabbit HRP Amersham NA934 1/5.000 
Table 5. List of antibodies for Western immunoblot analysis and their respective dilution ratios. 
Wound healing assay 
Mice were anaesthetized by intraperitoneal injection of 100l ketamine (10g/l)/xyline 
(8g/l) solution or by isoflurane (induction 5% and maintenance 1-2%). Their back skin was 
shaved and washed with ethanol. Full-thickness excisional wounds of 5mm in diameter were 
made on the back of both the transgenic and the littermate control mice. Wounds were left 
uncovered and were regularly monitored. Mice were injected with buprenorphine twice a day 
for 2 or 3 days if pain was observed. The complete wounds, including approximately 2mm of 
the epithelial margins, were excised and fixed in 4% PFA before embedding in paraffin wax. 
All surgical procedures were according to Swiss guidelines and authorized by the 
veterinarian authorities of the canton de Vaud. 
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Products & Kits (non-exhaustive list) 
 
Product Company 
Catalog 
number 
[32P]dCTP 3000Ci/mmol Hartmann SRP-205 
2-mercaptoethanol Invitrogen 31350010 
70m nylon cell strainer BD Falcon 352350 
Accuprime Pfx DNA polymerase Invitrogen 12344-024 
BCIP (25mg/ml in 50% dimethylformamide) 
Chemie Brunschwig 
Biotium 
10001 
Bradford protein assay Bio-Rad 500-0006 
BrdU (5-Bromo-2’-deoxyuridine) Sigma 858811 
Chelex resin BioRad 142-2842 
Collagen Vitrogen FXP-019 
Complete EDTA-free inhibitor cocktail Roche 11836170001 
DAB (3,3’-diaminobenzidine) Sigma D-5905 
DABCO (1,4-diazabicyclo[2.2.2]octane). Sigma D-2522 
DAPI (4,6-diamino-2-phenylindole) Sigma D-9542 
DAPT (N-[N-(3,5-Difluorophenacetyl-L-alanyl)]-
S-phenylglycine t-Butyl Ester) 
Calbiochem 565770 
DEPC (diethyl pyrocarbonate) Axon Applichem A0881.0100 
DIG RNA labeling mix Roche 
11 277 073 
910 
DMEM Invitrogen 31906-021 
DMSO (dimethyl sulfoxide) Sigma D-2650 
DNaseI Roche 104159 
Doxycycline hyclate Sigma-Aldrich/Fluka D9891 
Dual-Luciferase reporter assay Promega E1910 
Dynabeads® M-450 sheep anti-rat IgG Dynal Biotech 110.07 
EC100DTM pir+ electrocompetent E.coli 
Epicentre 
(Connectorate) 
ECP09500 
ECL Western blotting detection reagents 
Amersham/GE 
Healthcare 
RPN2106 
Eukitt solution 
Fluka/O. Kindler 
GmbH & Co 
03989 
Fetal bovine serum 
Gibco (lot 
#41G6550K) 
10270-106 
Fibronectin Calbiochem 341635 
Gentamicin Invitrogen 15710049 
GM-CSF (granulocyte-macrophage colony 
stimulating factor) 
Peprotech 315-03 
HBSS (Hank’s balanced salt solution) Invitrogen 14175129 
Hepes Bioconcept 5-31F00-H 
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Product Company 
Catalog 
number 
High prime DNA labeling kit Roche 1158559200 
Hybond N+ membrane 
Amersham/GE 
Healthcare 
RPN303S 
Hybond-ECL nitrocellulose membrane Amersham RPN303D 
IL-4 (interleukin 4) Peprotech 214-14 
Iscoves modified Dulbeccos medium (IMDM) Invitrogen 12440046 
JetPEI Polyplus transfection 101-10 
Large-construct kit Qiagen 12462 
Lympholyte®-M Bioconcept CL5035 
MEM Eagle with Earle’s BSS  
calcium free 
Invitrogen 041-94775M 
M-MLV reverse transcriptase Invitrogen 28025-013 
MOM kit Vector Lab 
BMK-2202 
 
NBT (75mg/ml in 70% dimethylformamide) 
Chemie Brunschwig 
Eurobio 
GAUNTBT00 
Optical 96-well Fast Thermal Cycler Plate with 
Barcode 
Applied Biosystems 4346906 
Penicillin/Streptomycin solution Invitrogen 15070-063 
PFA (paraformaldehyde) VWR (Merck) 1.04005.1000 
pI-pC InvivoGen tlrl-pic-5 
Proteinase K Roche 03115879001 
QIAquick nucleotide removal kit Qiagen 23306 
QuantiTect reverse transcription kit Qiagen 205311 
Rabbit complement  
Saxon Europe Ltd, 
HD supplies 
RC1 
RNase AWAY Catalys 7002 
RNase inhibitor (10U) RNAguard Amersham 27-0815-01 
RPMI 1640 medium Invitrogen 61870044 
SCF (stem cell factor) Peprotech 250-03 
SOC medium Invitrogen 15544034 
Tamoxifen Sigma T5648-1G 
TaqMan® Universal PCR Master Mix,  
No AmpErase® UNG 
Applied Biosystems 4324018 
TRIZOL reagent Invitrogen 15596-026 
Trypsin 0.25% Invitrogen 25050-014 
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Abbreviations 
 
AD Atopic dermatitis 
AGS Alagille syndrome 
Amp Ampicillin 
BAC Bacterial artificial chromosome 
BCC Basal cell carcinoma 
BM Bone marrow 
BMP Bone morphogenic protein 
bp Base pair 
Cdnk1a Cyclin-dependent kinase inhibitor 1a 
Chlor Chloramphenicol 
Chp Cdc42 homolog protein 
CMV Cytomegalovirus 
c-Myc c-Myelocytomatosis oncogene 
CNS Central nervous system 
cpm Counts per minute 
Cre Cyclic recombinase 
CSL CBF1/Su(H)/LAG1 
DC Dendritic cell 
DEPP Decidual protein induced by progesterone 
Dll1, 3, 4 Delta-like 1, 3, 4 
DN Double negative 
DP Dermal papilla 
DSL Delta Serrate Lag 
DsRed Discosoma-derived red fluorescent protein 
DTA Diphtheria toxin A-chain 
E Embryonic day 
ECM Extracellular matrix 
EGF Epidermal growth factor 
EGFP or eGFP Enhanced green fluorescent protein 
EPU Epidermal proliferative unit 
ERT Mutated ligand-binding domain of human estrogen receptor 
ES Embryonic stem cell 
F0 Founder line 
FACS Fluorescence activated cell sort 
FGF Fibroblast growth factor 
FIG Fasting-induced gene 
FRT FLP1 recombinase target 
FSEG Fat-specific expressed gene 
GAP GTPase-activating protein 
GEF Guanine nucleotide exchange factor 
GFP Green fluorescent protein 
H&E Haematoxylin/eosin 
HairKRNB MHKA1-driven RhoV dominant negative 
Hes Hairy/Enhancer of Split 
HF Hair follicle 
Hh Hedgehog 
 158 
HKRAB Human keratin14-driven RhoV dominant active 
Hprt Hypoxanthine phosphoribosyltransferase 
HRP Horse radish peroxidase 
HS Hair shaft 
IFE Interfollicular epidermis 
IFN or  Interferon- or - 
Ig Immunoglobulin 
IL1 Interleukin-1 
IRES Internal ribosome entry site 
IRNB Involucrin-driven RhoV dominant negative 
IRS Inner root sheath 
ISH In situ hybridization 
Jag1, 2 Jagged1, 2 
JNK c-Jun-N-terminal kinase 
K Keratin 
kb Kilo base 
KGF Keratinocyte growth factor 
Klf4 Krüppel-like factor 4 
LEF1 Lymphoid enhancer factor 1 
Lgr5 Leucine-rich G protein-coupled receptor 5 
LoxP Locus of crossing-over from phage P1 
LRC Label-retaining cell 
Lrig1 Immunoglobulin-like domain protein 1 
MAML Mastermind-like 
MHKA1 Mouse hair keratin A1 
MNNL Conserved N terminus of Notch ligands 
MOM Mouse on mouse 
mTORC2 Mammalian target of rapamycin complex 2 
Mx1 Myxovirus influenza resistance 1 
MZB Marginal zone B cell 
N1IP Notch1 intramembrane proteolysis 
NAS Notch activity sensor mouse 
NCS Newborn calf serum 
NFAT Nuclear factors of activated T cells 
NIC or NICD Notch intracellular domain 
OCT Optimal cutting temperature 
OD Optical density 
ORS Outer root sheath 
P Postnatal day 
Pak1, 2, 3 p21-activated kinase 1, 2, 3 
PCP Planar cell polarity 
PCR Polymerase chain reaction 
pI-pC Polyinosinic-polycytidylic acid (Toll-like receptor 3 ligand) 
Psen1 Presenilin-1 
qRT-PCR Quantitative reverse transcription PCR 
Rac1 Ras-related C3 botulinum substrate 1 
RAM domain Regulation of amino-acid metabolism domain 
Ras Retrovirus-associated DNA sequences 
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Rho Ras homologue 
RLU Relative luciferase unit 
rpm Revolutions per minute 
RT Room temperature 
SC Stem cell 
SCC Squamous cell carcinoma 
Shh Sonic hedgehog 
TA Transient-amplifying cell 
TACE TNF converting enzyme 
TAD Transactivating domain 
T-ALL T cell acute lymphoblastic leukemia 
TAM 4OH-tamoxifen 
TAN1 Translocation-associated Notch homologue 1 
TCF1 T cell-specific transcription factor 1 
TCR T cell receptor 
tetO Tet operator 
TetR Tetracycline repressor 
Tg Transgenic 
TGF or  Transforming growth factor- or - 
TM Transmembrane domain 
TNF Tumor necrosis factor- 
TNR Transgenic Notch reporter mouse 
TRE Tet response element 
tTA2 Tetracycline-controlled transactivator 2 
UI Upper isthmus 
UV Ultraviolet 
VP16 Virus protein 16 
Wrch Wnt-regulated Cdc42 homolog 
wt Wild-type 
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